<!DOCTYPE html>
<html lang="en">
<head>
    <title>Network-based prediction of drug combinations | Nature Communications</title>
    
        
<link rel="preload" href=/static/fonts/Lora-Regular.8861b0072d.woff2 as="font" type="font/woff2" crossorigin>


<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
<meta name="viewport" content="width=device-width,initial-scale=1.0,maximum-scale=2.5,user-scalable=yes"/>


<script>
    (function(e){var t=e.documentElement,n=e.implementation;t.className='js';if(n&&n.hasFeature('http://www.w3.org/TR/SVG11/feature#Image','1.1')){t.className+=' svg'}})(document)
</script>
<script>window.abTestSharedArticleRenderer = true;</script>


    <script id="mosaic-loader">
        (function (win, doc, bundles) {
            if (!doc.querySelector) { return; }

            var script = function(attrs) {
                var s = doc.createElement('script');
                for (var attr in attrs) {
                    if (attrs.hasOwnProperty(attr)) {
                        s[attr] = attrs[attr];
                    }
                }
                return s;
            };

            var insertAfter = function(node, dest) {
                dest.parentNode.insertBefore(node, dest.nextSibling);
            };

            win.Component = win.Component || {};
            win.Component.Loader = {
                init: function() {
                    this.main = script({src: '/static/js/nature.3cfebae16c.js', id: 'mosaic', defer: true});
                    insertAfter(this.main, doc.getElementById('mosaic-loader'));
                },
                loadPageBundles: function() {
                    var lastId = this.main.id;
                    for (var i = 0; bundles[i]; ++i) {
                        if (doc.querySelector(bundles[i].match)) {
                            insertAfter(script({src: bundles[i].src, id: 'bundle' + i, defer: true}), doc.getElementById(lastId));
                            lastId = 'bundle' + i;
                        }
                    }
                }
            };
            win.Component.Loader.init();

        })(window, document, [
            {match: 'div[data-pan-container]', src: '/static/js/pan-zoom.3e0716c442.js'},
            {match: 'math,span.mathjax-tex', src: '/static/js/math.f961232688.js'},
            {match: 'div.c-article-metrics__wrapper', src: '/static/js/graphing.09371cfbe8.js'},
            {match: 'body', src: 'https://verify.nature.com/verify/nature.min.js'}
        ]);
    </script>



    <link rel="apple-touch-icon" sizes="114x114" href="/static/images/favicons/nature/favicon-114x114.1431047068.png"/>
    <link rel="apple-touch-icon" sizes="144x144" href="/static/images/favicons/nature/favicon-144x144.3e61d1f755.png"/>
    <link rel="apple-touch-icon" sizes="180x180" href="/static/images/favicons/nature/favicon-180x180.5789768d66.png"/>
    <link rel="icon" type="image/png" href="/static/images/favicons/nature/favicon-16x16.bfd0e25c74.png" sizes="16x16"/>
    <link rel="icon" type="image/png" href="/static/images/favicons/nature/favicon-32x32.1c4a03347a.png" sizes="32x32"/>
    <link rel="icon" type="image/png" href="/static/images/favicons/nature/favicon-96x96.14ff9c7f48.png" sizes="96x96"/>
    <link rel="icon" type="image/png" href="/static/images/favicons/nature/favicon-194x194.5789768d66.png" sizes="194x194"/>
    <link rel="shortcut icon" href="/static/images/favicons/nature/favicon.14515a9f85.ico"/>
    <meta name="msapplication-TileColor" content="#940720"/>
    <meta name="msapplication-TileImage" content="/static/images/favicons/nature/favicon-144x144.3e61d1f755.png">
    <meta name="theme-color" content="#940720">


<link href="/static/css/grade-c.6deca6f143.css" rel="stylesheet"/>



<link id="mustard" data-test="open-access-css" href="/static/css/nature-open-access.12d3813302.css" rel="stylesheet"  media="only screen and (-webkit-min-device-pixel-ratio:0) and (min-color-index:0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio:0) and (min-resolution: 3e1dpcm)" />




<link rel="stylesheet" type="text/css" href="/static/css/article.ada45181f8.css" media="only screen and (-webkit-min-device-pixel-ratio:0) and (min-color-index:0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio:0) and (min-resolution: 3e1dpcm)" />
<link rel="stylesheet" type="text/css" href="/static/css/article-print.5d183fc5b2.css" media="print">




    
    <style>
         .background-brand-primary {
              background-color: #f2f7fa;
              color: #222;
         }

         .background-brand-secondary {
              background-color: #dee6e8;
              color: #222;
         }

         .background-brand-secondary-pdf {
              background-color: #036599;
              background-size: 22px auto;
              background-position: 80% 50%;
              color: #fff;
         }

         .background-brand-secondary-pdf a {
              color: #fff;
         }

         .background-brand-tertiary {
              background-color: #e7eff1;
              color: #222;
         }

         .background-gradient-brand-primary {
              background-image: linear-gradient(to right, #f2f7fa, #f2f7fa 50%, transparent 50%);
         }

         .background-gradient-brand-secondary-tertiary {
              background-image: linear-gradient(to right, #dee6e8, #dee6e8 50%, #e7eff1 50%);
         }

         .background-gradient-brand-gray {
              background-image: linear-gradient(to right, #e0e0e0, #e0e0e0 50%, transparent 50%);
         }

         .background-gradient-brand-gray-light {
              background-image: linear-gradient(to right, #eee, #eee 50%, transparent 50%);
         }

         

         

         

         .nav-border {
              border-bottom: 4px solid #dee6e8;
         }

         /* less than or equal to 875px */
         @media only screen and (max-width: 54.688em) {
              .banner {
                  background-color: #f2f7fa;
              }

              .nav-border .menu-cell li {
                  border-bottom: 1px solid #dee6e8;
              }
         }

         .sticky-header .inner-banner,
         .header-primary-color {
              background-color: #f2f7fa;
         }

         
             .menu-button,
             .menu-button-clone,
             .header-submit-button {
                 border: 1px solid #222;
                 border: 1px solid rgba(34,34,34,.75);
                 color: #222;
             }
             .nature-research-logo {
                 background-image: url("/static/images/product-logos/nature-research-logo-dark.2dec4e5439.svg"), none;
             }

             .icon-rotate.tools-menu-button-icon:after,
             .menu-button-icon:after {
                 background-image: url("/static/images/icons/icon-arrow-down-12x7-gray-dark.d2d673ff2e.svg"), none;
             }

             .header-search-button {
                 padding-right: 25px;
                 background-image: url("/static/images/icons/icon-search-24x24-gray.d711eca805.svg"), none;
             }
         
     </style>
     


<!-- SpringerLink's event tracker, as per: https://github.com/springernature/springerlink-event-tracker -->

<script type="text/javascript">
document.addEventListener('accessdetailsloaded', function(e) {
    var dL, doi, pageType, eventObject, i, script, loginEventData;

    for (i = 0; i < window.dataLayer.length; i++) {
        if (window.dataLayer[i]["content"] && window.dataLayer[i]["page"]) {
            dL = window.dataLayer[i];
        }
    }

    if (!dL
        || !dL.content.article
        || !(doi = dL.content.article.doi) && doi.length > 0
        || (pageType = dL.page.category.pageType.toLowerCase()) !== "article"
    ) {return false;}

    pageType = pageType.charAt(0).toUpperCase() + pageType.substring(1);

    eventObject = {'content_type': pageType, 'doi': doi};

    loginEventData = e.detail;
    if (loginEventData && loginEventData.business_partner_id) {
        eventObject['business_partner_ids'] = loginEventData.business_partner_id;
    }

    script = document.createElement('script');
    script.id = 'springerlink-event-tracker';
    script.src = 'https://event-tracker.springernature.com/dist/eventTracker.js';
    script.onload = function() {
        new EventTracker({'platform': 'Nature'}).sendEvent('display', eventObject);
    };
    document.head.appendChild(script);
});
</script>
<script>
    dataLayer = [{"content":{"category":{"contentType":"article","legacy":{"webtrendsPrimaryArticleType":"research","webtrendsSubjectTerms":"biochemical-networks;network-topology;networks-and-systems-biology;target-identification","webtrendsContentCategory":null,"webtrendsContentCollection":null,"webtrendsContentGroup":"Nature Communications","webtrendsContentGroupType":null,"webtrendsContentSubGroup":"Article"}},"article":{"doi":"10.1038/s41467-019-09186-x"},"attributes":{"cms":null,"deliveryPlatform":"oscar","copyright":{"open":true,"legacy":{"webtrendsLicenceType":"http://creativecommons.org/licenses/by/4.0/"}}},"contentInfo":{"authors":["Feixiong Cheng","István A. Kovács","Albert-László Barabási"],"publishedAt":1552435200,"publishedAtString":"2019-03-13","title":"Network-based prediction of drug combinations","legacy":null,"publishedAtTime":null,"documentType":"aplusplus"},"journal":{"pcode":"ncomms","title":"nature communications","volume":"10","issue":"1"},"authorization":{"status":true},"features":[{"name":"furtherReadingSection","present":true}],"collection":null},"page":{"category":{"pageType":"article"},"attributes":{"template":"mosaic","featureFlags":[{"name":"ab_test_nature_rebrand_150","active":false},{"name":"ab_test_subscribe_button","active":true},{"name":"ab_test_briefing_new_signup_box","active":true},{"name":"ab_test_best_available_version","active":false},{"name":"ab_test_magazine_article_native_ads","active":false},{"name":"ab_test_ncomms_banner","active":false}]},"search":null},"privacy":{},"version":"1.0.0","product":null,"session":null,"user":null,"backHalfContent":true}];
</script>
<!-- Google Tag Manager -->
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
    j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
    'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-NWDMT9Q');</script>
<!-- End Google Tag Manager -->


    <meta name="description" content="Combination therapy holds great promise, but discovery remains challenging. Here, the authors propose a method to identify efficacious drug combinations for specific diseases, and find that successful combinations tend to target separate neighbourhoods of the disease modu&hellip;"/>

<meta name="robots" content="noarchive">
<meta name="access" content="Yes">
<meta name="WT.cg_s" content="Article"/>
<meta name="WT.z_bandiera_abtest" content="a"/>
<meta name="WT.page_categorisation" content="Article_HTML"/>

    <meta name="WT.template" content="oscar"/>
    <meta name="WT.z_cg_type" content="Nature Research Journals"/>
    <meta name="WT.cg_n" content="Nature Communications"/>
    <meta name="dc.rights" content="©2019 Macmillan Publishers Limited. All Rights Reserved."/>
    <meta name="prism.issn" content="2041-1723"/>


<link rel="search" href="http://www.nature.com/search">
<link rel="search" href="http://www.nature.com/opensearch/opensearch.xml" type="application/opensearchdescription+xml" title="nature.com">
<link rel="search" href="http://www.nature.com/opensearch/request" type="application/sru+xml" title="nature.com">


    
    

    <meta name="journal_id" content="41467"/>

    <meta name="dc.title" content="Network-based prediction of drug combinations"/>

    <meta name="dc.source" content="Nature Communications 2019 10:1"/>

    <meta name="dc.format" content="text/html"/>

    <meta name="dc.publisher" content="Nature Publishing Group"/>

    <meta name="dc.date" content="2019-03-13"/>

    <meta name="dc.type" content="OriginalPaper"/>

    <meta name="dc.language" content="En"/>

    <meta name="dc.copyright" content="2019 The Author(s)"/>

    <meta name="dc.rightsAgent" content="journalpermissions@springernature.com"/>

    <meta name="dc.description" content="Drug combinations, offering increased therapeutic efficacy and reduced toxicity, play an important role in treating multiple complex diseases. Yet, our ability to identify and validate effective combinations is limited by a combinatorial explosion, driven by both the large number of drug pairs as well as dosage combinations. Here we propose a network-based methodology to identify clinically efficacious drug combinations for specific diseases. By quantifying the network-based relationship between drug targets and disease proteins in the human protein&#8211;protein interactome, we show the existence of six distinct classes of drug&#8211;drug&#8211;disease combinations. Relying on approved drug combinations for hypertension and cancer, we find that only one of the six classes correlates with therapeutic effects: if the targets of the drugs both hit disease module, but target separate neighborhoods. This finding allows us to identify and validate antihypertensive combinations, offering a generic, powerful network methodology to identify efficacious combination therapies in drug development. Combination therapy holds great promise, but discovery remains challenging. Here, the authors propose a method to identify efficacious drug combinations for specific diseases, and find that successful combinations tend to target separate neighbourhoods of the disease module in the human interactome."/>

    <meta name="prism.issn" content="2041-1723"/>

    <meta name="prism.publicationName" content="Nature Communications"/>

    <meta name="prism.publicationDate" content="2019-03-13"/>

    <meta name="prism.volume" content="10"/>

    <meta name="prism.number" content="1"/>

    <meta name="prism.section" content="OriginalPaper"/>

    <meta name="prism.startingPage" content="1"/>

    <meta name="prism.endingPage" content="11"/>

    <meta name="prism.copyright" content="2019 The Author(s)"/>

    <meta name="prism.rightsAgent" content="journalpermissions@springernature.com"/>

    <meta name="prism.url" content="https://www.nature.com/articles/s41467-019-09186-x"/>

    <meta name="prism.doi" content="doi:10.1038/s41467-019-09186-x"/>

    <meta name="citation_pdf_url" content="https://www.nature.com/articles/s41467-019-09186-x.pdf"/>

    <meta name="citation_fulltext_html_url" content="https://www.nature.com/articles/s41467-019-09186-x"/>

    <meta name="citation_journal_title" content="Nature Communications"/>

    <meta name="citation_journal_abbrev" content="Nat Commun"/>

    <meta name="citation_publisher" content="Nature Publishing Group"/>

    <meta name="citation_issn" content="2041-1723"/>

    <meta name="citation_title" content="Network-based prediction of drug combinations"/>

    <meta name="citation_volume" content="10"/>

    <meta name="citation_issue" content="1"/>

    <meta name="citation_online_date" content="2019/03/13"/>

    <meta name="citation_firstpage" content="1"/>

    <meta name="citation_lastpage" content="11"/>

    <meta name="citation_article_type" content="Article"/>

    <meta name="citation_fulltext_world_readable" content=""/>

    <meta name="citation_language" content="en"/>

    <meta name="dc.identifier" content="doi:10.1038/s41467-019-09186-x"/>

    <meta name="DOI" content="10.1038/s41467-019-09186-x"/>

    <meta name="citation_doi" content="10.1038/s41467-019-09186-x"/>

    <meta name="description" content="Drug combinations, offering increased therapeutic efficacy and reduced toxicity, play an important role in treating multiple complex diseases. Yet, our ability to identify and validate effective combinations is limited by a combinatorial explosion, driven by both the large number of drug pairs as well as dosage combinations. Here we propose a network-based methodology to identify clinically efficacious drug combinations for specific diseases. By quantifying the network-based relationship between drug targets and disease proteins in the human protein&#8211;protein interactome, we show the existence of six distinct classes of drug&#8211;drug&#8211;disease combinations. Relying on approved drug combinations for hypertension and cancer, we find that only one of the six classes correlates with therapeutic effects: if the targets of the drugs both hit disease module, but target separate neighborhoods. This finding allows us to identify and validate antihypertensive combinations, offering a generic, powerful network methodology to identify efficacious combination therapies in drug development. Combination therapy holds great promise, but discovery remains challenging. Here, the authors propose a method to identify efficacious drug combinations for specific diseases, and find that successful combinations tend to target separate neighbourhoods of the disease module in the human interactome."/>

    <meta name="dc.creator" content="Feixiong Cheng"/>

    <meta name="dc.creator" content="Istv&#225;n A. Kov&#225;cs"/>

    <meta name="dc.creator" content="Albert-L&#225;szl&#243; Barab&#225;si"/>

    <meta name="dc.subject" content="Biochemical networks"/>

    <meta name="dc.subject" content="Network topology"/>

    <meta name="dc.subject" content="Networks and systems biology"/>

    <meta name="dc.subject" content="Target identification"/>

    <meta name="citation_reference" content="citation_journal_title=Sci. Transl. Med.; citation_title=High-throughput methods for combinatorial drug discovery; citation_author=X Sun, S Vilar, NP Tatonetti; citation_volume=5; citation_publication_date=2013; citation_pages=205rv201; citation_doi=10.1126/scitranslmed.3006667; citation_id=CR1"/>

    <meta name="citation_reference" content="citation_journal_title=Nat. Rev. Drug Discov.; citation_title=Mechanisms of drug combinations: interaction and network perspectives; citation_author=J Jia; citation_volume=8; citation_publication_date=2009; citation_pages=111-128; citation_doi=10.1038/nrd2683; citation_id=CR2"/>

    <meta name="citation_reference" content="citation_journal_title=Nat. Rev. Drug Discov.; citation_title=Trends in the market for antihypertensive drugs; citation_author=MA Ali, S Rizvi, BA Syed; citation_volume=16; citation_publication_date=2017; citation_pages=309-310; citation_doi=10.1038/nrd.2016.262; citation_id=CR3"/>

    <meta name="citation_reference" content="citation_journal_title=Lancet; citation_title=Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study; citation_author=TD Giles; citation_volume=383; citation_publication_date=2014; citation_pages=1889-1898; citation_doi=10.1016/S0140-6736(14)60614-0; citation_id=CR4"/>

    <meta name="citation_reference" content="citation_journal_title=Science; citation_title=Patient-derived models of acquired resistance can identify effective drug combinations for cancer; citation_author=AS Crystal; citation_volume=346; citation_publication_date=2014; citation_pages=1480-1486; citation_doi=10.1126/science.1254721; citation_id=CR5"/>

    <meta name="citation_reference" content="citation_journal_title=Nat. Biotechnol.; citation_title=Systematic identification of synergistic drug pairs targeting HIV; citation_author=X Tan; citation_volume=30; citation_publication_date=2012; citation_pages=1125-1130; citation_doi=10.1038/nbt.2391; citation_id=CR6"/>

    <meta name="citation_reference" content="Zheng, W., Sun, W., &amp; Simeonov, A. Drug repurposing screens and synergistic drug-combinations for infectious diseases. Br. J. Pharmacol. 175, 181&#8211;191 (2018)."/>

    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=Navigating chemical space for biology and medicine; citation_author=C Lipinski, A Hopkins; citation_volume=432; citation_publication_date=2004; citation_pages=855-861; citation_doi=10.1038/nature03193; citation_id=CR8"/>

    <meta name="citation_reference" content="citation_journal_title=Drug Discov. Today; citation_title=Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectives; citation_author=KC Bulusu; citation_volume=21; citation_publication_date=2016; citation_pages=225-238; citation_doi=10.1016/j.drudis.2015.09.003; citation_id=CR9"/>

    <meta name="citation_reference" content="citation_journal_title=Nat. Commun.; citation_title=Combining genomic and network characteristics for extended capability in predicting synergistic drugs for cancer; citation_author=Y Sun; citation_volume=6; citation_publication_date=2015; citation_doi=10.1038/ncomms9481; citation_id=CR10"/>

    <meta name="citation_reference" content="citation_journal_title=Nat. Biotechnol.; citation_title=A community computational challenge to predict the activity of pairs of compounds; citation_author=M Bansal; citation_volume=32; citation_publication_date=2014; citation_pages=1213-1222; citation_doi=10.1038/nbt.3052; citation_id=CR11"/>

    <meta name="citation_reference" content="citation_journal_title=Proc. Natl. Acad. Sci. U.S.A.; citation_title=Prediction of multidimensional drug dose responses based on measurements of drug pairs; citation_author=A Zimmer, I Katzir, E Dekel, AE Mayo, U Alon; citation_volume=113; citation_publication_date=2016; citation_pages=10442-10447; citation_doi=10.1073/pnas.1606301113; citation_id=CR12"/>

    <meta name="citation_reference" content="citation_journal_title=Nat. Rev. Genet.; citation_title=Network biology: understanding the cell&#8217;s functional organization; citation_author=AL Barabasi, ZN Oltvai; citation_volume=5; citation_publication_date=2004; citation_pages=101-113; citation_doi=10.1038/nrg1272; citation_id=CR13"/>

    <meta name="citation_reference" content="citation_journal_title=Science; citation_title=Disease networks. Uncovering disease&#8211;disease relationships through the incomplete interactome; citation_author=J Menche; citation_volume=347; citation_publication_date=2015; citation_pages=1257601; citation_doi=10.1126/science.1257601; citation_id=CR14"/>

    <meta name="citation_reference" content="citation_journal_title=Nat. Commun.; citation_title=Network-based in silico drug efficacy screening; citation_author=E Guney, J Menche, M Vidal, AL Barabasi; citation_volume=7; citation_publication_date=2016; citation_doi=10.1038/ncomms10331; citation_id=CR15"/>

    <meta name="citation_reference" content="citation_journal_title=Nat. Commun.; citation_title=Network-based approach to prediction and population-based validation of in silico drug repurposing; citation_author=F Cheng; citation_volume=9; citation_publication_date=2018; citation_doi=10.1038/s41467-018-05116-5; citation_id=CR16"/>

    <meta name="citation_reference" content="citation_journal_title=Nat. Rev. Genet.; citation_title=Network medicine: a network-based approach to human disease; citation_author=AL Barabasi, N Gulbahce, J Loscalzo; citation_volume=12; citation_publication_date=2011; citation_pages=56-68; citation_doi=10.1038/nrg2918; citation_id=CR17"/>

    <meta name="citation_reference" content="citation_journal_title=Cell; citation_title=Interactome networks and human disease; citation_author=M Vidal, ME Cusick, AL Barabasi; citation_volume=144; citation_publication_date=2011; citation_pages=986-998; citation_doi=10.1016/j.cell.2011.02.016; citation_id=CR18"/>

    <meta name="citation_reference" content="citation_journal_title=Nat. Biotechnol.; citation_title=Drug&#8211;target network; citation_author=MA Yildirim, KI Goh, ME Cusick, AL Barabasi, M Vidal; citation_volume=25; citation_publication_date=2007; citation_pages=1119-1126; citation_doi=10.1038/nbt1338; citation_id=CR19"/>

    <meta name="citation_reference" content="citation_journal_title=Nat. Chem. Biol.; citation_title=Network pharmacology: the next paradigm in drug discovery; citation_author=AL Hopkins; citation_volume=4; citation_publication_date=2008; citation_pages=682-690; citation_doi=10.1038/nchembio.118; citation_id=CR20"/>

    <meta name="citation_reference" content="citation_journal_title=Nat. Biotechnol.; citation_title=Network pharmacology; citation_author=AL Hopkins; citation_volume=25; citation_publication_date=2007; citation_pages=1110-1111; citation_doi=10.1038/nbt1007-1110; citation_id=CR21"/>

    <meta name="citation_reference" content="citation_journal_title=Leukemia; citation_title=Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV; citation_author=L Kalmanti; citation_volume=29; citation_publication_date=2015; citation_pages=1123-1132; citation_doi=10.1038/leu.2015.36; citation_id=CR22"/>

    <meta name="citation_reference" content="citation_journal_title=Blood; citation_title=Phase 1 clinical results with tandutinib (MLN518), a novel FLT3 antagonist, in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome: safety, pharmacokinetics, and pharmacodynamics; citation_author=DJ DeAngelo; citation_volume=108; citation_publication_date=2006; citation_pages=3674-3681; citation_doi=10.1182/blood-2006-02-005702; citation_id=CR23"/>

    <meta name="citation_reference" content="citation_journal_title=N. Engl. J. Med.; citation_title=A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis; citation_author=CH Polman; citation_volume=354; citation_publication_date=2006; citation_pages=899-910; citation_doi=10.1056/NEJMoa044397; citation_id=CR24"/>

    <meta name="citation_reference" content="citation_journal_title=Nephrol. Dial. Transplant.; citation_title=A woman with increasing weakness of the legs and irregular heartbeat who took her husband&#8217;s medication; citation_author=G Wolf, RA Stahl; citation_volume=17; citation_publication_date=2002; citation_pages=1698-1701; citation_doi=10.1093/ndt/17.9.1698; citation_id=CR25"/>

    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors; citation_author=Y Jia; citation_volume=534; citation_publication_date=2016; citation_pages=129-132; citation_doi=10.1038/nature17960; citation_id=CR26"/>

    <meta name="citation_reference" content="citation_journal_title=Lancet Diabetes Endocrinol.; citation_title=Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial; citation_author=MJ Brown; citation_volume=4; citation_publication_date=2016; citation_pages=136-147; citation_doi=10.1016/S2213-8587(15)00377-0; citation_id=CR27"/>

    <meta name="citation_reference" content="citation_journal_title=Clin. Pharmacol. Ther.; citation_title=Absorption, metabolism, and excretion of hydrochlorothiazide; citation_author=B Beermann, M Groschinsky-Grind, A Rosen; citation_volume=19; citation_publication_date=1976; citation_pages=531-537; citation_doi=10.1002/cpt1976195part1531; citation_id=CR28"/>

    <meta name="citation_reference" content="citation_journal_title=Acta Pharmacol. Sin.; citation_title=Synergism of hydrochlorothiazide and nitrendipine on reduction of blood pressure and blood pressure variability in spontaneously hypertensive rats; citation_author=P Han, ZX Chu, FM Shen, HH Xie, DF Su; citation_volume=27; citation_publication_date=2006; citation_pages=1575-1579; citation_doi=10.1111/j.1745-7254.2006.00366.x; citation_id=CR29"/>

    <meta name="citation_reference" content="citation_journal_title=JAMA; citation_title=Response of thiazide-induced hypokalemia to amiloride; citation_author=RF Maronde, M Milgrom, ND Vlachakis, L Chan; citation_volume=249; citation_publication_date=1983; citation_pages=237-241; citation_doi=10.1001/jama.1983.03330260055032; citation_id=CR30"/>

    <meta name="citation_reference" content="citation_journal_title=N. Engl. J. Med.; citation_title=Putting the patient back together&#8212;social medicine, network medicine, and the limits of reductionism; citation_author=JA Greene, J Loscalzo; citation_volume=377; citation_publication_date=2017; citation_pages=2493-2499; citation_doi=10.1056/NEJMms1706744; citation_id=CR31"/>

    <meta name="citation_reference" content="citation_journal_title=Nutr. Metab.; citation_title=Role of cytochrome P450 in drug interactions; citation_author=Z Bibi; citation_volume=5; citation_publication_date=2008; citation_pages=27; citation_doi=10.1186/1743-7075-5-27; citation_id=CR32"/>

    <meta name="citation_reference" content="citation_journal_title=PLoS One; citation_title=Pharmacointeraction network models predict unknown drug&#8211;drug interactions; citation_author=A Cami, S Manzi, A Arnold, BY Reis; citation_volume=8; citation_publication_date=2013; citation_pages=e61468; citation_doi=10.1371/journal.pone.0061468; citation_id=CR33"/>

    <meta name="citation_reference" content="citation_journal_title=Sci. Transl. Med.; citation_title=Systems pharmacology of adverse event mitigation by drug combinations; citation_author=S Zhao; citation_volume=5; citation_publication_date=2013; citation_pages=206ra140; citation_doi=10.1126/scitranslmed.3006548; citation_id=CR34"/>

    <meta name="citation_reference" content="citation_journal_title=Sci. Transl. Med.; citation_title=Data-driven prediction of drug effects and interactions; citation_author=NP Tatonetti, PP Ye, R Daneshjou, RB Altman; citation_volume=4; citation_publication_date=2012; citation_pages=125ra131; citation_doi=10.1126/scitranslmed.3003377; citation_id=CR35"/>

    <meta name="citation_reference" content="citation_journal_title=Proc. Natl. Acad. Sci. U.S.A.; citation_title=Computing global structural balance in large-scale signed social networks; citation_author=G Facchetti, G Iacono, C Altafini; citation_volume=108; citation_publication_date=2011; citation_pages=20953-20958; citation_doi=10.1073/pnas.1109521108; citation_id=CR36"/>

    <meta name="citation_reference" content="Istvan, A. K. et al. Network-based prediction of protein interactions. Preprint at 
                    https://doi.org/10.1101/275529
                    
                   (2018)."/>

    <meta name="citation_reference" content="citation_journal_title=Cell; citation_title=A proteome-scale map of the human interactome network; citation_author=T Rolland; citation_volume=159; citation_publication_date=2014; citation_pages=1212-1226; citation_doi=10.1016/j.cell.2014.10.050; citation_id=CR38"/>

    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=Towards a proteome-scale map of the human protein-protein interaction network; citation_author=JF Rual; citation_volume=437; citation_publication_date=2005; citation_pages=1173-1178; citation_doi=10.1038/nature04209; citation_id=CR39"/>

    <meta name="citation_reference" content="citation_journal_title=Nucleic Acids Res.; citation_title=DrugBank 4.0: shedding new light on drug metabolism; citation_author=V Law; citation_volume=42; citation_publication_date=2014; citation_pages=D1091-D1097; citation_doi=10.1093/nar/gkt1068; citation_id=CR40"/>

    <meta name="citation_reference" content="citation_journal_title=Nucleic Acids Res.; citation_title=Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery; citation_author=F Zhu; citation_volume=40; citation_publication_date=2012; citation_pages=D1128-D1136; citation_doi=10.1093/nar/gkr797; citation_id=CR41"/>

    <meta name="citation_reference" content="citation_journal_title=Nucleic Acids Res.; citation_title=The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge; citation_author=T Hernandez-Boussard; citation_volume=36; citation_publication_date=2008; citation_pages=D913-D918; citation_doi=10.1093/nar/gkm1009; citation_id=CR42"/>

    <meta name="citation_reference" content="citation_journal_title=Nucleic Acids Res.; citation_title=ChEMBL: a large-scale bioactivity database for drug discovery; citation_author=A Gaulton; citation_volume=40; citation_publication_date=2012; citation_pages=D1100-D1107; citation_doi=10.1093/nar/gkr777; citation_id=CR43"/>

    <meta name="citation_reference" content="citation_journal_title=Nucleic Acids Res.; citation_title=BindingDB: a web-accessible database of experimentally determined protein&#8211;ligand binding affinities; citation_author=TQ Liu, YM Lin, X Wen, RN Jorissen, MK Gilson; citation_volume=35; citation_publication_date=2007; citation_pages=D198-D201; citation_doi=10.1093/nar/gkl999; citation_id=CR44"/>

    <meta name="citation_reference" content="citation_journal_title=Nucleic Acids Res.; citation_title=The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands; citation_author=AJ Pawson; citation_volume=42; citation_publication_date=2014; citation_pages=D1098-D1106; citation_doi=10.1093/nar/gkt1143; citation_id=CR45"/>

    <meta name="citation_reference" content="citation_journal_title=Nucleic Acids Res.; citation_title=UniProt: the universal protein knowledgebase; citation_author=R Apweiler; citation_volume=32; citation_publication_date=2004; citation_pages=D115-D119; citation_doi=10.1093/nar/gkh131; citation_id=CR46"/>

    <meta name="citation_reference" content="citation_journal_title=Nucleic Acids Res.; citation_title=The Unified Medical Language System (UMLS): integrating biomedical terminology; citation_author=O Bodenreider; citation_volume=32; citation_publication_date=2004; citation_pages=D267-D270; citation_doi=10.1093/nar/gkh061; citation_id=CR47"/>

    <meta name="citation_reference" content="citation_journal_title=J. Cheminform.; citation_title=Open Babel: an open chemical toolbox; citation_author=NM O&#8217;Boyle; citation_volume=3; citation_publication_date=2011; citation_pages=33; citation_doi=10.1186/1758-2946-3-33; citation_id=CR48"/>

    <meta name="citation_reference" content="citation_journal_title=Drug Discov. Today; citation_title=Similarity-based virtual screening using 2D fingerprints; citation_author=P Willett; citation_volume=11; citation_publication_date=2006; citation_pages=1046-1053; citation_doi=10.1016/j.drudis.2006.10.005; citation_id=CR49"/>

    <meta name="citation_reference" content="citation_journal_title=J. Mol. Biol.; citation_title=Identification of common molecular subsequences; citation_author=TF Smith, MS Waterman; citation_volume=147; citation_publication_date=1981; citation_pages=195-197; citation_doi=10.1016/0022-2836(81)90087-5; citation_id=CR50"/>

    <meta name="citation_reference" content="citation_journal_title=Mol. Biol. Evol.; citation_title=Studying tumorigenesis through network evolution and somatic mutational perturbations in the cancer interactome; citation_author=F Cheng; citation_volume=31; citation_publication_date=2014; citation_pages=2156-2169; citation_doi=10.1093/molbev/msu167; citation_id=CR51"/>

    <meta name="citation_reference" content="citation_journal_title=Bioinformatics; citation_title=A new method to measure the semantic similarity of GO terms; citation_author=JZ Wang, Z Du, R Payattakool, PS Yu, CF Chen; citation_volume=23; citation_publication_date=2007; citation_pages=1274-1281; citation_doi=10.1093/bioinformatics/btm087; citation_id=CR52"/>

    <meta name="citation_reference" content="citation_journal_title=Bioinformatics; citation_title=GOSemSim: an R package for measuring semantic similarity among GO terms and gene products; citation_author=G Yu; citation_volume=26; citation_publication_date=2010; citation_pages=976-978; citation_doi=10.1093/bioinformatics/btq064; citation_id=CR53"/>

    <meta name="citation_reference" content="citation_journal_title=J. Chem. Inf. Model.; citation_title=Prediction of polypharmacological profiles of drugs by the integration of chemical, side effect, and therapeutic space; citation_author=F Cheng; citation_volume=53; citation_publication_date=2013; citation_pages=753-762; citation_doi=10.1021/ci400010x; citation_id=CR54"/>

    <meta name="citation_reference" content="citation_journal_title=Nucleic Acids Res.; citation_title=Database resources of the National Center for Biotechnology Information; citation_author=null NCBI Resource Coordinators; citation_volume=44; citation_publication_date=2016; citation_pages=D7-D19; citation_doi=10.1093/nar/gkv1290; citation_id=CR55"/>

    <meta name="citation_author" content="Feixiong Cheng"/>

    <meta name="citation_author_institution" content="Center for Complex Networks Research and Department of Physics, Northeastern University, Boston, USA"/>

    <meta name="citation_author_institution" content="Center for Cancer Systems Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, USA"/>

    <meta name="citation_author_institution" content="Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, USA"/>

    <meta name="citation_author_institution" content="Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, USA"/>

    <meta name="citation_author_institution" content="Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, USA"/>

    <meta name="citation_author" content="Istv&#225;n A. Kov&#225;cs"/>

    <meta name="citation_author_institution" content="Center for Complex Networks Research and Department of Physics, Northeastern University, Boston, USA"/>

    <meta name="citation_author_institution" content="Center for Cancer Systems Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, USA"/>

    <meta name="citation_author" content="Albert-L&#225;szl&#243; Barab&#225;si"/>

    <meta name="citation_author_institution" content="Center for Complex Networks Research and Department of Physics, Northeastern University, Boston, USA"/>

    <meta name="citation_author_institution" content="Center for Cancer Systems Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, USA"/>

    <meta name="citation_author_institution" content="Channing Division of Network Medicine, Department of Medicine, Brigham and Women&#8217;s Hospital, Harvard Medical School, Boston, USA"/>

    <meta name="citation_author_institution" content="Center for Network Science, Central European University, Budapest, Hungary"/>

    <meta name="access_endpoint" content="https://www.nature.com/platform/readcube-access"/>

    <meta name="twitter:card" content="summary"/>

    <meta name="twitter:title" content="Network-based prediction of drug combinations"/>

    <meta name="twitter:site" content="@NatureComms"/>

    <meta name="twitter:description" content="Combination therapy holds great promise, but discovery remains challenging. Here, the authors propose a method to identify efficacious drug combinations for specific diseases, and find that successful combinations tend to target separate neighbourhoods of the disease module in the human interactome."/>

    <meta name="twitter:image" content="https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-019-09186-x/MediaObjects/41467_2019_9186_Fig1_HTML.png"/>

    <meta name="twitter:image:alt" content="Content cover image"/>

    <meta name="WT.z_cc_license_type" content="cc_by"/>

    <meta name="WT.z_primary_atype" content="Research"/>

    <meta name="WT.z_subject_term" content="Biochemical networks;Network topology;Networks and systems biology;Target identification"/>

    <meta name="WT.z_subject_term_id" content="biochemical-networks;network-topology;networks-and-systems-biology;target-identification"/>


    
        <meta property="og:url" content="https://www.nature.com/articles/s41467-019-09186-x"/>
        <meta property="og:type" content="article"/>
        <meta property="og:site_name" content="Nature Communications"/>
        <meta property="og:title" content="Network-based prediction of drug combinations"/>
        <meta property="og:description" content="Combination therapy holds great promise, but discovery remains challenging. Here, the authors propose a method to identify efficacious drug combinations for specific diseases, and find that successful combinations tend to target separate neighbourhoods of the disease module in the human interactome."/>
        <meta property="og:image" content="https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-019-09186-x/MediaObjects/41467_2019_9186_Fig1_HTML.png"/>
    
</head>
<!--[if IE 9]><body class="ie9 article-page"><![endif]-->
<!--[if gt IE 9]><!--><body class="article-page"><!--<![endif]-->
<!-- Google Tag Manager (noscript) -->
<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-NWDMT9Q"
                  height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<!-- End Google Tag Manager (noscript) -->
<div role="banner" class="position-relative cleared z-index-50" data-test="top-containers">
    <div class="hide-print container background-gray-dark">
    <div class="content mq1200-padded">
        <a href="#content" id="skiplink" class="skiplink contrast-text js-no-scroll" data-track="click"
           data-track-action="skip to content" data-track-category="header" data-track-label="link">Skip to main content</a>
    </div>
</div>



<div class="container cleared container-type-banner-advert inline-group" data-container-type="banner-advert">
    <div class="hide-print pt10 pb10 mq875-pa0 position-relative z-index-100 clear-float cleared leaderboard-or-billboard-container">
        <div class="leaderboard-or-billboard-inner ad-with-label">
            
                
    <div id="div-gpt-ad-top-1"
         class="div-gpt-ad advert leaderboard js-ad text-center hide-print grade-c-hide"
         data-ad-type="top"
         data-gpt-unitpath="/285/nature_communications/article"
         data-gpt-sizes="728x90"
         data-gpt-targeting="type=article;pos=top;artid=s41467-019-09186-x;doi=10.1038/s41467-019-09186-x;techmeta=118,119,129;subjmeta=114,154,2408,2710,360,553,555,631,92;kwrd=Biochemical networks,Network topology,Networks and systems biology,Target identification">
        <noscript>
            <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/285/nature_communications/article&amp;sz=728x90&amp;c=-1973012359&amp;t=pos%3Dtop%26type%3Darticle%26artid%3Ds41467-019-09186-x%26doi%3D10.1038/s41467-019-09186-x%26techmeta%3D118,119,129%26subjmeta%3D114,154,2408,2710,360,553,555,631,92%26kwrd%3DBiochemical networks,Network topology,Networks and systems biology,Target identification">
                <img data-test="gpt-advert-fallback-img"
                     src="//pubads.g.doubleclick.net/gampad/ad?iu=/285/nature_communications/article&amp;sz=728x90&amp;c=-1973012359&amp;t=pos%3Dtop%26type%3Darticle%26artid%3Ds41467-019-09186-x%26doi%3D10.1038/s41467-019-09186-x%26techmeta%3D118,119,129%26subjmeta%3D114,154,2408,2710,360,553,555,631,92%26kwrd%3DBiochemical networks,Network topology,Networks and systems biology,Target identification"
                     alt="Advertisement"
                     width="728"
                     height="90"></a>
        </noscript>
    </div>

            
        </div>
    </div>
</div>

<div class="hide-print text-orange content grade-c-show"><p>Thank you for visiting nature.com. You are using a browser version with
    limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off
    compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site
    without styles and JavaScript.</p></div>

    
        
            <div class="c-banner">
                <div class="content cleared mq1200-padded">
                    <p>Help us improve our products.<a href="https://mailchi.mp/bcbfa719e0ab/snuxresearch" data-track="click" data-track-action="click" data-track-category="feedback banner top of page" data-track-label="ux recruitment link"> Sign up to take part.</a></p>
                </div>
            </div>
        
    
    
    <div class="hide-print container background-bluegray contrast-text text14 strong lower mq640-hide position-relative z-index-100"
         data-test="header-breadcrumbs">
        <div class="content cleared mq1200-padded">
            <div class="breadcrumbs pin-left">
                    <ol class="ma0 cleared clean-list inline-list"><li id="breadcrumb0" itemscope="itemscope" itemtype="http://data-vocabulary.org/Breadcrumb"
                                     itemref="breadcrumb1"><a href="/" itemprop="url" class="icon icon-right icon-arrow-right-6x10-white pr15"
                                                                                                                 data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:nature"><span itemprop="title">nature</span></a></li><li id="breadcrumb1" itemscope="itemscope" itemtype="http://data-vocabulary.org/Breadcrumb"
                                     itemref="breadcrumb2" class="ml6"><a href="/ncomms" itemprop="url" class="icon icon-right icon-arrow-right-6x10-white pr15"
                                                                                                                 data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:nature communications"><span itemprop="title">nature communications</span></a></li><li id="breadcrumb2" itemscope="itemscope" itemtype="http://data-vocabulary.org/Breadcrumb"
                                     itemref="breadcrumb3" class="ml6"><a href="/ncomms/articles?type&#x3D;article" itemprop="url" class="icon icon-right icon-arrow-right-6x10-white pr15"
                                                                                                                 data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:articles"><span itemprop="title">articles</span></a></li><li id="breadcrumb3" itemscope="itemscope" itemtype="http://data-vocabulary.org/Breadcrumb"><a href="/articles/s41467-019-09186-x" itemprop="url" data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:article" class="ml6"><span itemprop="title">article</span></a></li></ol>
            </div>
            
                <p class="pin-right box-sizing header-primary-color nature-research-logo ma0 pa6 hide-text grade-c-hide">A Nature Research Journal</p>
            
        </div>
    </div>


    
    
        <div class="hide-print container js-header-container mb20 position-relative z-index-50" data-ui="header-container"
             data-container-type="header">
            <div class="cleared clear hide-print position-relative background-gradient-brand-primary js-header default-header z-index-100 composite-layer tighten-line-height">
                <div class="banner js-banner content mq1200-padded position-relative">
                    <div class="inner-banner cleared">
                        <div class="main-column small-header-main pin-left">
                            <div class="header-logo-container header-primary-color">
                                <a href="#menu" id="menu-button" class="js-header-menu-button menu-button js-no-scroll"
                                   data-test="menu-button">
                                            <span class="menu-button-icon icon-rotate">
                                                <span class="menu-button-label">Menu</span>
                                            </span>
                                </a>
                                    <h1 class="inline-block"><a href="/ncomms" class="header-logo inline-block"
                                        data-track="click" data-track-action="home"
                                        data-track-category="header" data-track-label="image"><img alt="Nature Communications"
                                                               src="//media.springernature.com/full/nature-cms/uploads/product/ncomms/header-aa7f836a57fbef4ef15c560ab4ce386f.svg"
                                                               class="grade-c-invisible header-logo-primary js-svg"
                                                               data-png="//media.springernature.com/full/nature-cms/uploads/product/ncomms/header-ad455ad76a3630f410bf4c569e7f3aaa.png"><img
                                            alt="Nature Communications" src="//media.springernature.com/full/nature-cms/uploads/product/ncomms/header-aa6f7c33d1ba82f8cce520a556a024c0.svg"
                                            class="grade-c-invisible header-logo-secondary js-svg"
                                            data-png="//media.springernature.com/full/nature-cms/uploads/product/ncomms/header-8390435b3a84674c7a7895bc7a60eef0.png"></a></h1>
                            </div>
                        </div>
                        <div class="position-absolute position-right small-header-side">
                            <div class="pin-right">
                              
                                <a href="#search-menu" data-component="tray-button"
                                   class="pin-left inline-group-top pa10 pr15 pl15 small-header-icons background-bluegray text11 contrast-text mr1"
                                   data-test="search-link" data-track="click" data-track-category="header"
                                   data-track-action="open tray" data-track-label="button">
                                            <span
                                                class="icon icon-above icon-search-25x25-white icon-search-25x25-gray block text-center">
                                                <span class="block mt6 small-header-hide">Search</span>
                                            </span>
                                </a>
                                
                                  <a href="https://www.nature.com/my-account/alerts/subscribe-journal?list-id&#x3D;264"
                                     class="mq640-hide pin-left inline-group-top pa10 small-header-icons background-bluegray text11 contrast-text mr1"
                                     data-test="ealert-link" data-track="click" data-track-action="ealert"
                                     data-track-category="header" data-track-label="link">
                                            <span
                                                class="icon icon-above icon-ealert-25x25-white icon-ealert-25x25-gray block text-center">
                                                <span class="block mt6 small-header-hide">E-alert</span>
                                            </span>
                                  </a>
                                
                                
                                  <a href="http://mts-ncomms.nature.com/"
                                     class="mq640-hide inline-block pin-left inline-group-top pa10 pr15 pl15 small-header-icons background-bluegray text11 contrast-text mr1"
                                     data-test="submit-link" data-track="click" data-track-action="manuscript submission"
                                     data-track-category="header" data-track-label="link">
                                            <span
                                                class="icon icon-above icon-submit-25x25-white icon-submit-25x25-gray block text-center">
                                                <span class="block mt6 small-header-hide">Submit</span>
                                            </span>
                                  </a>
                                
                                
<a href="/nams/svc/myaccount"
   id="my-account"
   class="placeholder inline-block pin-left inline-group-top pa10 pr15 pl15 small-header-icons background-bluegray text11 contrast-text"
   data-test="login-link" data-track="click" data-track-action="my account" data-track-category="header" data-track-label="link">
            <span class="icon icon-above icon-login-25x25-white icon-login-25x25-gray block text-center">
                <span class="block mt6 small-header-hide">My Account</span>
            </span>
</a>
<a href="https://idp.nature.com/authorize/natureuser?client_id&#x3D;grover&amp;redirect_uri&#x3D;https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41467-019-09186-x"
   id="login-button"
   style="display: none;"
   class="placeholder inline-block pin-left inline-group-top pa10 pr15 pl15 small-header-icons background-bluegray text11 contrast-text"
   data-test="login-link" data-track="click" data-track-action="login" data-track-category="header" data-track-label="link">
            <span class="icon icon-above icon-login-25x25-white icon-login-25x25-gray block text-center">
                <span class="block mt6 small-header-hide">Login</span>
            </span>
</a>




                              
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    

    
    

</div>



<div id="content" class="position-relative z-index-1">
    <div class="container cleared container-type-article" data-container-type="article">
        <div class="content position-relative cleared clear mq1200-padded" data-component="article-container">
            <article itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle" lang="en">
                <div class="full-width-print main-column pin-left js-main-column highlighter" role="main">
                    <div class="c-article-header">
                        <header>
                            <ul class="c-article-identifiers" data-test="article-identifier">
                                <li class="c-article-identifiers__item">Article</li>
                                
                                <li class="c-article-identifiers__item">
                                    <span class="c-article-identifiers__open">Open Access</span>
                                </li>
                                
                                <li class="c-article-identifiers__item"><a href="#article-info">Published: <time datetime="2019-03-13" itemprop="datePublished">13 March 2019</time></a></li>
                            </ul>

                            
                            <h1 class="c-article-title u-h1" data-test="article-title" data-article-title="" itemprop="name headline">Network-based prediction of drug combinations</h1>
                            <ul class="c-author-list js-list-authors js-etal-collapsed" data-etal="25" data-etal-small="3" data-test="authors-list"><li class="c-author-list__item" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span itemprop="name"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-category="article body" data-track-label="link" href="#auth-1">Feixiong Cheng</a></span><sup class="u-js-hide"><a href="#Aff1">1</a><span itemprop="affiliation" itemscope="itemscope" itemtype="http://schema.org/Organization" class="u-visually-hidden"><meta itemprop="name" content="Northeastern University" /><meta itemprop="address" content="0000 0001 2173 3359, grid.261112.7, Center for Complex Networks Research and Department of Physics, Northeastern University, Boston, MA, 02115, USA" /></span>,<a href="#Aff2">2</a><span itemprop="affiliation" itemscope="itemscope" itemtype="http://schema.org/Organization" class="u-visually-hidden"><meta itemprop="name" content="Dana-Farber Cancer Institute" /><meta itemprop="address" content="0000 0001 2106 9910, grid.65499.37, Center for Cancer Systems Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA" /></span>,<a href="#Aff3">3</a><span itemprop="affiliation" itemscope="itemscope" itemtype="http://schema.org/Organization" class="u-visually-hidden"><meta itemprop="name" content="Cleveland Clinic" /><meta itemprop="address" content="0000 0001 0675 4725, grid.239578.2, Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44106, USA" /></span>,<a href="#Aff4">4</a><span itemprop="affiliation" itemscope="itemscope" itemtype="http://schema.org/Organization" class="u-visually-hidden"><meta itemprop="name" content="Case Western Reserve University" /><meta itemprop="address" content="0000 0001 2164 3847, grid.67105.35, Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, 44195, USA" /></span>,<a href="#Aff5">5</a><span itemprop="affiliation" itemscope="itemscope" itemtype="http://schema.org/Organization" class="u-visually-hidden"><meta itemprop="name" content="Case Western Reserve University School of Medicine" /><meta itemprop="address" content="0000 0001 2164 3847, grid.67105.35, Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA" /></span></sup><sup class="u-js-hide"> <a href="#na1">na1</a></sup>, </li><li class="c-author-list__item" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span itemprop="name"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-category="article body" data-track-label="link" href="#auth-2">István A. Kovács</a></span><sup class="u-js-hide"><a href="#Aff1">1</a><span itemprop="affiliation" itemscope="itemscope" itemtype="http://schema.org/Organization" class="u-visually-hidden"><meta itemprop="name" content="Northeastern University" /><meta itemprop="address" content="0000 0001 2173 3359, grid.261112.7, Center for Complex Networks Research and Department of Physics, Northeastern University, Boston, MA, 02115, USA" /></span>,<a href="#Aff2">2</a><span itemprop="affiliation" itemscope="itemscope" itemtype="http://schema.org/Organization" class="u-visually-hidden"><meta itemprop="name" content="Dana-Farber Cancer Institute" /><meta itemprop="address" content="0000 0001 2106 9910, grid.65499.37, Center for Cancer Systems Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA" /></span></sup><sup class="u-js-hide"> <a href="#na1">na1</a></sup> &amp; </li><li class="c-author-list__item" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span itemprop="name"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-category="article body" data-track-label="link" href="#auth-3" class="c-author-list__item-icon" data-corresp-id="c1">Albert-László Barabási</a></span><sup class="u-js-hide"><a href="#Aff1">1</a><span itemprop="affiliation" itemscope="itemscope" itemtype="http://schema.org/Organization" class="u-visually-hidden"><meta itemprop="name" content="Northeastern University" /><meta itemprop="address" content="0000 0001 2173 3359, grid.261112.7, Center for Complex Networks Research and Department of Physics, Northeastern University, Boston, MA, 02115, USA" /></span>,<a href="#Aff2">2</a><span itemprop="affiliation" itemscope="itemscope" itemtype="http://schema.org/Organization" class="u-visually-hidden"><meta itemprop="name" content="Dana-Farber Cancer Institute" /><meta itemprop="address" content="0000 0001 2106 9910, grid.65499.37, Center for Cancer Systems Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA" /></span>,<a href="#Aff6">6</a><span itemprop="affiliation" itemscope="itemscope" itemtype="http://schema.org/Organization" class="u-visually-hidden"><meta itemprop="name" content="Harvard Medical School" /><meta itemprop="address" content="000000041936754X, grid.38142.3c, Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 02215, USA" /></span>,<a href="#Aff7">7</a><span itemprop="affiliation" itemscope="itemscope" itemtype="http://schema.org/Organization" class="u-visually-hidden"><meta itemprop="name" content="Central European University" /><meta itemprop="address" content="0000 0001 2149 6445, grid.5146.6, Center for Network Science, Central European University, Budapest, 1051, Hungary" /></span></sup> </li></ul>
                            

                            <p class="c-article-info-details" data-container-section="info"><i data-test="journal-title">Nature Communications</i><b data-test="journal-volume"><span class="u-visually-hidden">volume</span> 10</b>, Article number: <span data-test="article-number">1197</span> (<span data-test="article-publication-year">2019</span>)
                <span class="c-article-info-details__divider u-hide-print"> | </span><a class="c-article-info-details__download-citation u-hide-print" data-test="citation-link" data-track="click" data-track-action="download article citation" data-track-category="article body" data-track-label="link" href="/articles/s41467-019-09186-x.ris">
                Download Citation
            </a></p>
                            
                        </header>

                        
    <div class="js-hide" data-component="article-subject-links">
        
            <h3 class="c-article__sub-heading">Subjects</h3>
            <ul class="c-article-subject-list">
                <li class="c-article-subject-list__subject"><a href="/subjects/biochemical-networks" data-track="click" data-track-action="view subject" data-track-category="article body" data-track-label="link" itemprop="about">Biochemical networks</a></li><li class="c-article-subject-list__subject"><a href="/subjects/network-topology" data-track="click" data-track-action="view subject" data-track-category="article body" data-track-label="link" itemprop="about">Network topology</a></li><li class="c-article-subject-list__subject"><a href="/subjects/networks-and-systems-biology" data-track="click" data-track-action="view subject" data-track-category="article body" data-track-label="link" itemprop="about">Networks and systems biology</a></li><li class="c-article-subject-list__subject"><a href="/subjects/target-identification" data-track="click" data-track-action="view subject" data-track-category="article body" data-track-label="link" itemprop="about">Target identification</a></li>
            </ul>
        
    </div>

                        
    
        
        <ul class="c-article-events">
            
                
                    <li class="c-article-events__item"><span>A <a href="/articles/s41467-019-09692-y" class="relation-link" data-track="click" data-track-action="view linked article" data-track-category="article body" data-track-label="link">Publisher Correction</a> to this article was published on 15 April 2019</span></li>
                
            
        </ul>
        
    

                        <ul class="c-article-events">
              <li class="c-article-events__item"><span><a href="#change-history">This article has been updated</a></span></li>
            </ul>
                    </div>

                    <div data-article-body="true" data-track-component="article body" class="c-article-body">
                        <section aria-labelledby="Abs1" lang="en"><div class="c-article-section js-article-section" id="Abs1-section"><h2 class="c-article-section__title u-h2 js-section-title js-c-reading-companion-sections-item" id="Abs1">Abstract</h2><div class="c-article-section__content js-collapsible-section" id="Abs1-content"><p>Drug combinations, offering increased therapeutic efficacy and reduced toxicity, play an important role in treating multiple complex diseases. Yet, our ability to identify and validate effective combinations is limited by a combinatorial explosion, driven by both the large number of drug pairs as well as dosage combinations. Here we propose a network-based methodology to identify clinically efficacious drug combinations for specific diseases. By quantifying the network-based relationship between drug targets and disease proteins in the human protein–protein interactome, we show the existence of six distinct classes of drug–drug–disease combinations. Relying on approved drug combinations for hypertension and cancer, we find that only one of the six classes correlates with therapeutic effects: if the targets of the drugs both hit disease module, but target separate neighborhoods. This finding allows us to identify and validate antihypertensive combinations, offering a generic, powerful network methodology to identify efficacious combination therapies in drug development.</p></div></div></section>

                        

                        
                            <section aria-labelledby="Sec1"><div class="c-article-section js-article-section" id="Sec1-section"><h2 class="c-article-section__title u-h2 js-section-title js-c-reading-companion-sections-item" id="Sec1">Introduction</h2><div class="c-article-section__content js-collapsible-section" id="Sec1-content"><p>Combination therapy, the use of multiple drugs to improve clinical outcomes, has multiple advantages compared to monotherapy<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Sun, X., Vilar, S. &amp; Tatonetti, N. P. High-throughput methods for combinatorial drug discovery. Sci. Transl. Med. 5, 205rv201 (2013)." href="/articles/s41467-019-09186-x#ref-CR1" id="ref-link-section-d4768e552">1</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Jia, J. et al. Mechanisms of drug combinations: interaction and network perspectives. Nat. Rev. Drug Discov. 8, 111–128 (2009)." href="/articles/s41467-019-09186-x#ref-CR2" id="ref-link-section-d4768e555">2</a></sup>: it offers higher efficacies or, through lower individual dosage, it can reduce the risk of adverse effects<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Ali, M. A., Rizvi, S. &amp; Syed, B. A. Trends in the market for antihypertensive drugs. Nat. Rev. Drug Discov. 16, 309–310 (2017)." href="/articles/s41467-019-09186-x#ref-CR3" id="ref-link-section-d4768e559">3</a></sup>. Consequently, combination therapies are widely used in the treatment of multiple complex diseases, from hypertension <sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 4" title="Giles, T. D. et al. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study. Lancet 383, 1889–1898 (2014)." href="/articles/s41467-019-09186-x#ref-CR4" id="ref-link-section-d4768e563">4</a></sup> to cancer<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 5" title="Crystal, A. S. et al. Patient-derived models of acquired resistance can identify effective drug combinations for cancer. Science 346, 1480–1486 (2014)." href="/articles/s41467-019-09186-x#ref-CR5" id="ref-link-section-d4768e567">5</a></sup> and infectious diseases<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Tan, X. et al. Systematic identification of synergistic drug pairs targeting HIV. Nat. Biotechnol. 30, 1125–1130 (2012)." href="/articles/s41467-019-09186-x#ref-CR6" id="ref-link-section-d4768e571">6</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 7" title="Zheng, W., Sun, W., &amp; Simeonov, A. Drug repurposing screens and synergistic drug-combinations for infectious diseases. Br. J. Pharmacol. 175, 181–191 (2018)." href="/articles/s41467-019-09186-x#ref-CR7" id="ref-link-section-d4768e574">7</a></sup>. However, the systematic identification of drug combinations that simultaneously offer high clinical efficacy and low toxicity is often driven by intuition and experience rather than established principles. There is a pressing need, therefore, for novel methodologies to facilitate the discovery of multicomponent therapy.</p><p>One approach is the systematic high-throughput testing of pairwise drug combinations, which, however, faces a combinatorial challenge: for 1000 U.S. Food and Drug Administration (FDA)-approved drugs, there are 499,500 possible pairwise combinations that should be tested over approximately 3000 human diseases and multiple dosage combinations<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 5" title="Crystal, A. S. et al. Patient-derived models of acquired resistance can identify effective drug combinations for cancer. Science 346, 1480–1486 (2014)." href="/articles/s41467-019-09186-x#ref-CR5" id="ref-link-section-d4768e581">5</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Tan, X. et al. Systematic identification of synergistic drug pairs targeting HIV. Nat. Biotechnol. 30, 1125–1130 (2012)." href="/articles/s41467-019-09186-x#ref-CR6" id="ref-link-section-d4768e584">6</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 8" title="Lipinski, C. &amp; Hopkins, A. Navigating chemical space for biology and medicine. Nature 432, 855–861 (2004)." href="/articles/s41467-019-09186-x#ref-CR8" id="ref-link-section-d4768e587">8</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 9" title="Bulusu, K. C. et al. Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectives. Drug Discov. Today 21, 225–238 (2016)." href="/articles/s41467-019-09186-x#ref-CR9" id="ref-link-section-d4768e590">9</a></sup>. We are, therefore, far from even a cursory exploration of the vast number of possible combinations with potentially positive clinical outcomes. To be sure, several machine learning-based “black-box” models have been developed to predict drug combinations<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Sun, Y. et al. Combining genomic and network characteristics for extended capability in predicting synergistic drugs for cancer. Nat. Commun. 6, 8481 (2015)." href="#ref-CR10" id="ref-link-section-d4768e594">10</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Bansal, M. et al. A community computational challenge to predict the activity of pairs of compounds. Nat. Biotechnol. 32, 1213–1222 (2014)." href="#ref-CR11" id="ref-link-section-d4768e594_1">11</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 12" title="Zimmer, A., Katzir, I., Dekel, E., Mayo, A. E. &amp; Alon, U. Prediction of multidimensional drug dose responses based on measurements of drug pairs. Proc. Natl Acad. Sci. USA 113, 10442–10447 (2016)." href="/articles/s41467-019-09186-x#ref-CR12" id="ref-link-section-d4768e597">12</a></sup>, offering a modest increase in accuracy<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 10" title="Sun, Y. et al. Combining genomic and network characteristics for extended capability in predicting synergistic drugs for cancer. Nat. Commun. 6, 8481 (2015)." href="/articles/s41467-019-09186-x#ref-CR10" id="ref-link-section-d4768e601">10</a></sup> over random guesses<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 11" title="Bansal, M. et al. A community computational challenge to predict the activity of pairs of compounds. Nat. Biotechnol. 32, 1213–1222 (2014)." href="/articles/s41467-019-09186-x#ref-CR11" id="ref-link-section-d4768e605">11</a></sup>. We lack, however, predictive, mechanism-driven, network-medicine-based approaches to predict efficacious drug combinations.</p><p>Network-based approaches have already offered a promising framework to identify novel insights to accelerate drug discovery<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Barabasi, A. L. &amp; Oltvai, Z. N. Network biology: understanding the cell’s functional organization. Nat. Rev. Genet. 5, 101–113 (2004)." href="/articles/s41467-019-09186-x#ref-CR13" id="ref-link-section-d4768e612">13</a></sup>, helping us quantify both disease–disease<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Menche, J. et al. Disease networks. Uncovering disease–disease relationships through the incomplete interactome. Science 347, 1257601 (2015)." href="/articles/s41467-019-09186-x#ref-CR14" id="ref-link-section-d4768e616">14</a></sup> and drug–disease<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 15" title="Guney, E., Menche, J., Vidal, M. &amp; Barabasi, A. L. Network-based in silico drug efficacy screening. Nat. Commun. 7, 10331 (2016)." href="/articles/s41467-019-09186-x#ref-CR15" id="ref-link-section-d4768e620">15</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 16" title="Cheng, F. et al. Network-based approach to prediction and population-based validation of in silico drug repurposing. Nat. Commun. 9, 2691 (2018)." href="/articles/s41467-019-09186-x#ref-CR16" id="ref-link-section-d4768e623">16</a></sup> relationships. These methodological advances have raised the possibility of moving beyond the “one-drug, one-target” paradigm and exploring the “multiple-drugs, multiple-targets” possibilities offered by aiming at simultaneously modulating multiple disease proteins within the same disease module, while minimizing toxicity profiles<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Barabasi, A. L., Gulbahce, N. &amp; Loscalzo, J. Network medicine: a network-based approach to human disease. Nat. Rev. Genet. 12, 56–68 (2011)." href="#ref-CR17" id="ref-link-section-d4768e627">17</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Vidal, M., Cusick, M. E. &amp; Barabasi, A. L. Interactome networks and human disease. Cell 144, 986–998 (2011)." href="#ref-CR18" id="ref-link-section-d4768e627_1">18</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Yildirim, M. A., Goh, K. I., Cusick, M. E., Barabasi, A. L. &amp; Vidal, M. Drug–target network. Nat. Biotechnol. 25, 1119–1126 (2007)." href="#ref-CR19" id="ref-link-section-d4768e627_2">19</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Hopkins, A. L. Network pharmacology: the next paradigm in drug discovery. Nat. Chem. Biol. 4, 682–690 (2008)." href="#ref-CR20" id="ref-link-section-d4768e627_3">20</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 21" title="Hopkins, A. L. Network pharmacology. Nat. Biotechnol. 25, 1110–1111 (2007)." href="/articles/s41467-019-09186-x#ref-CR21" id="ref-link-section-d4768e630">21</a></sup>. In this study, we quantify the relationship between drug targets and disease proteins in the human protein–protein interactome, leading to a rational, network-based drug combination design strategy.</p></div></div></section><section aria-labelledby="Sec2"><div class="c-article-section js-article-section" id="Sec2-section"><h2 class="c-article-section__title u-h2 js-section-title js-c-reading-companion-sections-item" id="Sec2">Results</h2><div class="c-article-section__content js-collapsible-section" id="Sec2-content"><h3 class="c-article__sub-heading u-h3" id="Sec3">Network-based proximity measure of drug–drug relationships</h3><p>Disease proteins are not scattered randomly in the interactome, but tend to form localized neighborhoods, known as disease modules<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Menche, J. et al. Disease networks. Uncovering disease–disease relationships through the incomplete interactome. Science 347, 1257601 (2015)." href="/articles/s41467-019-09186-x#ref-CR14" id="ref-link-section-d4768e646">14</a></sup>. An efficient way to capture network proximity between a drug (<i>X</i>) and a disease (<i>Y</i>) is by the <i>z</i>-score (<span class="mathjax-tex">\(z = \frac{{{d} - {\mu }}}{{\sigma }}\)</span>), which relies on the shortest path lengths <i>d</i>(<i>x</i>, <i>y</i>) between drug targets (<i>x</i>) and disease proteins (<i>y</i>).</p><div id="Equ1" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$${\mathrm{d}}\left( {X,Y} \right) = \frac{1}{{\left\Vert Y \right\Vert}}\mathop {\sum }\limits_{{\mathrm{y}} \in Y} {\mathrm{min}}_{{\mathrm{x}} \in X}{\mathrm{d}}({\mathrm{x}},{\mathrm{y}})$$</span></div><div class="c-article-equation__number">
                    (1)
                </div></div><p>The <i>z</i>-score is obtained by comparing the observed distance to a reference distance distribution between a randomly selected group of proteins of matching size and degree distribution as the disease proteins and drug targets in the human interactome. The <i>z</i>-score is applicable when the reference distribution is well described by a Gaussian (Supplementary Note <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">1</a>) and was successfully used to identify well-known and new drug–disease relationships in the human interactome for monotherapy<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 15" title="Guney, E., Menche, J., Vidal, M. &amp; Barabasi, A. L. Network-based in silico drug efficacy screening. Nat. Commun. 7, 10331 (2016)." href="/articles/s41467-019-09186-x#ref-CR15" id="ref-link-section-d4768e838">15</a></sup>. Here, we hypothesize that exploring the network-based relationship between two drugs and their targets, and the disease proteins in the disease module would help clarify the mechanism-of-action of effective drug combinations while minimizing adverse effects (Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">1</a>).</p><p>To test our hypothesis, we assembled 243,603 experimentally confirmed protein–protein interactions (PPIs) connecting 16,677 unique proteins from five data sources (Supplementary Note <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">2</a> and Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM3">1</a>). We also compiled 1978 FDA-approved or clinically investigational drugs that have at least two experimentally reported targets by pooling the high-quality drug–target binding affinity profiles from six data sources (Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM4">2</a>). In order to fully characterize the mutual relationship of two drugs and a disease module, we need a network-based proximity measure between the two drugs’ targets, as well. Although it has not been tested for this purpose, in principle, we could rely on the <i>z</i>-score for this task. However, in contrast to the relatively large disease modules, each drug has only a small number of experimentally reported targets (on average 3, Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">2</a>). Therefore, the randomization procedure is not producing a Gaussian distribution as described in our previous study<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 15" title="Guney, E., Menche, J., Vidal, M. &amp; Barabasi, A. L. Network-based in silico drug efficacy screening. Nat. Commun. 7, 10331 (2016)." href="/articles/s41467-019-09186-x#ref-CR15" id="ref-link-section-d4768e864">15</a></sup>, limiting the applicability of the <i>z</i>-score. Indeed, we find that the <i>z</i>-score cannot discriminate FDA-approved pairwise combinations or clinically reported adverse drug interactions from random drug pairs (Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">3</a>). Instead of relying on randomization, therefore, we measure the network proximity of drug–target modules A, B as reflected in their target localizations using the recently introduced separation measure<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Menche, J. et al. Disease networks. Uncovering disease–disease relationships through the incomplete interactome. Science 347, 1257601 (2015)." href="/articles/s41467-019-09186-x#ref-CR14" id="ref-link-section-d4768e877">14</a></sup>:</p><div id="Equ2" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$${\mathrm{s}}_{{\mathrm{AB}}} \equiv \left\langle {{\mathrm{d}}_{{\mathrm{AB}}}} \right\rangle - \frac{{\left\langle {{\mathrm{d}}_{{\mathrm{AA}}}} \right\rangle + \left\langle {{\mathrm{d}}_{{\mathrm{BB}}}} \right\rangle }}{2}$$</span></div><div class="c-article-equation__number">
                    (2)
                </div></div><p>which compares the mean shortest distance within the interactome between the targets of each drug, 〈d<sub>AA</sub>〉 and 〈d<sub>BB</sub>〉, to the mean shortest distance 〈d<sub>AB</sub>〉 between A–B target pairs (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig1">1a</a>). In 〈d<sub>AB</sub>〉, targets associated with both drugs A and B have a zero distance by definition. For s<sub>AB</sub> &lt; 0, the targets of the two drugs are located in the same network neighborhood (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig1">1b</a>), while for s<sub>AB</sub> ≥ 0, the two drug targets are topologically separated (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig1">1c</a>). For example, imatinib (I) is an FDA-approved agent for the treatment of chronic myeloid leukemia<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 22" title="Kalmanti, L. et al. Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV. Leukemia 29, 1123–1132 (2015)." href="/articles/s41467-019-09186-x#ref-CR22" id="ref-link-section-d4768e1018">22</a></sup>. Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig1">1a, b</a> shows that imatinib’s targets are in the same network neighborhood as the targets of tandutinib (T), a FMS-like tyrosine kinase 3 (FLT3) inhibitor under phase III trial for treating acute myeloid leukemia<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="DeAngelo, D. J. et al. Phase 1 clinical results with tandutinib (MLN518), a novel FLT3 antagonist, in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome: safety, pharmacokinetics, and pharmacodynamics. Blood 108, 3674–3681 (2006)." href="/articles/s41467-019-09186-x#ref-CR23" id="ref-link-section-d4768e1025">23</a></sup>; consequently the separation score between their targets is negative, s<sub>IT</sub> = −0.35. However, the targets of natalizumab (N), an FDA-approved monoclonal antibody for treating multiple sclerosis<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 24" title="Polman, C. H. et al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 354, 899–910 (2006)." href="/articles/s41467-019-09186-x#ref-CR24" id="ref-link-section-d4768e1032">24</a></sup>, are in a topologically distinct neighborhood from the targets of imatinib and tandutinib, having a positive s<sub>IN</sub> = 0.59 and s<sub>TN</sub> = 0.49, respectively (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig1">1c</a>).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-1"><figure><figcaption><b id="Fig1" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 1</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-category="article body" data-track-label="image" data-track-action="view figure" href="/articles/s41467-019-09186-x/figures/1" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-019-09186-x/MediaObjects/41467_2019_9186_Fig1_HTML.png?as=webp"></source><img aria-describedby="figure-1-desc" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-019-09186-x/MediaObjects/41467_2019_9186_Fig1_HTML.png" alt="figure1" loading="lazy" /></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-1-desc"><p>Network-based model of drug–drug relationship. <b>a</b> A subnetwork of the human interactome illustrating the network-based relationship between drug targets associated with three drugs (imatinib [I], tandutinib [T], and natalizumab [N]). <b>b</b>, <b>c</b> The definition of drug pairs that are topologically overlapping (s<sub>AB</sub> &lt; 0, <b>b</b>) or topologically separated (s<sub>AB</sub> ≥ 0, <b>c</b>). <b>d</b>–<b>j</b> The interplay between topological separation of drug pairs and five types of drug profiles: drug–drug chemical similarity (<b>d</b>); drug target-encoding gene co-expression pattern across human tissues (<b>e</b>); drug target protein sequence similarity (<b>f</b>). Using the Gene Ontology (GO) annotations, we determine for each drug how similar its associated target-encoding genes are in terms of their biological processes (<b>g</b>), cellular component (<b>h</b>), and molecular function (<b>i</b>); and clinical similarity (<b>j</b>) of drug pairs derived from Anatomical Therapeutic Chemical Classification Systems codes (see Methods). Overlapping drug pairs are highlighted in orange (s<sub>AB</sub> &lt; 0); topologically separated drug pairs are highlighted in blue (s<sub>AB</sub> ≥ 0)</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-category="article body" data-track-label="button" data-track-action="view figure" href="/articles/s41467-019-09186-x/figures/1" data-track-dest="link:Figure1 Full size image" rel="nofollow"><span>Full size image</span></a></div></figure></div><p>For a network-based approach to drug combinations to be effective, we need to establish if the topological relationship between two drug–target modules, as captured by s<sub>AB</sub>, reflects biological and pharmacological relationships, as well. We find that the network proximity (s<sub>AB</sub>; Eq. (<a data-track="click" data-track-label="link" data-track-action="equation anchor" href="/articles/s41467-019-09186-x#Equ2">2</a>)) of the targets of drug–drug pairs in the human interactome correlates with chemical, biological, functional, and clinical similarities (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig1">1d–j</a>), outperforming the target-overlap approaches (Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">4</a>). This suggests that each drug–target module has a well-defined network-based footprint. If the footprints of two drug–target modules are topologically separated (s<sub>AB</sub> ≥ 0), then the drugs are pharmacologically distinct. If the footprints of two drug–target modules overlap (s<sub>AB</sub> &lt; 0), the magnitude of the overlap is indicative of their pharmacological relationship: closer network proximity of targets of a drug pair indicates higher similarities in their chemical, biological, functional, and clinical profiles (Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">5</a>). In contrast, we find that the <i>z</i>-score measure of the targets of drug–drug pairs in the human interactome does not correlate with chemical, biological, functional, and clinical similarities (Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">6</a>). We also compared network proximity (s<sub>AB</sub>) against five other network-based measures between targets of drug–drug pairs (Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">7</a>): (1) separation (Eq.  (<a data-track="click" data-track-label="link" data-track-action="equation anchor" href="/articles/s41467-019-09186-x#Equ2">2</a>)), (2) closest, (3) shortest, (4) kernel, and (5) centre (see Methods). Relying on 681 FDA-approved or experimentally validated pairwise drug combinations across all human diseases (Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM5">3</a>), we find that FDA-approved drug combinations have lower s<sub>AB</sub> compared to random drug pairs and the separation-based measure outperforms all four alternative measures as well as traditional chemoinformatics and bioinformatics approaches (Supplementary Figs. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">7</a>–<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">9</a>), confirming that s<sub>AB</sub> offers a reliable measure of drug–drug relationships within the human interactome.</p><h3 class="c-article__sub-heading u-h3" id="Sec4">Network configurations of drug–drug–disease combinations</h3><p>Next, we turn to quantify the network-based relationship between two drug–target modules and a disease module (drug–drug–disease combinations). We find that from a network perspective, all possible drug–drug–disease combinations can be classified into six topologically distinct classes: (a) Overlapping Exposure: Two overlapping drug–target modules that also overlap with the disease module of interest (P1 in Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig2">2a)</a>; (b) Complementary Exposure: Two separated drug–target modules that overlap individually with the disease module (P2 in Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig2">2b</a>); (c) Indirect Exposure: One drug–target module of two overlapping drug–target modules overlaps with the disease module (P3 in Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig2">2c</a>); (d) Single Exposure: One drug–target module separated from another drug–target module overlaps with the disease module (P4 in Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig2">2d</a>); (e) Non-exposure: Two overlapping drug–target modules are topologically separated from the disease module (P5 in Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig2">2e</a>); and (f) Independent Action: Each of the drug–target modules and the disease module are topologically separated (P6 in Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig2">2f</a>). The question is, do these six classes manifest in detectable differences in clinical efficacy for drug combinations?</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-2"><figure><figcaption><b id="Fig2" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 2</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-category="article body" data-track-label="image" data-track-action="view figure" href="/articles/s41467-019-09186-x/figures/2" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-019-09186-x/MediaObjects/41467_2019_9186_Fig2_HTML.png?as=webp"></source><img aria-describedby="figure-2-desc" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-019-09186-x/MediaObjects/41467_2019_9186_Fig2_HTML.png" alt="figure2" loading="lazy" /></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-2-desc"><p>The efficacy of hypertensive drug–drug interactions. <b>a</b>–<b>f</b> Schematic diagrams of the six distinct classes capturing the network-based relationship between two drug–target modules and one disease module on a drug–drug–disease combination. For s<sub>AB</sub> &lt; 0, the two sets of drug targets overlap topologically (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig1">1b</a>); while for s<sub>AB</sub> ≥ 0, the two sets of drug targets are separated topologically (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig1">1c</a>). The <i>z</i>-scores (<i>z</i>), measuring the drug–disease separation, are calculated for quantifying the significance of the shortest paths between drug targets and disease proteins in the human protein–protein interactome. For <i>z</i> &lt; 0, the drug–target module and the disease module overlap; while for <i>z</i> ≥ 0, the drug–target module and the disease module are separated. Color histograms (Real) show the antihypertensive combinations (purple) and clinically reported adverse drug interactions on high blood pressure (blue), respectively. We assembled the antihypertensive combinations from three types of experimental evidences: (i) FDA-approved evidence, (ii) clinical data from Clinicaltrials.gov database, and (iii) preclinical studies from literature (Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM5">3</a>). We randomly selected the same number of adverse drug–drug interactions related to high blood pressure from 1512 clinically reported adverse drug–drug interactions (Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM6">4</a>) corresponding to the number of antihypertensive combinations using a bootstrapping algorithm in R software and this process was repeated 100 times (Supplementary Note <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">5</a>). Gray boxes (Random) show random expectation. Error bars indicate the standard deviation. The <i>P</i>-value (<i>P</i>) is calculated by testing 10,000 permutations (Supplementary Note <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">5</a>). The network-based relationships between two drug–target modules and one disease module for FDA-approved hypertensive drug combinations only are illustrated in Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">11</a></p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-category="article body" data-track-label="button" data-track-action="view figure" href="/articles/s41467-019-09186-x/figures/2" data-track-dest="link:Figure2 Full size image" rel="nofollow"><span>Full size image</span></a></div></figure></div><p>To understand which of these drug–drug–disease configurations have the greatest clinical efficacy, we focus on hypertension and cancer, two diseases with a large number of FDA-approved pairwise combinations (Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM5">3</a>). We find that four out of six drug–drug–disease configurations (P3–P6 in Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig2">2c–f</a>) do not show a statistically significant tendency to co-treat cancer (Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">10c</a>–<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">10f</a>) or hypertension (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig2">2c–f</a> and Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">11c</a>–<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">11f</a>). In other words, if at least one drug in a combination fails to be localized to the vicinity of the disease module, the combination does not have a therapeutic effect greater than monotherapy. This leads to our first major finding: for a drug pair to have a therapeutic effect, both drug–target modules must overlap with the disease module. This finding highlights the need to inspect the network-relationship between drug targets and disease proteins as we search for therapeutically beneficial combinations.</p><p>The second finding is that Overlapping Exposure, i.e., when the drug–target modules overlap with each other as well as with the disease module, has no statistically significant efficacy in treating the disease over monotherapy. Overlapping Exposure does, however, have statistically significant adverse effects, such as causing high blood pressure (Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM6">4</a>) compared to the control group (<i>P</i> &lt; 1.0 × 10<sup>−4</sup>, permutation test, Overlapping Exposure [P1], Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig2">2a</a>). For example, two FDA-approved hypertensive drugs, nadroparin and spironolactone, fall into the Overlapping Exposure (P1, Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41467-019-09186-x#Tab1">1</a>) category with the hypertension disease module, in line with the observation that nadroparin increased the hyperkalemic effect (adverse effect) of spironolactone<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Wolf, G. &amp; Stahl, R. A. A woman with increasing weakness of the legs and irregular heartbeat who took her husband’s medication. Nephrol. Dial. Transplant. 17, 1698–1701 (2002)." href="/articles/s41467-019-09186-x#ref-CR25" id="ref-link-section-d4768e1305">25</a></sup>. Cancer is a chronic disease with a strong genetic contribution, rarely caused by adverse drug–drug interactions. We therefore limit our testing of Overlapping Exposure in three cardiovascular outcomes, finding that Overlapping Exposure has statistically significant adverse effects on three cardiovascular outcomes (Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">12</a>): arrhythmia (<i>P</i> &lt; 1.0 × 10<sup>−4</sup>, permutation test), heart failure (<i>P</i> &lt; 1.0 × 10<sup>−4</sup>, permutation test), and myocardial infarction (<i>P</i> &lt; 1.0 × 10<sup>−4</sup>, permutation test), consistent with previously reported overlapping toxicities<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 26" title="Jia, Y. et al. Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors. Nature 534, 129–132 (2016)." href="/articles/s41467-019-09186-x#ref-CR26" id="ref-link-section-d4768e1328">26</a></sup>.</p><div class="c-article-table" data-test="inline-table" data-container-section="table" id="table-1"><figure><figcaption class="c-article-table__figcaption"><b id="Tab1" data-test="table-caption">Table 1 Network configurations of the selected hypertensive drug–drug pairs</b></figcaption><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="table-link" data-track="click" data-track-action="view table" data-track-category="article body" data-track-label="button" rel="nofollow" href="/articles/s41467-019-09186-x/tables/1"><span>Full size table</span></a></div></figure></div><p>The third key finding is that only drug pairs that have a Complementary Exposure relationship to the disease module (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig2">2b</a> and Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">10b</a>) show a statistically significant efficacy for drug combination therapies. Consider, for example, amiloride and hydrochlorothiazide, in the Complementary Exposure (P2 in Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41467-019-09186-x#Tab1">1</a>) class. This combination has been shown to prevent glucose intolerance and to improve blood pressure control compared with monotherapy with either drug in the PATHWAY-3 trial<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 27" title="Brown, M. J. et al. Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial. Lancet Diabetes Endocrinol. 4, 136–147 (2016)." href="/articles/s41467-019-09186-x#ref-CR27" id="ref-link-section-d4768e1692">27</a></sup>. In other words, we find that only separated drugs that individually overlap with the disease module show statistical significance in co-treatment of hypertension (<i>P</i> &lt; 1.0 × 10<sup>−4</sup>, permutation test, Complementary Exposure in Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig2">2b</a> and Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">11b</a>) and similarly for cancer (<i>P</i> &lt; 1.0 × 10<sup>−4</sup>, permutation test, Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">10b</a>). Specifically, we assembled hypertensive drug combination data from FDA-approved evidence, clinical trials from the Clinicaltrials.gov database, and pre-clinical studies from literature curation (Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM5">3</a>), finding again that drug pairs with Complementary Exposure (P2) significantly tend to co-treat hypertension efficiently (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig2">2b</a>) compared to FDA-approved antihypertensive combinations (Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">11b</a>), indicating low selection bias. The unique network-based relationship that drug pairs with Complementary Exposure to the disease module tend to be effective drug combinations is consistent with the non-overlapping pharmacological principle in rational drug combination design<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 26" title="Jia, Y. et al. Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors. Nature 534, 129–132 (2016)." href="/articles/s41467-019-09186-x#ref-CR26" id="ref-link-section-d4768e1726">26</a></sup>. In summary, characterizing the network-based relationship between drug–target modules and the disease module (Complementary Exposure) within the human interactome offers a powerful, network-based strategy for rational drug combination design.</p><h3 class="c-article__sub-heading u-h3" id="Sec5">Network-based uncovering of hypertensive drug combinations</h3><p>The finding that Complementary Exposure is predictive of effective drug combinations prompts us to offer network-based predictions of new drug combinations using hypertension data as a validation set (Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM5">3</a>). Such a predictor builds on two established network approaches: (a) network-based separation (Eq. (<a data-track="click" data-track-label="link" data-track-action="equation anchor" href="/articles/s41467-019-09186-x#Equ2">2</a>)) between targets of two drugs<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Menche, J. et al. Disease networks. Uncovering disease–disease relationships through the incomplete interactome. Science 347, 1257601 (2015)." href="/articles/s41467-019-09186-x#ref-CR14" id="ref-link-section-d4768e1744">14</a></sup>; and (b) network proximity (Eq. (<a data-track="click" data-track-label="link" data-track-action="equation anchor" href="/articles/s41467-019-09186-x#Equ1">1</a>)) between the disease (hypertension) module and the two drug–target modules<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 15" title="Guney, E., Menche, J., Vidal, M. &amp; Barabasi, A. L. Network-based in silico drug efficacy screening. Nat. Commun. 7, 10331 (2016)." href="/articles/s41467-019-09186-x#ref-CR15" id="ref-link-section-d4768e1751">15</a></sup>. Specifically, we rank all possible drug pairs by increasing separation score (s<sub>AB</sub>). We then restrict this list to drug pairs with Complementary Exposure (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig2">2b</a>) to the hypertension disease module. In principle, this approach allows us to identify pairwise combinations not only between two hypertensive drugs, but also between one hypertensive drug and one non-hypertensive drug, or between two non-hypertensive drugs. Here, we focus on drug combinations involving 65 FDA-approved hypertensive drugs (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig3">3a</a>). The 24 FDA-approved combinations involving hypertensive drugs (Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM5">3</a>) lead to a 59% accuracy (AUC = 0.589 ± 0.002) for the network-based discrimination of the approved hypertensive drug combinations from random drug pairs. This network-based approach outperforms traditional chemoinformatics (AUC = 0.489 ± 0.002) and bioinformatics approaches (AUC = 0.529 ± 0.002, Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">13</a>), indicating that network proximity offers an efficacious strategy to identify new drug combinations for treatment of hypertension.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-3"><figure><figcaption><b id="Fig3" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 3</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-category="article body" data-track-label="image" data-track-action="view figure" href="/articles/s41467-019-09186-x/figures/3" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-019-09186-x/MediaObjects/41467_2019_9186_Fig3_HTML.png?as=webp"></source><img aria-describedby="figure-3-desc" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-019-09186-x/MediaObjects/41467_2019_9186_Fig3_HTML.png" alt="figure3" loading="lazy" /></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-3-desc"><p>Network-based stratification of hypertensive drug combinations. <b>a</b> Heatmap showing the predicted network-based separation (s<sub>AB</sub>) among 65 FDA-approved anti-hypertensive drugs. Drugs are clustered based on their target families. FDA-approved or experimentally validated drug combinations for the treatment of hypertension are highlighted by circles (o). Clinically reported adverse drug interactions are highlighted by X. Color keys are shown by s<sub>AB</sub>. The right heatmap highlighting the four distinct classes capturing the network-based relationship (P1–P4, Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig2">2a–d</a>) for 65 FDA-approved anti-hypertensive drugs on the hypertension disease module. <b>b</b> A network map showing the relationship between the drug–target modules and the hypertension disease module (the largest connected subgraph by red) in the human interactome. Complementary Exposure for two FDA-approved drug combinations (hydrochlorothiazide–amiloride and hydrochlorothiazide–spironolactone) are highlighted by blue and orange via blue arrow, respectively. Overlapping Exposure for two clinically reported adverse drug–drug interactions (diazoxide–hydrochlorothiazide and diazoxide–bendroflumethiazide) are also illustrated by red arrow. The target families of 65 FDA-approved anti-hypertensive drugs are highlighted by different colors in both (<b>a</b>) and (<b>b</b>). The edges in (<b>b</b>) denote the protein–protein interactions (PPIs) colored by different types of hypertensive drug target families or known hypertension disease proteins (genes)</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-category="article body" data-track-label="button" data-track-action="view figure" href="/articles/s41467-019-09186-x/figures/3" data-track-dest="link:Figure3 Full size image" rel="nofollow"><span>Full size image</span></a></div></figure></div><p>To exploit the predictive power of this network-based prediction prospectively, we first focus on hydrochlorothiazide, an FDA-approved inhibitor on the sodium-chloride symporter for treatment of hypertension<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 28" title="Beermann, B., Groschinsky-Grind, M. &amp; Rosen, A. Absorption, metabolism, and excretion of hydrochlorothiazide. Clin. Pharmacol. Ther. 19, 531–537 (1976)." href="/articles/s41467-019-09186-x#ref-CR28" id="ref-link-section-d4768e1814">28</a></sup>. Our network-based algorithm offers 30 potentially efficacious combinations involving hydrochlorothiazide, of which 21 (70% success rate) are already validated by FDA-approved evidence, clinical studies from Clinicaltrials.gov, or previously reported preclinical data (Supplementary Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">1</a>). Specifically, we restrict the predicted drug pairs on hydrochlorothiazide with Complementary Exposure and select the top 30 candidates ranked based on their increasing separation score (s<sub>AB</sub>). For example, the predicted spironolactone and hydrochlorothiazide combination has been approved for treating hypertension and fluid retention in patients with congestive heart failure or nephrotic syndrome (Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41467-019-09186-x#Tab1">1</a>). Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig3">3b</a> shows the network-based relationship between targets of spironolactone and hydrochlorothiazide within the hypertension disease module. We find that hydrochlorothiazide targets the sodium-chloride symporter pathway (e.g., SLC12A3) and spironolactone targets the mineralocorticoid receptor pathway (e.g., NR3C2), both in the hypertension disease module following by the Complementary Exposure category (Figs. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig2">2b</a>, <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig3">3b</a>). Avapro, a combination of irbesartan (an FDA-approved angiotensin receptor blocker for the treatment of hypertension) and hydrochlorothiazide, has been approved for the treatment of hypertension (Application No. 20758S003, Supplementary Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">1</a>) is predicted to be an efficacious combination by this approach. Nifedipine, an approved voltage-dependent calcium channel blocker for the treatment of hypertension, is another network-predicted combination partner for hydrochlorothiazide. A recent preclinical study reported that combining nifedipine (10 mg/kg/day) with hydrochlorothiazide (10 mg/kg/day) showed a significant synergistic effect on blood pressure reduction, blood pressure variability enhancement, and organ protection in spontaneously hypertensive rats<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 29" title="Han, P., Chu, Z. X., Shen, F. M., Xie, H. H. &amp; Su, D. F. Synergism of hydrochlorothiazide and nitrendipine on reduction of blood pressure and blood pressure variability in spontaneously hypertensive rats. Acta Pharmacol. Sin. 27, 1575–1579 (2006)." href="/articles/s41467-019-09186-x#ref-CR29" id="ref-link-section-d4768e1839">29</a></sup>. Telmisartan, an angiotensin II receptor antagonist, is the other network-predicted combination partner for hydrochlorothiazide. Multiple clinical trials registered in Clinicaltrials.gov are under way or have been completed that reveal potentially therapeutic combination effects of telmisartan and hydrochlorothiazide on the treatment of hypertension (NCT00509470, NCT00239369, and NCT00144222). Altogether, the network-based model has successfully identified well-known hypertensive drug combinations with well-defined drug pharmacological pathways in the hypertension disease module (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig3">3b</a>).</p><p>Finally, our approach helps us computationally identify several drug combinations for the treatment of hypertension. For example, ethacrynic acid, a sodium/potassium/chloride symporter inhibitor, is approved by FDA to treat hypertension, congestive heart failure, and kidney failure. Our network-based model reveals that ethacrynic acid has the highest likelihood for validating combination with hydrochlorothiazide to treat hypertension (Supplementary Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">1</a>), representing a potential drug combination. Guanfacine, an approved alpha-2 adrenoreceptor inhibitor to treat hypertension and attention deficit hyperactivity disorder, is predicted to have a high likelihood when used together with hydrochlorothiazide (Supplementary Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">1</a>), representing another potential drug combination for the treatment of hypertension. In total, we computationally identified 1455 potential combinations involving 65 hypertensive drugs with Complementary Exposure to the hypertension disease module (Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM7">5</a>). In addition, we provide an exhaustive list of predicted drug combinations involving non-hypertensive drugs with Complementary Exposure and potential adverse drug interactions involving drug pairs with Overlapping Exposure to the hypertension disease module (Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM7">5</a>), offering a potential virtual hypertensive drug combination database for future experimental validation and prospective clinical trials. Taken together, the network-based models developed here offer a powerful tool to identify efficacious drug combinations for the treatment of hypertension.</p></div></div></section><section aria-labelledby="Sec6"><div class="c-article-section js-article-section" id="Sec6-section"><h2 class="c-article-section__title u-h2 js-section-title js-c-reading-companion-sections-item" id="Sec6">Discussion</h2><div class="c-article-section__content js-collapsible-section" id="Sec6-content"><p>Combination therapies offer widespread well-documented advantages in the treatment of complex diseases. Here, we demonstrated that a network-based methodology that identifies the relative network configuration of drug–target modules with respect to the disease module can help prioritize potentially efficacious pairwise drug combinations for both hypertension and cancer. Specifically, our interactome-based approach offers a network-level view of therapeutic combinations in terms of comparative efficacy and adverse interactions. Our key finding is that a drug combination is therapeutically effective only if it follows a specific network topological relationship to the disease module, as captured by the Complementary Exposure pattern. Somewhat surprisingly, if we are searching for therapeutically synergistic combinations, the two drug–target modules must not only overlap with the disease module, but also need to be separated in the human interactome without overlapping toxicities<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 26" title="Jia, Y. et al. Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors. Nature 534, 129–132 (2016)." href="/articles/s41467-019-09186-x#ref-CR26" id="ref-link-section-d4768e1870">26</a></sup>. Here we documented the predictive power of Complementary Exposure in two complex diseases (hypertension and cancer) based on known drug combination data from publicly available databases. Therefore, future work is needed to explore the generalizability of our findings to other diseases.</p><p>Drug pairs with Complementary Exposure are expected to have either therapeutic (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig2">2b</a>) or adverse effects (Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">11b</a> and Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">12b</a>). For example, a recent clinical study has reported that combining amiloride and hydrochlorothiazide (Complementary Exposure in Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41467-019-09186-x#Fig3">3b</a>) induced hypokalemia (adverse effect) in hypertensive patients<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 30" title="Maronde, R. F., Milgrom, M., Vlachakis, N. D. &amp; Chan, L. Response of thiazide-induced hypokalemia to amiloride. JAMA 249, 237–241 (1983)." href="/articles/s41467-019-09186-x#ref-CR30" id="ref-link-section-d4768e1889">30</a></sup>. Altogether, adverse effects can appear independently from the separation of the two drug target modules, occurring significantly in both Overlapping Exposure (Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">11a</a> and Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">12a</a>) and Complementary Exposure (Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">11b</a> and Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">12b</a>). Lack of dose-dependent information and precise perturbation effects of disease-causing variants and drug exposure generate a coupled interplay between adverse and therapeutic effects<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 31" title="Greene, J. A. &amp; Loscalzo, J. Putting the patient back together—social medicine, network medicine, and the limits of reductionism. N. Engl. J. Med. 377, 2493–2499 (2017)." href="/articles/s41467-019-09186-x#ref-CR31" id="ref-link-section-d4768e1906">31</a></sup> for Complementary Exposure. Integration of network proximity, high-throughput in vitro or in vivo assays, pharmacokinetics-based mathematical modeling (e.g., cytochrome P450 enzymes<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 32" title="Bibi, Z. Role of cytochrome P450 in drug interactions. Nutr. Metab. 5, 27 (2008)." href="/articles/s41467-019-09186-x#ref-CR32" id="ref-link-section-d4768e1910">32</a></sup>), large-scale pharmacointeraction networks<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 33" title="Cami, A., Manzi, S., Arnold, A. &amp; Reis, B. Y. Pharmacointeraction network models predict unknown drug–drug interactions. PLoS ONE 8, e61468 (2013)." href="/articles/s41467-019-09186-x#ref-CR33" id="ref-link-section-d4768e1915">33</a></sup>, and patient data (i.e., health insurance claims and electronic health records)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 16" title="Cheng, F. et al. Network-based approach to prediction and population-based validation of in silico drug repurposing. Nat. Commun. 9, 2691 (2018)." href="/articles/s41467-019-09186-x#ref-CR16" id="ref-link-section-d4768e1919">16</a></sup> could establish the causal mechanism and clinical evidence through which drug combinations could be identified with specific therapeutic indications without obvious adverse effects<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 34" title="Zhao, S. et al. Systems pharmacology of adverse event mitigation by drug combinations. Sci. Transl. Med. 5, 206ra140 (2013)." href="/articles/s41467-019-09186-x#ref-CR34" id="ref-link-section-d4768e1923">34</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 35" title="Tatonetti, N. P., Ye, P. P., Daneshjou, R. &amp; Altman, R. B. Data-driven prediction of drug effects and interactions. Sci. Transl. Med. 4, 125ra131 (2012)." href="/articles/s41467-019-09186-x#ref-CR35" id="ref-link-section-d4768e1926">35</a></sup>. In addition, future work is needed to explore the effects of potential data selection bias. For example, combinations of drugs that target related proteins in the same disease module are more likely to be tested in drug combination clinical trials. Finally, given the lack of large-scale, systematic data on combinations of multiple drugs, in our current study, we limited our exploration on drug pairs only. Yet, we expect that Complementary Exposure remains an efficient design principle even upon combining multiple drugs. To fight the combinatorial explosion upon inspecting network relationships of multiple drug–target modules with a disease module, theories of signed networks can be of great help, such as structural balance theories<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 36" title="Facchetti, G., Iacono, G. &amp; Altafini, C. Computing global structural balance in large-scale signed social networks. Proc. Natl. Acad. Sci. U.S.A. 108, 20953–20958 (2011)." href="/articles/s41467-019-09186-x#ref-CR36" id="ref-link-section-d4768e1930">36</a></sup>, reducing the number of network patterns to investigate in the human interactome. In addition, advanced network-based link prediction methods rooted in biological principles<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 37" title="Istvan, A. K. et al. Network-based prediction of protein interactions. Preprint at &#xA;                    https://doi.org/10.1101/275529&#xA;                    &#xA;                   (2018)." href="/articles/s41467-019-09186-x#ref-CR37" id="ref-link-section-d4768e1934">37</a></sup> can help to develop a combined, quantitative score for each predicted drug combination. Eventually, experimental validation and prospective clinical trials must be conducted to verify the network-predicted drug combinations under controlled conditions. As for the input data, having a more complete human interactome and more complete, systematic drug–target network with well-annotated pharmacokinetics and pharmacodynamics information would improve the performance of the network-based model further.</p><p>In summary, our findings suggest that the discovery of efficacious drug combinations could benefit from network-based, rational drug combination screenings, exploring the relationship between drug–target modules and the disease modules via network proximity in the human interactome. From a translational perspective, the network tools developed here could help develop novel, efficacious combination therapies for multiple complex diseases if broadly applied.</p></div></div></section><section aria-labelledby="Sec7"><div class="c-article-section js-article-section" id="Sec7-section"><h2 class="c-article-section__title u-h2 js-section-title js-c-reading-companion-sections-item" id="Sec7">Methods</h2><div class="c-article-section__content js-collapsible-section" id="Sec7-content"><h3 class="c-article__sub-heading u-h3" id="Sec8">Constructing the human protein–protein interactome</h3><p>We assembled 15 commonly used databases, focusing on high-quality PPIs with five types of evidences: (1) binary, physical PPIs tested by high-throughput yeast-two-hybrid (Y2H) screening system, combining binary PPIs tested from two publicly available high-quality Y2H datasets<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 38" title="Rolland, T. et al. A proteome-scale map of the human interactome network. Cell 159, 1212–1226 (2014)." href="/articles/s41467-019-09186-x#ref-CR38" id="ref-link-section-d4768e1953">38</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Rual, J. F. et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature 437, 1173–1178 (2005)." href="/articles/s41467-019-09186-x#ref-CR39" id="ref-link-section-d4768e1956">39</a></sup>, and one unpublished dataset, available at <a href="http://ccsb.dana-farber.org/interactome-data.html">http://ccsb.dana-farber.org/interactome-data.html</a>; (2) literature-curated PPIs identified by affinity purification followed by affinity-purification mass spectrometry (AP-MS), Y2H, and literature-derived low-throughput experiments; (3) binary, physical PPIs derived from protein three-dimensional structures; (4) kinase-substrate interactions by literature-derived low-throughput and high-throughput experiments; and (5) signaling networks by literature-derived low-throughput experiments. The protein-coding genes were mapped to their official gene symbols based on GeneCards (<a href="http://www.genecards.org/">http://www.genecards.org/</a>) and their Entrez ID. Computationally inferred interactions rooted in evolutionary analysis, gene expression data, and metabolic associations were excluded. The updated human interactome includes 243,603 PPIs connecting 16,677 unique proteins, and is 40% greater in size compared to our previously used human interactome<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Menche, J. et al. Disease networks. Uncovering disease–disease relationships through the incomplete interactome. Science 347, 1257601 (2015)." href="/articles/s41467-019-09186-x#ref-CR14" id="ref-link-section-d4768e1974">14</a></sup>. The human protein–protein interactome are provided in the Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM3">1</a>.</p><h3 class="c-article__sub-heading u-h3" id="Sec9">Construction of drug–target network</h3><p>We collected high-quality physical drug–target interactions on FDA-approved or clinically investigational drugs from 6 commonly used data sources, and defined a physical drug–target interaction using reported binding affinity data: inhibition constant/potency (<i>K</i><sub>i</sub>), dissociation constant (<i>K</i><sub>d</sub>), median effective concentration (EC<sub>50</sub>), or median inhibitory concentration (IC<sub>50</sub>) ≤ 10 µM. Drug–target interactions were acquired from the DrugBank database (v4.3)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 40" title="Law, V. et al. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 42, D1091–D1097 (2014)." href="/articles/s41467-019-09186-x#ref-CR40" id="ref-link-section-d4768e2002">40</a></sup>, the Therapeutic Target Database (TTD, v4.3.02)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 41" title="Zhu, F. et al. Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res. 40, D1128–D1136 (2012)." href="/articles/s41467-019-09186-x#ref-CR41" id="ref-link-section-d4768e2006">41</a></sup>, and the PharmGKB database (December 30, 2015)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 42" title="Hernandez-Boussard, T. et al. The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge. Nucleic Acids Res. 36, D913–D918 (2008)." href="/articles/s41467-019-09186-x#ref-CR42" id="ref-link-section-d4768e2010">42</a></sup>. Specifically, bioactivity data of drug–target pairs were collected from three widely used databases: ChEMBL (v20, accessed in December 2015)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 43" title="Gaulton, A. et al. ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res. 40, D1100–D1107 (2012)." href="/articles/s41467-019-09186-x#ref-CR43" id="ref-link-section-d4768e2014">43</a></sup>, BindingDB (downloaded in December 2015)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 44" title="Liu, T. Q., Lin, Y. M., Wen, X., Jorissen, R. N. &amp; Gilson, M. K. BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities. Nucleic Acids Res. 35, D198–D201 (2007)." href="/articles/s41467-019-09186-x#ref-CR44" id="ref-link-section-d4768e2018">44</a></sup>, and IUPHAR/BPS Guide to PHARMACOLOGY (downloaded in December 2015)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 45" title="Pawson, A. J. et al. The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucleic Acids Res. 42, D1098–D1106 (2014)." href="/articles/s41467-019-09186-x#ref-CR45" id="ref-link-section-d4768e2022">45</a></sup>. After extracting the bioactivity data related to drugs from these databases, we retained only the drug–target interactions that meet the following four criteria: (i) binding affinities, including <i>K</i><sub>i</sub>, <i>K</i><sub>d</sub>, IC<sub>50</sub> or EC<sub>50</sub> each ≤10 μM; (ii) proteins can be represented by unique UniProt accession number; (iii) proteins are marked as “reviewed” in the UniProt database<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 46" title="Apweiler, R. et al. UniProt: the universal protein knowledgebase. Nucleic Acids Res. 32, D115–D119 (2004)." href="/articles/s41467-019-09186-x#ref-CR46" id="ref-link-section-d4768e2039">46</a></sup>; and (iv) proteins are from Homo sapiens. In total, 15,051 drug–target interactions connecting 4428 drugs and 2256 unique human targets were built, including 1978 drugs that have at least two experimentally validated targets (Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM4">2</a>).</p><h3 class="c-article__sub-heading u-h3" id="Sec10">Collecting gold-standard pairwise drug combinations</h3><p>In this study, we focused on pairwise drug combinations by assembling the clinical data from the multiple data sources (Supplementary Note <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">3</a>). Each drug in combinations was required to have the experimentally validated target information: each EC<sub>50</sub>, IC<sub>50</sub>, <i>K</i><sub>i</sub>, or <i>K</i><sub>d</sub> ≤ 10 µM. Compound name, generic name, or commercial name of each drug was standardized by MeSH and UMLS vocabularies<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 47" title="Bodenreider, O. The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Res. 32, D267–D270 (2004)." href="/articles/s41467-019-09186-x#ref-CR47" id="ref-link-section-d4768e2071">47</a></sup> and further transferred to DrugBank ID from the DrugBank database (v4.3)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 40" title="Law, V. et al. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 42, D1091–D1097 (2014)." href="/articles/s41467-019-09186-x#ref-CR40" id="ref-link-section-d4768e2075">40</a></sup>. Duplicated drug pairs were removed. In total, 681 unique pairwise drug combinations connecting 362 drugs were retained (Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM5">3</a>).</p><h3 class="c-article__sub-heading u-h3" id="Sec11">Collecting adverse drug–drug interactions</h3><p>We compiled clinically reported adverse drug–drug interactions (DDIs) data from the DrugBank database (v4.3)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 40" title="Law, V. et al. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 42, D1091–D1097 (2014)." href="/articles/s41467-019-09186-x#ref-CR40" id="ref-link-section-d4768e2090">40</a></sup>. Here, we focused on adverse drug interactions where each drug has the experimentally validated target information. Compound name, generic name, or commercial name of each drug were standardized by MeSH and UMLS vocabularies<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 47" title="Bodenreider, O. The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Res. 32, D267–D270 (2004)." href="/articles/s41467-019-09186-x#ref-CR47" id="ref-link-section-d4768e2094">47</a></sup> and further transferred to DrugBank ID from the DrugBank database (v4.3)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 40" title="Law, V. et al. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 42, D1091–D1097 (2014)." href="/articles/s41467-019-09186-x#ref-CR40" id="ref-link-section-d4768e2098">40</a></sup>. In total, 13,397 clinically reported adverse DDIs connecting 658 unique drugs were retained (Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM6">4</a>). In addition, we collected cardiovascular event-specific adverse DDIs from the TWOSIDE database<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 35" title="Tatonetti, N. P., Ye, P. P., Daneshjou, R. &amp; Altman, R. B. Data-driven prediction of drug effects and interactions. Sci. Transl. Med. 4, 125ra131 (2012)." href="/articles/s41467-019-09186-x#ref-CR35" id="ref-link-section-d4768e2105">35</a></sup>. TWOSIDE includes over 868,221 significant associations connecting 59,220 drug pairs and 1301 adverse events<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 35" title="Tatonetti, N. P., Ye, P. P., Daneshjou, R. &amp; Altman, R. B. Data-driven prediction of drug effects and interactions. Sci. Transl. Med. 4, 125ra131 (2012)." href="/articles/s41467-019-09186-x#ref-CR35" id="ref-link-section-d4768e2110">35</a></sup>. In this study, we focused on 4 types of cardiovascular events: arrhythmia (MeSH ID: D001145), heart failure (MeSH ID: D006333), myocardial infarction (MeSH ID: D009203), and high blood pressure (MeSH ID: D006973).</p><h3 class="c-article__sub-heading u-h3" id="Sec12">Chemical similarity analysis of drug pairs</h3><p>We downloaded chemical structure information (SMILES format) from the DrugBank database (v4.3)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 40" title="Law, V. et al. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 42, D1091–D1097 (2014)." href="/articles/s41467-019-09186-x#ref-CR40" id="ref-link-section-d4768e2123">40</a></sup> and computed MACCS fingerprints of each drug using Open Babel v2.3.1<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 48" title="O’Boyle, N. M. et al. Open Babel: an open chemical toolbox. J. Cheminform. 3, 33 (2011)." href="/articles/s41467-019-09186-x#ref-CR48" id="ref-link-section-d4768e2127">48</a></sup>. If two drug molecules have a and b bits set in their MACCS fragment bit-strings, with c of these bits being set in the fingerprints of both drugs, the Tanimoto coefficient (T) of a drug–drug pair is defined as:</p><div id="Equ3" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$${\mathrm{T}} = \frac{c}{{a + b - c}}$$</span></div><div class="c-article-equation__number">
                    (3)
                </div></div><p>T is widely used in drug discovery and development<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 49" title="Willett, P. Similarity-based virtual screening using 2D fingerprints. Drug Discov. Today 11, 1046–1053 (2006)." href="/articles/s41467-019-09186-x#ref-CR49" id="ref-link-section-d4768e2176">49</a></sup>, offering a value in the range of zero (no bits in common) to one (all bits are the same).</p><h3 class="c-article__sub-heading u-h3" id="Sec13">Protein sequence similarity (identity) analysis</h3><p>We downloaded the canonical protein sequences of drug targets (proteins) in <i>Homo sapiens</i> from UniProt database (<a href="http://www.uniprot.org/">http://www.uniprot.org/</a>). We calculated the protein sequence similarity <i>S</i><sub><i>P</i></sub>(<i>a, b</i>) of two drug targets a and b using the Smith–Waterman algorithm<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 50" title="Smith, T. F. &amp; Waterman, M. S. Identification of common molecular subsequences. J. Mol. Biol. 147, 195–197 (1981)." href="/articles/s41467-019-09186-x#ref-CR50" id="ref-link-section-d4768e2207">50</a></sup>. The Smith–Waterman algorithm performs local sequence alignment by comparing segments of all possible lengths and optimizing the similarity measure for determining similar regions between two strings of protein canonical sequences of drug targets. The overall sequence similarity of the targets binding two drugs A and B is determined by Eq. (<a data-track="click" data-track-label="link" data-track-action="equation anchor" href="/articles/s41467-019-09186-x#Equ4">4</a>) by averaging all pairs of proteins a and b with <span class="mathjax-tex">\(a \in A\)</span> and <span class="mathjax-tex">\(b \in B\)</span> under the condition <span class="mathjax-tex">\(a \ne b\)</span>. This condition ensures that for drugs with common targets we do not take pairs into account where a target would be compared to itself.</p><div id="Equ4" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$\langle S_p \rangle = \frac{1}{{n_{\mathrm{pairs}}}}\mathop {\sum }\limits_{\{ a,b\} } S_p\left( {a,b} \right)$$</span></div><div class="c-article-equation__number">
                    (4)
                </div></div><h3 class="c-article__sub-heading u-h3" id="Sec14">Gene co-expression analysis</h3><p>We downloaded the RNA-seq data (RPKM value) across 32 tissues from GTEx V6 release (accessed on April 2016, <a href="https://gtexportal.org/">https://gtexportal.org/</a>). For each tissue, we regarded those genes with RPKM ≥ 1 in more than 80% samples as tissue-expressed genes. To measure the extent to which drug target-coding genes (a and b) associated with the drug-treated diseases are co-expressed, we calculated the Pearson’s correlation coefficient (<span class="mathjax-tex">\(PCC\left( {a,b} \right)\)</span>) and the corresponding <i>P</i>-value via <i>F</i>-statistics for each pair of drug target-coding genes a and b across 32 human tissues. In order to reduce the noise of co-expression analysis, we mapped <i>PCC</i>(<i>a, b</i>) into the human protein–protein interactome network (Supplementary <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">Methods 2</a>) to build a co-expressed protein–protein interactome network as described previously<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 51" title="Cheng, F. et al. Studying tumorigenesis through network evolution and somatic mutational perturbations in the cancer interactome. Mol. Biol. Evol. 31, 2156–2169 (2014)." href="/articles/s41467-019-09186-x#ref-CR51" id="ref-link-section-d4768e2465">51</a></sup>. The co-expression similarity of the drug target-coding genes associated with two drugs A and B is computed by averaging <i>PCC</i>(<i>a,b</i>) over all pairs of targets a and b with <span class="mathjax-tex">\(a \in A\)</span> and <span class="mathjax-tex">\(b \in B\)</span> as below:</p><div id="Equ5" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$\langle S_{\mathrm{co}} \rangle = \frac{1}{{n_{\mathrm{pairs}}}}\mathop {\sum }\limits_{\{ a,b\} } |PCC\left( {a,b} \right)|$$</span></div><div class="c-article-equation__number">
                    (5)
                </div></div><h3 class="c-article__sub-heading u-h3" id="Sec15">Gene Ontology (GO) similarity analysis</h3><p>The Gene Ontology (GO) annotation for all drug target-coding genes was downloaded from the website: <a href="http://www.geneontology.org/">http://www.geneontology.org/</a>. We used three types of the experimentally validated or literature-derived evidences: biological processes (BP), molecular function (MF), and cellular component (CC), excluding annotations inferred computationally. The semantic comparison of GO annotations offers quantitative ways to compute similarities between genes and gene products. We computed GO similarity <i>S</i><sub>GO</sub>(<i>a,b</i>) for each pair of drug target-coding genes a and b using a graph-based semantic similarity measure algorithm<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 52" title="Wang, J. Z., Du, Z., Payattakool, R., Yu, P. S. &amp; Chen, C. F. A new method to measure the semantic similarity of GO terms. Bioinformatics 23, 1274–1281 (2007)." href="/articles/s41467-019-09186-x#ref-CR52" id="ref-link-section-d4768e2658">52</a></sup> implemented in an R package, named GOSemSim<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 53" title="Yu, G. et al. GOSemSim: an R package for measuring semantic similarity among GO terms and gene products. Bioinformatics 26, 976–978 (2010)." href="/articles/s41467-019-09186-x#ref-CR53" id="ref-link-section-d4768e2662">53</a></sup>. The overall GO similarity of the drug target-coding genes binding to two drugs A and B was determined by Eq. (<a data-track="click" data-track-label="link" data-track-action="equation anchor" href="/articles/s41467-019-09186-x#Equ6">6</a>), averaging all pairs of drug target-coding genes a and b with <span class="mathjax-tex">\(a \in A\)</span> and <span class="mathjax-tex">\(b \in B\)</span>.</p><div id="Equ6" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$\langle S_{\mathrm{GO}} \rangle = \frac{1}{{n_{\mathrm{pairs}}}}\mathop {\sum }\limits_{\{ a,b\} } S_{\mathrm{GO}}\left( {a,b} \right)$$</span></div><div class="c-article-equation__number">
                    (6)
                </div></div><h3 class="c-article__sub-heading u-h3" id="Sec16">Clinical similarity analysis</h3><p>Clinical similarities of drug pairs derived from the drug Anatomical Therapeutic Chemical (ATC) classification systems codes have been commonly used to predict new drug targets<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 54" title="Cheng, F. et al. Prediction of polypharmacological profiles of drugs by the integration of chemical, side effect, and therapeutic space. J. Chem. Inf. Model. 53, 753–762 (2013)." href="/articles/s41467-019-09186-x#ref-CR54" id="ref-link-section-d4768e2841">54</a></sup>. The ATC codes for all FDA-approved drugs used in this study were downloaded from the DrugBank database (v4.3)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 40" title="Law, V. et al. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 42, D1091–D1097 (2014)." href="/articles/s41467-019-09186-x#ref-CR40" id="ref-link-section-d4768e2845">40</a></sup>. The kth level drug clinical similarity (<i>S</i><sub><i>k</i></sub>) of drugs A and B is defined via the ATC codes as below.</p><div id="Equ7" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$S_k\left( {A,B} \right) = \frac{{ATC_k(A) \cap ATC_k(B)}}{{ATC_k(A) \cup ATC_k(B)}}$$</span></div><div class="c-article-equation__number">
                    (7)
                </div></div><p>where <i>ATC</i><sub><i>k</i></sub> represents all ATC codes at the <i>k</i>th level. A score <i>S</i><sub><i>atc</i></sub>(<i>A, B</i>) is used to define the clinical similarity between drugs A and B:</p><div id="Equ8" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$S_{atc}\left( {A,B} \right) = \frac{{\mathop {\sum }\nolimits_{k = 1}^n S_k\left( {A,B} \right)}}{n}$$</span></div><div class="c-article-equation__number">
                    (8)
                </div></div><p>where <i>n</i> represents the five levels of ATC codes (ranging from 1 to 5). Note that drugs can have multiple ATC codes. For example, nicotine (a potent parasympathomimetic stimulant) has four different ATC codes: N07BA01, A11HA01, C04AC01, C10AD02. For a drug with multiple ATC codes, the clinical similarity was computed for each ATC code, and then, the average clinical similarity was used<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 54" title="Cheng, F. et al. Prediction of polypharmacological profiles of drugs by the integration of chemical, side effect, and therapeutic space. J. Chem. Inf. Model. 53, 753–762 (2013)." href="/articles/s41467-019-09186-x#ref-CR54" id="ref-link-section-d4768e3163">54</a></sup>.</p><h3 class="c-article__sub-heading u-h3" id="Sec17">Comparison with target set-overlapping approach</h3><p>In this section, we compared the introduced network-based separation (Eq. (<a data-track="click" data-track-label="link" data-track-action="equation anchor" href="/articles/s41467-019-09186-x#Equ2">2</a>)) of drugs with overlap measures that are solely based on shared targets, without using the PPI network. Here, we examined two measures to quantify the overlap between target sets of drug A and drug B:</p><div id="Equ9" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$${\mathrm{Overlap}}\;{\mathrm{coefficient}}\;C = \left| {A \cap B} \right|/\mathrm{min}(\left| A \right|,\left| B \right|)$$</span></div><div class="c-article-equation__number">
                    (9)
                </div></div><div id="Equ10" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$${\mathrm{Jaccard - index}}\;J = \left| {A \cap B} \right|/\left| {A \cup B} \right|$$</span></div><div class="c-article-equation__number">
                    (10)
                </div></div><p>Both values range from 0 to 1: <i>J</i>, <i>C</i> = 0 revealing no common targets shared by the drugs. An overlap coefficient <i>C</i> = 1 indicates that one set is a complete subset of the other, where Jaccard-index <i>J</i> = 1 is for two identical target sets (Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">4a</a>). Supplementary Figs. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">4b</a> and <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">4c</a> show the distribution of <i>C</i> and <i>J</i> for all 1,955,253 drug pairs. The target-set overlap is low for most drug pairs, and the majority (96.8% = 1,892,455/1,955,253) do not share any targets. To investigate the statistical significance of the observed overlaps, we used a hypergeometric model. The null hypothesis is that drug targets are randomly located from the space of all N protein-coding genes in the human interactome. The overlap expected for two target sets A and B is then given by</p><div id="Equ11" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$c_{rand} = \frac{{\left| A \right| \times \left| B \right|}}{N}$$</span></div><div class="c-article-equation__number">
                    (11)
                </div></div><p>For every observed overlap <span class="mathjax-tex">\(c_{obs} = \left| {A \cap B} \right|\)</span>, we then determined the fold-change</p><div id="Equ12" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$fc = \frac{{c_{obs}}}{{c_{rand}}}$$</span></div><div class="c-article-equation__number">
                    (12)
                </div></div><p>and the <i>P</i>-values for enrichment and depletion (e.g., fewer common targets than expected), based on the hypergeometric distribution.</p><h3 class="c-article__sub-heading u-h3" id="Sec18">Network-based separation of drugs</h3><p>A network-based separation of a drug pair, A and B, is calculated via Eq. (<a data-track="click" data-track-label="link" data-track-action="equation anchor" href="/articles/s41467-019-09186-x#Equ2">2</a>). We evaluated four other different distance measures that take into account the path lengths between two drug target sets: (a) the closest measure, representing the average shortest path length between targets of drug A and the nearest target of the drug A; (b) the shortest measure, representing the average shortest path length among all targets of drugs; (c) the kernel measure, down-weighting longer paths via an exponential penalty; (d) the centre measure, representing the shortest path length among all targets of drugs with the greatest closeness centrality among drug targets. Given A and B, the set of drug targets for A and B, and <i>d</i><sub><i>AB</i></sub>, the shortest path length between nodes a and b in the interactome, we define these distance measures as follows:</p><div id="Equ13" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$${\mathrm{Closest}}:\langle d_{AB}^C\rangle = \frac{1}{{\left| {\left| A \right|} \right| + \left\Vert B \right\Vert}}\left( {\mathop {\sum }\limits_{a \in A} min_{b \in B}d\left( {a,b} \right) + \mathop {\sum }\limits_{b \in B} min_{a \in A}d\left( {a,b} \right)} \right)$$</span></div><div class="c-article-equation__number">
                    (13)
                </div></div><div id="Equ14" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$${\mathrm{Shortest}}:\langle d_{AB}^S\rangle = \frac{1}{{\left\Vert A \right\Vert \times \left\Vert B \right\Vert}}\mathop {\sum }\limits_{a \in A,b \in B} d(a,b)$$</span></div><div class="c-article-equation__number">
                    (14)
                </div></div><div id="Equ15" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$${\mathrm{Kernel}}:\langle d_{AB}^k\rangle = \frac{{ - 1}}{{\left| {\left| A \right|} \right| + \left\Vert B \right\Vert}}\left( {\mathop {\sum }\limits_{a \in A} {\it{ln}}\mathop {\sum }\limits_{b \in B} \frac{{e^{ - (d\left( {a,b} \right) + 1)}}}{{\left\Vert B \right\Vert}} + \mathop {\sum }\limits_{b \in B} {\it{ln}}\mathop {\sum }\limits_{a \in A} \frac{{e^{ - (d\left( {a,b} \right) + 1)}}}{{\left\Vert A \right\Vert}}} \right)$$</span></div><div class="c-article-equation__number">
                    (15)
                </div></div><div id="Equ16" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$${\mathrm{Centre}}:\langle d_{AB}^{cc}\rangle = d(centre_A,centre_B)$$</span></div><div class="c-article-equation__number">
                    (16)
                </div></div><p>where <span class="mathjax-tex">\(centre_B\)</span>, the topological centre of A, is defined as</p><div id="Equ17" class="c-article-equation"><div class="c-article-equation__content"><span class="mathjax-tex">$$centre_B = argmin_{u \in B}\mathop {\sum }\limits_{b \in B} d(b,u)$$</span></div><div class="c-article-equation__number">
                    (17)
                </div></div><p>If the <span class="mathjax-tex">\(centre_A\)</span> or <span class="mathjax-tex">\(centre_B\)</span> is not unique, all the nodes in <span class="mathjax-tex">\(centre_A\)</span> or <span class="mathjax-tex">\(centre_B\)</span> are used to define the centre, and shortest path lengths between these nodes are averaged. If the <span class="mathjax-tex">\(centre_B\)</span> is not unique, all nodes are used to define the centre and the shortest path lengths to these nodes are averaged.</p><h3 class="c-article__sub-heading u-h3" id="Sec19">Collecting disease-association genes</h3><p>We integrated disease–gene annotation data from 8 different resources and excluded the duplicated entries (Supplementary Note <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM1">4</a>). We annotated all protein-coding genes using gene Entrez ID, chromosomal location, and the official gene symbols from the NCBI database<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 55" title="NCBI Resource Coordinators. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 44, D7–D19 (2016)." href="/articles/s41467-019-09186-x#ref-CR55" id="ref-link-section-d4768e4644">55</a></sup>. Each cardiovascular event was defined by MeSH and UMLS vocabularies<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 47" title="Bodenreider, O. The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Res. 32, D267–D270 (2004)." href="/articles/s41467-019-09186-x#ref-CR47" id="ref-link-section-d4768e4648">47</a></sup>. In this study, we constructed disease-associated genes for 4 types of cardiovascular events: arrhythmia (MeSH ID: D001145), heart failure (MeSH ID: D006333), myocardial infarction (MeSH ID: D009203), and hypertension/high blood pressure (MeSH ID: D006973).</p><h3 class="c-article__sub-heading u-h3" id="Sec20">Performance evaluation</h3><p>We used area under the receiver operating characteristic (ROC) curve (AUC) to evaluate how well the network proximity discriminates FDA-approved or experimentally validated pairwise combinations from random drug pairs. We counted the true positive rate and false positive rate at different network proximities as thresholds to illustrate the ROC curve. As negative drug pairs are not typically reported in the literature or publicly available databases, we use all unknown drug pairs as negative samples. In addition, we selected the same portion of unknown drug pairs as positive samples to control the size imbalance. We repeated this procedure 100 times and reported the average AUC values to compare the performance of different approaches.</p><h3 class="c-article__sub-heading u-h3" id="Sec21">Statistical analysis</h3><p>All statistical analyses were performed using the R package (v3.2.3, <a href="http://www.r-project.org/">http://www.r-project.org/</a>).</p><h3 class="c-article__sub-heading u-h3" id="Sec22">Reporting summary</h3><p>Further information on experimental design is available in the <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM9">Nature Research Reporting Summary</a> linked to this article.</p></div></div></section>
                        

                        <section aria-labelledby="code-availability"><div class="c-article-section js-article-section" id="code-availability-section"><h2 class="c-article-section__title u-h2 js-section-title js-c-reading-companion-sections-item" id="code-availability">Code availability</h2><div class="c-article-section__content js-collapsible-section" id="code-availability-content">
              
              <p>The code for network proximity calculation is available at <a href="http://github.com/emreg00/toolbox">github.com/emreg00/toolbox</a>. All other codes used in this study are available from the corresponding author upon reasonable request.</p>
            </div></div></section><section aria-labelledby="data-availability"><div class="c-article-section js-article-section" id="data-availability-section"><h2 class="c-article-section__title u-h2 js-section-title js-c-reading-companion-sections-item" id="data-availability">Data availability</h2><div class="c-article-section__content js-collapsible-section" id="data-availability-content">
              
              <p>The publicly available human protein–protein interactome (Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM3">1</a>), experimentally validated drug–target interactions (Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM4">2</a>), experimentally validated drug combinations (Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM5">3</a>), clinically reported adverse drug–drug interactions (Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM6">4</a>), and network-predicted hypertensive drug combinations (Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM7">5</a>) are available in Supplementary Data <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM3">1</a>–<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41467-019-09186-x#MOESM7">5</a>. The unpublished binary human protein–protein interactions are available at <a href="http://ccsb.dana-farber.org/interactome-data.html">http://ccsb.dana-farber.org/interactome-data.html</a>.</p>
            </div></div></section><section aria-labelledby="change-history"><div class="c-article-section js-article-section" id="change-history-section"><h2 class="c-article-section__title u-h2 js-section-title js-c-reading-companion-sections-item" id="change-history">Change history</h2><div class="c-article-section__content js-collapsible-section" id="change-history-content"><ul class="c-article-change-list"><li class="c-article-change-list__item" id="chg1"><ins datetime="2019-04-15"><h3 class="c-article-change-list__heading u-h3">15 April 2019</h3><div class="c-article-change-list__details"><p>The original version of this Article contained an error in Acknowledgements, which incorrectly omitted the following: ‘This work was also supported by NHLBI grant P01HL132825 to A.-L.B.’ This has been corrected in both the PDF and HTML versions of the Article.</p></div></ins></li></ul></div></div></section><section aria-labelledby="Bib1"><div class="c-article-section js-article-section" id="Bib1-section"><h2 class="c-article-section__title u-h2 js-section-title js-c-reading-companion-sections-item" id="Bib1">References</h2><div class="c-article-section__content js-collapsible-section" id="Bib1-content"><div data-container-section="references"><ol class="c-article-references"><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">1.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR1">Sun, X., Vilar, S. &amp; Tatonetti, N. P. High-throughput methods for combinatorial drug discovery. <i>Sci. Transl. Med.</i> <b>5</b>, 205rv201 (2013).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1126%2Fscitranslmed.3006667" aria-label="View reference 1">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 1 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=High-throughput%20methods%20for%20combinatorial%20drug%20discovery&amp;journal=Sci.%20Transl.%20Med.&amp;volume=5&amp;publication_year=2013&amp;author=Sun%2CX&amp;author=Vilar%2CS&amp;author=Tatonetti%2CNP">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">2.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR2">Jia, J. et al. Mechanisms of drug combinations: interaction and network perspectives. <i>Nat. Rev. Drug Discov.</i> <b>8</b>, 111–128 (2009).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD1MXhtFOqt7w%253D" aria-label="View reference 2 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1038%2Fnrd2683" aria-label="View reference 2">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 2 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Mechanisms%20of%20drug%20combinations%3A%20interaction%20and%20network%20perspectives&amp;journal=Nat.%20Rev.%20Drug%20Discov.&amp;volume=8&amp;pages=111-128&amp;publication_year=2009&amp;author=Jia%2CJ">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">3.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR3">Ali, M. A., Rizvi, S. &amp; Syed, B. A. Trends in the market for antihypertensive drugs. <i>Nat. Rev. Drug Discov.</i> <b>16</b>, 309–310 (2017).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC2sXkt1Ontrw%253D" aria-label="View reference 3 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1038%2Fnrd.2016.262" aria-label="View reference 3">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 3 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Trends%20in%20the%20market%20for%20antihypertensive%20drugs&amp;journal=Nat.%20Rev.%20Drug%20Discov.&amp;volume=16&amp;pages=309-310&amp;publication_year=2017&amp;author=Ali%2CMA&amp;author=Rizvi%2CS&amp;author=Syed%2CBA">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">4.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR4">Giles, T. D. et al. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study. <i>Lancet</i> <b>383</b>, 1889–1898 (2014).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC2cXpslCks7s%253D" aria-label="View reference 4 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1016%2FS0140-6736%2814%2960614-0" aria-label="View reference 4">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 4 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Efficacy%20and%20safety%20of%20nebivolol%20and%20valsartan%20as%20fixed-dose%20combination%20in%20hypertension%3A%20a%20randomised%2C%20multicentre%20study&amp;journal=Lancet&amp;volume=383&amp;pages=1889-1898&amp;publication_year=2014&amp;author=Giles%2CTD">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">5.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR5">Crystal, A. S. et al. Patient-derived models of acquired resistance can identify effective drug combinations for cancer. <i>Science</i> <b>346</b>, 1480–1486 (2014).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;bibcode=2014Sci...346.1480C" aria-label="View reference 5 on ADS">ADS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC2cXitV2gtr3M" aria-label="View reference 5 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1126%2Fscience.1254721" aria-label="View reference 5">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 5 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Patient-derived%20models%20of%20acquired%20resistance%20can%20identify%20effective%20drug%20combinations%20for%20cancer&amp;journal=Science&amp;volume=346&amp;pages=1480-1486&amp;publication_year=2014&amp;author=Crystal%2CAS">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">6.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR6">Tan, X. et al. Systematic identification of synergistic drug pairs targeting HIV. <i>Nat. Biotechnol.</i> <b>30</b>, 1125–1130 (2012).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC38XhsV2rsLbN" aria-label="View reference 6 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1038%2Fnbt.2391" aria-label="View reference 6">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 6 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Systematic%20identification%20of%20synergistic%20drug%20pairs%20targeting%20HIV&amp;journal=Nat.%20Biotechnol.&amp;volume=30&amp;pages=1125-1130&amp;publication_year=2012&amp;author=Tan%2CX">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">7.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR7">Zheng, W., Sun, W., &amp; Simeonov, A. Drug repurposing screens and synergistic drug-combinations for infectious diseases. <i>Br. J. Pharmacol.</i> <b>175</b>, 181–191 (2018).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">8.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR8">Lipinski, C. &amp; Hopkins, A. Navigating chemical space for biology and medicine. <i>Nature</i> <b>432</b>, 855–861 (2004).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;bibcode=2004Natur.432..855L" aria-label="View reference 8 on ADS">ADS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD2cXhtVOht7jO" aria-label="View reference 8 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1038%2Fnature03193" aria-label="View reference 8">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 8 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Navigating%20chemical%20space%20for%20biology%20and%20medicine&amp;journal=Nature&amp;volume=432&amp;pages=855-861&amp;publication_year=2004&amp;author=Lipinski%2CC&amp;author=Hopkins%2CA">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">9.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR9">Bulusu, K. C. et al. Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectives. <i>Drug Discov. Today</i> <b>21</b>, 225–238 (2016).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC2MXhsFSitLfP" aria-label="View reference 9 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1016%2Fj.drudis.2015.09.003" aria-label="View reference 9">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 9 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Modelling%20of%20compound%20combination%20effects%20and%20applications%20to%20efficacy%20and%20toxicity%3A%20state-of-the-art%2C%20challenges%20and%20perspectives&amp;journal=Drug%20Discov.%20Today&amp;volume=21&amp;pages=225-238&amp;publication_year=2016&amp;author=Bulusu%2CKC">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">10.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR10">Sun, Y. et al. Combining genomic and network characteristics for extended capability in predicting synergistic drugs for cancer. <i>Nat. Commun.</i> <b>6</b>, 8481 (2015).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC2MXhsFOktLfN" aria-label="View reference 10 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1038%2Fncomms9481" aria-label="View reference 10">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 10 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Combining%20genomic%20and%20network%20characteristics%20for%20extended%20capability%20in%20predicting%20synergistic%20drugs%20for%20cancer&amp;journal=Nat.%20Commun.&amp;volume=6&amp;publication_year=2015&amp;author=Sun%2CY">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">11.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR11">Bansal, M. et al. A community computational challenge to predict the activity of pairs of compounds. <i>Nat. Biotechnol.</i> <b>32</b>, 1213–1222 (2014).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC2cXhvFKlsrnJ" aria-label="View reference 11 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1038%2Fnbt.3052" aria-label="View reference 11">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 11 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20community%20computational%20challenge%20to%20predict%20the%20activity%20of%20pairs%20of%20compounds&amp;journal=Nat.%20Biotechnol.&amp;volume=32&amp;pages=1213-1222&amp;publication_year=2014&amp;author=Bansal%2CM">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">12.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR12">Zimmer, A., Katzir, I., Dekel, E., Mayo, A. E. &amp; Alon, U. Prediction of multidimensional drug dose responses based on measurements of drug pairs. <i>Proc. Natl Acad. Sci. USA</i> <b>113</b>, 10442–10447 (2016).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC28XhsVWjtrnF" aria-label="View reference 12 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1073%2Fpnas.1606301113" aria-label="View reference 12">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 12 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Prediction%20of%20multidimensional%20drug%20dose%20responses%20based%20on%20measurements%20of%20drug%20pairs&amp;journal=Proc.%20Natl.%20Acad.%20Sci.%20U.S.A.&amp;volume=113&amp;pages=10442-10447&amp;publication_year=2016&amp;author=Zimmer%2CA&amp;author=Katzir%2CI&amp;author=Dekel%2CE&amp;author=Mayo%2CAE&amp;author=Alon%2CU">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">13.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR13">Barabasi, A. L. &amp; Oltvai, Z. N. Network biology: understanding the cell’s functional organization. <i>Nat. Rev. Genet.</i> <b>5</b>, 101–113 (2004).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD2cXovV2mtg%253D%253D" aria-label="View reference 13 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1038%2Fnrg1272" aria-label="View reference 13">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 13 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Network%20biology%3A%20understanding%20the%20cell%E2%80%99s%20functional%20organization&amp;journal=Nat.%20Rev.%20Genet.&amp;volume=5&amp;pages=101-113&amp;publication_year=2004&amp;author=Barabasi%2CAL&amp;author=Oltvai%2CZN">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">14.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR14">Menche, J. et al. Disease networks. Uncovering disease–disease relationships through the incomplete interactome. <i>Science</i> <b>347</b>, 1257601 (2015).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1126%2Fscience.1257601" aria-label="View reference 14">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 14 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Disease%20networks.%20Uncovering%20disease%E2%80%93disease%20relationships%20through%20the%20incomplete%20interactome&amp;journal=Science&amp;volume=347&amp;publication_year=2015&amp;author=Menche%2CJ">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">15.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR15">Guney, E., Menche, J., Vidal, M. &amp; Barabasi, A. L. Network-based in silico drug efficacy screening. <i>Nat. Commun.</i> <b>7</b>, 10331 (2016).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;bibcode=2016NatCo...710331G" aria-label="View reference 15 on ADS">ADS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC28XhslOrsL4%253D" aria-label="View reference 15 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1038%2Fncomms10331" aria-label="View reference 15">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 15 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Network-based%20in%20silico%20drug%20efficacy%20screening&amp;journal=Nat.%20Commun.&amp;volume=7&amp;publication_year=2016&amp;author=Guney%2CE&amp;author=Menche%2CJ&amp;author=Vidal%2CM&amp;author=Barabasi%2CAL">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">16.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR16">Cheng, F. et al. Network-based approach to prediction and population-based validation of in silico drug repurposing. <i>Nat. Commun.</i> <b>9</b>, 2691 (2018).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;bibcode=2018NatCo...9.2691C" aria-label="View reference 16 on ADS">ADS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1038%2Fs41467-018-05116-5" aria-label="View reference 16">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 16 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Network-based%20approach%20to%20prediction%20and%20population-based%20validation%20of%20in%20silico%20drug%20repurposing&amp;journal=Nat.%20Commun.&amp;volume=9&amp;publication_year=2018&amp;author=Cheng%2CF">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">17.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR17">Barabasi, A. L., Gulbahce, N. &amp; Loscalzo, J. Network medicine: a network-based approach to human disease. <i>Nat. Rev. Genet.</i> <b>12</b>, 56–68 (2011).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC3cXhsFOiu7vM" aria-label="View reference 17 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1038%2Fnrg2918" aria-label="View reference 17">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 17 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Network%20medicine%3A%20a%20network-based%20approach%20to%20human%20disease&amp;journal=Nat.%20Rev.%20Genet.&amp;volume=12&amp;pages=56-68&amp;publication_year=2011&amp;author=Barabasi%2CAL&amp;author=Gulbahce%2CN&amp;author=Loscalzo%2CJ">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">18.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR18">Vidal, M., Cusick, M. E. &amp; Barabasi, A. L. Interactome networks and human disease. <i>Cell</i> <b>144</b>, 986–998 (2011).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC3MXjsFCrtrs%253D" aria-label="View reference 18 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1016%2Fj.cell.2011.02.016" aria-label="View reference 18">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 18 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Interactome%20networks%20and%20human%20disease&amp;journal=Cell&amp;volume=144&amp;pages=986-998&amp;publication_year=2011&amp;author=Vidal%2CM&amp;author=Cusick%2CME&amp;author=Barabasi%2CAL">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">19.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR19">Yildirim, M. A., Goh, K. I., Cusick, M. E., Barabasi, A. L. &amp; Vidal, M. Drug–target network. <i>Nat. Biotechnol.</i> <b>25</b>, 1119–1126 (2007).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD2sXhtFagt7rO" aria-label="View reference 19 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1038%2Fnbt1338" aria-label="View reference 19">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 19 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Drug%E2%80%93target%20network&amp;journal=Nat.%20Biotechnol.&amp;volume=25&amp;pages=1119-1126&amp;publication_year=2007&amp;author=Yildirim%2CMA&amp;author=Goh%2CKI&amp;author=Cusick%2CME&amp;author=Barabasi%2CAL&amp;author=Vidal%2CM">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">20.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR20">Hopkins, A. L. Network pharmacology: the next paradigm in drug discovery. <i>Nat. Chem. Biol.</i> <b>4</b>, 682–690 (2008).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://www.ams.org/mathscinet-getitem?mr=2457080" aria-label="View reference 20 on MathSciNet">MathSciNet</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD1cXht1Kgs7fK" aria-label="View reference 20 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1038%2Fnchembio.118" aria-label="View reference 20">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 20 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Network%20pharmacology%3A%20the%20next%20paradigm%20in%20drug%20discovery&amp;journal=Nat.%20Chem.%20Biol.&amp;volume=4&amp;pages=682-690&amp;publication_year=2008&amp;author=Hopkins%2CAL">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">21.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR21">Hopkins, A. L. Network pharmacology. <i>Nat. Biotechnol.</i> <b>25</b>, 1110–1111 (2007).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD2sXhtFagt7vO" aria-label="View reference 21 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1038%2Fnbt1007-1110" aria-label="View reference 21">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 21 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Network%20pharmacology&amp;journal=Nat.%20Biotechnol.&amp;volume=25&amp;pages=1110-1111&amp;publication_year=2007&amp;author=Hopkins%2CAL">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">22.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR22">Kalmanti, L. et al. Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV. <i>Leukemia</i> <b>29</b>, 1123–1132 (2015).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC2MXks1aitbw%253D" aria-label="View reference 22 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1038%2Fleu.2015.36" aria-label="View reference 22">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 22 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Safety%20and%20efficacy%20of%20imatinib%20in%20CML%20over%20a%20period%20of%2010%20years%3A%20data%20from%20the%20randomized%20CML-study%20IV&amp;journal=Leukemia&amp;volume=29&amp;pages=1123-1132&amp;publication_year=2015&amp;author=Kalmanti%2CL">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">23.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR23">DeAngelo, D. J. et al. Phase 1 clinical results with tandutinib (MLN518), a novel FLT3 antagonist, in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome: safety, pharmacokinetics, and pharmacodynamics. <i>Blood</i> <b>108</b>, 3674–3681 (2006).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD28Xht1Kgs7%252FM" aria-label="View reference 23 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1182%2Fblood-2006-02-005702" aria-label="View reference 23">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 23 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Phase%201%20clinical%20results%20with%20tandutinib%20%28MLN518%29%2C%20a%20novel%20FLT3%20antagonist%2C%20in%20patients%20with%20acute%20myelogenous%20leukemia%20or%20high-risk%20myelodysplastic%20syndrome%3A%20safety%2C%20pharmacokinetics%2C%20and%20pharmacodynamics&amp;journal=Blood&amp;volume=108&amp;pages=3674-3681&amp;publication_year=2006&amp;author=DeAngelo%2CDJ">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">24.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR24">Polman, C. H. et al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. <i>N. Engl. J. Med.</i> <b>354</b>, 899–910 (2006).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD28XitVertL4%253D" aria-label="View reference 24 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1056%2FNEJMoa044397" aria-label="View reference 24">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 24 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20randomized%2C%20placebo-controlled%20trial%20of%20natalizumab%20for%20relapsing%20multiple%20sclerosis&amp;journal=N.%20Engl.%20J.%20Med.&amp;volume=354&amp;pages=899-910&amp;publication_year=2006&amp;author=Polman%2CCH">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">25.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR25">Wolf, G. &amp; Stahl, R. A. A woman with increasing weakness of the legs and irregular heartbeat who took her husband’s medication. <i>Nephrol. Dial. Transplant.</i> <b>17</b>, 1698–1701 (2002).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1093%2Fndt%2F17.9.1698" aria-label="View reference 25">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 25 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20woman%20with%20increasing%20weakness%20of%20the%20legs%20and%20irregular%20heartbeat%20who%20took%20her%20husband%E2%80%99s%20medication&amp;journal=Nephrol.%20Dial.%20Transplant.&amp;volume=17&amp;pages=1698-1701&amp;publication_year=2002&amp;author=Wolf%2CG&amp;author=Stahl%2CRA">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">26.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR26">Jia, Y. et al. Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors. <i>Nature</i> <b>534</b>, 129–132 (2016).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;bibcode=2016Natur.534..129J" aria-label="View reference 26 on ADS">ADS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC28XosFWht7k%253D" aria-label="View reference 26 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1038%2Fnature17960" aria-label="View reference 26">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 26 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Overcoming%20EGFR%28T790M%29%20and%20EGFR%28C797S%29%20resistance%20with%20mutant-selective%20allosteric%20inhibitors&amp;journal=Nature&amp;volume=534&amp;pages=129-132&amp;publication_year=2016&amp;author=Jia%2CY">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">27.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR27">Brown, M. J. et al. Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial. <i>Lancet Diabetes Endocrinol.</i> <b>4</b>, 136–147 (2016).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC28XmslKktL8%253D" aria-label="View reference 27 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1016%2FS2213-8587%2815%2900377-0" aria-label="View reference 27">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 27 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Effect%20of%20amiloride%2C%20or%20amiloride%20plus%20hydrochlorothiazide%2C%20versus%20hydrochlorothiazide%20on%20glucose%20tolerance%20and%20blood%20pressure%20%28PATHWAY-3%29%3A%20a%20parallel-group%2C%20double-blind%20randomised%20phase%204%20trial&amp;journal=Lancet%20Diabetes%20Endocrinol.&amp;volume=4&amp;pages=136-147&amp;publication_year=2016&amp;author=Brown%2CMJ">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">28.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR28">Beermann, B., Groschinsky-Grind, M. &amp; Rosen, A. Absorption, metabolism, and excretion of hydrochlorothiazide. <i>Clin. Pharmacol. Ther.</i> <b>19</b>, 531–537 (1976).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADyaE28XksFKntbg%253D" aria-label="View reference 28 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1002%2Fcpt1976195part1531" aria-label="View reference 28">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 28 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Absorption%2C%20metabolism%2C%20and%20excretion%20of%20hydrochlorothiazide&amp;journal=Clin.%20Pharmacol.%20Ther.&amp;volume=19&amp;pages=531-537&amp;publication_year=1976&amp;author=Beermann%2CB&amp;author=Groschinsky-Grind%2CM&amp;author=Rosen%2CA">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">29.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR29">Han, P., Chu, Z. X., Shen, F. M., Xie, H. H. &amp; Su, D. F. Synergism of hydrochlorothiazide and nitrendipine on reduction of blood pressure and blood pressure variability in spontaneously hypertensive rats. <i>Acta Pharmacol. Sin.</i> <b>27</b>, 1575–1579 (2006).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD28XhtlemsbjE" aria-label="View reference 29 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1111%2Fj.1745-7254.2006.00366.x" aria-label="View reference 29">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 29 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Synergism%20of%20hydrochlorothiazide%20and%20nitrendipine%20on%20reduction%20of%20blood%20pressure%20and%20blood%20pressure%20variability%20in%20spontaneously%20hypertensive%20rats&amp;journal=Acta%20Pharmacol.%20Sin.&amp;volume=27&amp;pages=1575-1579&amp;publication_year=2006&amp;author=Han%2CP&amp;author=Chu%2CZX&amp;author=Shen%2CFM&amp;author=Xie%2CHH&amp;author=Su%2CDF">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">30.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR30">Maronde, R. F., Milgrom, M., Vlachakis, N. D. &amp; Chan, L. Response of thiazide-induced hypokalemia to amiloride. <i>JAMA</i> <b>249</b>, 237–241 (1983).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ASTN%3A280%3ADyaL3s%252Fos1Squw%253D%253D" aria-label="View reference 30 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1001%2Fjama.1983.03330260055032" aria-label="View reference 30">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 30 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Response%20of%20thiazide-induced%20hypokalemia%20to%20amiloride&amp;journal=JAMA&amp;volume=249&amp;pages=237-241&amp;publication_year=1983&amp;author=Maronde%2CRF&amp;author=Milgrom%2CM&amp;author=Vlachakis%2CND&amp;author=Chan%2CL">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">31.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR31">Greene, J. A. &amp; Loscalzo, J. Putting the patient back together—social medicine, network medicine, and the limits of reductionism. <i>N. Engl. J. Med.</i> <b>377</b>, 2493–2499 (2017).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1056%2FNEJMms1706744" aria-label="View reference 31">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 31 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Putting%20the%20patient%20back%20together%E2%80%94social%20medicine%2C%20network%20medicine%2C%20and%20the%20limits%20of%20reductionism&amp;journal=N.%20Engl.%20J.%20Med.&amp;volume=377&amp;pages=2493-2499&amp;publication_year=2017&amp;author=Greene%2CJA&amp;author=Loscalzo%2CJ">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">32.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR32">Bibi, Z. Role of cytochrome P450 in drug interactions. <i>Nutr. Metab.</i> <b>5</b>, 27 (2008).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1186%2F1743-7075-5-27" aria-label="View reference 32">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 32 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Role%20of%20cytochrome%20P450%20in%20drug%20interactions&amp;journal=Nutr.%20Metab.&amp;volume=5&amp;publication_year=2008&amp;author=Bibi%2CZ">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">33.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR33">Cami, A., Manzi, S., Arnold, A. &amp; Reis, B. Y. Pharmacointeraction network models predict unknown drug–drug interactions. <i>PLoS ONE</i> <b>8</b>, e61468 (2013).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;bibcode=2013PLoSO...861468C" aria-label="View reference 33 on ADS">ADS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC3sXntVWjs7c%253D" aria-label="View reference 33 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1371%2Fjournal.pone.0061468" aria-label="View reference 33">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 33 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Pharmacointeraction%20network%20models%20predict%20unknown%20drug%E2%80%93drug%20interactions&amp;journal=PLoS%20One&amp;volume=8&amp;publication_year=2013&amp;author=Cami%2CA&amp;author=Manzi%2CS&amp;author=Arnold%2CA&amp;author=Reis%2CBY">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">34.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR34">Zhao, S. et al. Systems pharmacology of adverse event mitigation by drug combinations. <i>Sci. Transl. Med.</i> <b>5</b>, 206ra140 (2013).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1126%2Fscitranslmed.3006548" aria-label="View reference 34">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 34 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Systems%20pharmacology%20of%20adverse%20event%20mitigation%20by%20drug%20combinations&amp;journal=Sci.%20Transl.%20Med.&amp;volume=5&amp;publication_year=2013&amp;author=Zhao%2CS">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">35.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR35">Tatonetti, N. P., Ye, P. P., Daneshjou, R. &amp; Altman, R. B. Data-driven prediction of drug effects and interactions. <i>Sci. Transl. Med.</i> <b>4</b>, 125ra131 (2012).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1126%2Fscitranslmed.3003377" aria-label="View reference 35">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 35 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Data-driven%20prediction%20of%20drug%20effects%20and%20interactions&amp;journal=Sci.%20Transl.%20Med.&amp;volume=4&amp;publication_year=2012&amp;author=Tatonetti%2CNP&amp;author=Ye%2CPP&amp;author=Daneshjou%2CR&amp;author=Altman%2CRB">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">36.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR36">Facchetti, G., Iacono, G. &amp; Altafini, C. Computing global structural balance in large-scale signed social networks. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <b>108</b>, 20953–20958 (2011).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;bibcode=2011PNAS..10820953F" aria-label="View reference 36 on ADS">ADS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC38XnvVCqsg%253D%253D" aria-label="View reference 36 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1073%2Fpnas.1109521108" aria-label="View reference 36">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 36 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Computing%20global%20structural%20balance%20in%20large-scale%20signed%20social%20networks&amp;journal=Proc.%20Natl.%20Acad.%20Sci.%20U.S.A.&amp;volume=108&amp;pages=20953-20958&amp;publication_year=2011&amp;author=Facchetti%2CG&amp;author=Iacono%2CG&amp;author=Altafini%2CC">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">37.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR37">Istvan, A. K. et al. Network-based prediction of protein interactions. Preprint at <a href="https://doi.org/10.1101/275529">https://doi.org/10.1101/275529</a> (2018).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">38.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR38">Rolland, T. et al. A proteome-scale map of the human interactome network. <i>Cell</i> <b>159</b>, 1212–1226 (2014).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC2cXhvFOgsr7I" aria-label="View reference 38 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1016%2Fj.cell.2014.10.050" aria-label="View reference 38">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 38 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20proteome-scale%20map%20of%20the%20human%20interactome%20network&amp;journal=Cell&amp;volume=159&amp;pages=1212-1226&amp;publication_year=2014&amp;author=Rolland%2CT">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">39.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR39">Rual, J. F. et al. Towards a proteome-scale map of the human protein-protein interaction network. <i>Nature</i> <b>437</b>, 1173–1178 (2005).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;bibcode=2005Natur.437.1173R" aria-label="View reference 39 on ADS">ADS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD2MXhtFahtLzP" aria-label="View reference 39 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1038%2Fnature04209" aria-label="View reference 39">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 39 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Towards%20a%20proteome-scale%20map%20of%20the%20human%20protein-protein%20interaction%20network&amp;journal=Nature&amp;volume=437&amp;pages=1173-1178&amp;publication_year=2005&amp;author=Rual%2CJF">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">40.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR40">Law, V. et al. DrugBank 4.0: shedding new light on drug metabolism. <i>Nucleic Acids Res.</i> <b>42</b>, D1091–D1097 (2014).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC2cXos1Kh" aria-label="View reference 40 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1093%2Fnar%2Fgkt1068" aria-label="View reference 40">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 40 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=DrugBank%204.0%3A%20shedding%20new%20light%20on%20drug%20metabolism&amp;journal=Nucleic%20Acids%20Res.&amp;volume=42&amp;pages=D1091-D1097&amp;publication_year=2014&amp;author=Law%2CV">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">41.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR41">Zhu, F. et al. Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. <i>Nucleic Acids Res.</i> <b>40</b>, D1128–D1136 (2012).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC3MXhs12htb7O" aria-label="View reference 41 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1093%2Fnar%2Fgkr797" aria-label="View reference 41">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 41 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Therapeutic%20target%20database%20update%202012%3A%20a%20resource%20for%20facilitating%20target-oriented%20drug%20discovery&amp;journal=Nucleic%20Acids%20Res.&amp;volume=40&amp;pages=D1128-D1136&amp;publication_year=2012&amp;author=Zhu%2CF">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">42.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR42">Hernandez-Boussard, T. et al. The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge. <i>Nucleic Acids Res.</i> <b>36</b>, D913–D918 (2008).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD1cXhtVSqsL4%253D" aria-label="View reference 42 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1093%2Fnar%2Fgkm1009" aria-label="View reference 42">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 42 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20pharmacogenetics%20and%20pharmacogenomics%20knowledge%20base%3A%20accentuating%20the%20knowledge&amp;journal=Nucleic%20Acids%20Res.&amp;volume=36&amp;pages=D913-D918&amp;publication_year=2008&amp;author=Hernandez-Boussard%2CT">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">43.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR43">Gaulton, A. et al. ChEMBL: a large-scale bioactivity database for drug discovery. <i>Nucleic Acids Res.</i> <b>40</b>, D1100–D1107 (2012).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC3MXhs12htbjN" aria-label="View reference 43 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1093%2Fnar%2Fgkr777" aria-label="View reference 43">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 43 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=ChEMBL%3A%20a%20large-scale%20bioactivity%20database%20for%20drug%20discovery&amp;journal=Nucleic%20Acids%20Res.&amp;volume=40&amp;pages=D1100-D1107&amp;publication_year=2012&amp;author=Gaulton%2CA">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">44.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR44">Liu, T. Q., Lin, Y. M., Wen, X., Jorissen, R. N. &amp; Gilson, M. K. BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities. <i>Nucleic Acids Res.</i> <b>35</b>, D198–D201 (2007).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD2sXivFKktg%253D%253D" aria-label="View reference 44 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1093%2Fnar%2Fgkl999" aria-label="View reference 44">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 44 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=BindingDB%3A%20a%20web-accessible%20database%20of%20experimentally%20determined%20protein%E2%80%93ligand%20binding%20affinities&amp;journal=Nucleic%20Acids%20Res.&amp;volume=35&amp;pages=D198-D201&amp;publication_year=2007&amp;author=Liu%2CTQ&amp;author=Lin%2CYM&amp;author=Wen%2CX&amp;author=Jorissen%2CRN&amp;author=Gilson%2CMK">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">45.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR45">Pawson, A. J. et al. The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. <i>Nucleic Acids Res.</i> <b>42</b>, D1098–D1106 (2014).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC2cXosF2i" aria-label="View reference 45 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1093%2Fnar%2Fgkt1143" aria-label="View reference 45">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 45 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20IUPHAR%2FBPS%20Guide%20to%20PHARMACOLOGY%3A%20an%20expert-driven%20knowledgebase%20of%20drug%20targets%20and%20their%20ligands&amp;journal=Nucleic%20Acids%20Res.&amp;volume=42&amp;pages=D1098-D1106&amp;publication_year=2014&amp;author=Pawson%2CAJ">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">46.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR46">Apweiler, R. et al. UniProt: the universal protein knowledgebase. <i>Nucleic Acids Res.</i> <b>32</b>, D115–D119 (2004).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD3sXhtVSru7vK" aria-label="View reference 46 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1093%2Fnar%2Fgkh131" aria-label="View reference 46">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 46 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=UniProt%3A%20the%20universal%20protein%20knowledgebase&amp;journal=Nucleic%20Acids%20Res.&amp;volume=32&amp;pages=D115-D119&amp;publication_year=2004&amp;author=Apweiler%2CR">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">47.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR47">Bodenreider, O. The Unified Medical Language System (UMLS): integrating biomedical terminology. <i>Nucleic Acids Res.</i> <b>32</b>, D267–D270 (2004).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD3sXhtVSrurvM" aria-label="View reference 47 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1093%2Fnar%2Fgkh061" aria-label="View reference 47">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 47 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20Unified%20Medical%20Language%20System%20%28UMLS%29%3A%20integrating%20biomedical%20terminology&amp;journal=Nucleic%20Acids%20Res.&amp;volume=32&amp;pages=D267-D270&amp;publication_year=2004&amp;author=Bodenreider%2CO">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">48.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR48">O’Boyle, N. M. et al. Open Babel: an open chemical toolbox. <i>J. Cheminform.</i> <b>3</b>, 33 (2011).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1186%2F1758-2946-3-33" aria-label="View reference 48">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 48 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Open%20Babel%3A%20an%20open%20chemical%20toolbox&amp;journal=J.%20Cheminform.&amp;volume=3&amp;publication_year=2011&amp;author=O%E2%80%99Boyle%2CNM">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">49.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR49">Willett, P. Similarity-based virtual screening using 2D fingerprints. <i>Drug Discov. Today</i> <b>11</b>, 1046–1053 (2006).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD28Xht1eqtb%252FN" aria-label="View reference 49 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1016%2Fj.drudis.2006.10.005" aria-label="View reference 49">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 49 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Similarity-based%20virtual%20screening%20using%202D%20fingerprints&amp;journal=Drug%20Discov.%20Today&amp;volume=11&amp;pages=1046-1053&amp;publication_year=2006&amp;author=Willett%2CP">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">50.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR50">Smith, T. F. &amp; Waterman, M. S. Identification of common molecular subsequences. <i>J. Mol. Biol.</i> <b>147</b>, 195–197 (1981).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC3cXitlCnsLw%253D" aria-label="View reference 50 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1016%2F0022-2836%2881%2990087-5" aria-label="View reference 50">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 50 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Identification%20of%20common%20molecular%20subsequences&amp;journal=J.%20Mol.%20Biol.&amp;volume=147&amp;pages=195-197&amp;publication_year=1981&amp;author=Smith%2CTF&amp;author=Waterman%2CMS">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">51.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR51">Cheng, F. et al. Studying tumorigenesis through network evolution and somatic mutational perturbations in the cancer interactome. <i>Mol. Biol. Evol.</i> <b>31</b>, 2156–2169 (2014).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC2cXht1SqtL%252FO" aria-label="View reference 51 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1093%2Fmolbev%2Fmsu167" aria-label="View reference 51">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 51 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Studying%20tumorigenesis%20through%20network%20evolution%20and%20somatic%20mutational%20perturbations%20in%20the%20cancer%20interactome&amp;journal=Mol.%20Biol.%20Evol.&amp;volume=31&amp;pages=2156-2169&amp;publication_year=2014&amp;author=Cheng%2CF">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">52.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR52">Wang, J. Z., Du, Z., Payattakool, R., Yu, P. S. &amp; Chen, C. F. A new method to measure the semantic similarity of GO terms. <i>Bioinformatics</i> <b>23</b>, 1274–1281 (2007).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BD2sXntVOjur8%253D" aria-label="View reference 52 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1093%2Fbioinformatics%2Fbtm087" aria-label="View reference 52">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 52 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20new%20method%20to%20measure%20the%20semantic%20similarity%20of%20GO%20terms&amp;journal=Bioinformatics&amp;volume=23&amp;pages=1274-1281&amp;publication_year=2007&amp;author=Wang%2CJZ&amp;author=Du%2CZ&amp;author=Payattakool%2CR&amp;author=Yu%2CPS&amp;author=Chen%2CCF">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">53.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR53">Yu, G. et al. GOSemSim: an R package for measuring semantic similarity among GO terms and gene products. <i>Bioinformatics</i> <b>26</b>, 976–978 (2010).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC3cXjvFyku78%253D" aria-label="View reference 53 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1093%2Fbioinformatics%2Fbtq064" aria-label="View reference 53">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 53 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=GOSemSim%3A%20an%20R%20package%20for%20measuring%20semantic%20similarity%20among%20GO%20terms%20and%20gene%20products&amp;journal=Bioinformatics&amp;volume=26&amp;pages=976-978&amp;publication_year=2010&amp;author=Yu%2CG">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">54.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR54">Cheng, F. et al. Prediction of polypharmacological profiles of drugs by the integration of chemical, side effect, and therapeutic space. <i>J. Chem. Inf. Model.</i> <b>53</b>, 753–762 (2013).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="/articles/cas-redirect/1%3ACAS%3A528%3ADC%252BC3sXksFKnuro%253D" aria-label="View reference 54 on CAS">CAS</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1021%2Fci400010x" aria-label="View reference 54">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 54 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Prediction%20of%20polypharmacological%20profiles%20of%20drugs%20by%20the%20integration%20of%20chemical%2C%20side%20effect%2C%20and%20therapeutic%20space&amp;journal=J.%20Chem.%20Inf.%20Model.&amp;volume=53&amp;pages=753-762&amp;publication_year=2013&amp;author=Cheng%2CF">
                        Google Scholar</a></li></ul></li><li class="c-article-references__item js-c-reading-companion-references-item" itemprop="citation" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle"><span class="c-article-references__counter">55.</span><p class="c-article-references__text" itemprop="headline" id="ref-CR55">NCBI Resource Coordinators. Database resources of the National Center for Biotechnology Information. <i>Nucleic Acids Res.</i> <b>44</b>, D7–D19 (2016).</p><ul class="c-article-references__links u-hide-print"><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" href="https://doi.org/10.1093%2Fnar%2Fgkv1290" aria-label="View reference 55">Article</a></li><li><a data-track="click" data-track-action="outbound reference" data-track-category="article body" data-track-label="link" aria-label="Search for reference 55 on Google Scholar" href="http://scholar.google.com/scholar_lookup?&amp;title=Database%20resources%20of%20the%20National%20Center%20for%20Biotechnology%20Information&amp;journal=Nucleic%20Acids%20Res.&amp;volume=44&amp;pages=D7-D19&amp;publication_year=2016&amp;author=NCBI%20Resource%20Coordinators%2C">
                        Google Scholar</a></li></ul></li></ol><p class="c-article-references__download u-hide-print"><a data-track="click" data-track-action="download citation references" data-track-category="article body" data-track-label="link" href="/articles/s41467-019-09186-x-references.ris">
                    Download references
                </a></p></div></div></div></section><section aria-labelledby="Ack1"><div class="c-article-section js-article-section" id="Ack1-section"><h2 class="c-article-section__title u-h2 js-section-title js-c-reading-companion-sections-item" id="Ack1">Acknowledgements</h2><div class="c-article-section__content js-collapsible-section" id="Ack1-content"><p>The authors thank Yifang Ma, Marc Vidal, and Joseph Loscalzo for useful discussions on the manuscript. The authors thank Alice Grishchenko for polishing the figures. This work was supported by NIH grants P50-HG004233 and U01-HG001715 to A.-L.B. from NHGRI, P01HL132825 to A.-L.B. from NHLBI, and K99HL138272 and R00HL138272 to F.C. from NHLBI.</p></div></div></section><section aria-labelledby="author-information"><div class="c-article-section js-article-section" id="author-information-section"><h2 class="c-article-section__title u-h2 js-section-title js-c-reading-companion-sections-item" id="author-information">Author information</h2><div class="c-article-section__content js-collapsible-section" id="author-information-content"><h3 class="c-article-author-information__subtitle u-h3 u-visually-hidden" id="author-notes">Author notes</h3><ol class="c-article-author-information__list"><li class="c-article-author-information__item" id="na1"><p>These authors contributed equally: Feixiong Cheng, István A. Kovács.</p></li></ol><h3 class="c-article-author-information__subtitle u-h3" id="affiliations">Affiliations</h3><ol class="c-article-author-affiliation__list"><li id="Aff1"><h4 class="c-article-author-affiliation__address u-h3">Center for Complex Networks Research and Department of Physics, Northeastern University, Boston, MA, 02115, USA</h4><ul class="c-article-author-affiliation__authors-list"><li class="c-article-author-affiliation__authors-item">Feixiong Cheng</li><li class="c-article-author-affiliation__authors-item">, István A. Kovács</li><li class="c-article-author-affiliation__authors-item"> &amp; Albert-László Barabási</li></ul></li><li id="Aff2"><h4 class="c-article-author-affiliation__address u-h3">Center for Cancer Systems Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA</h4><ul class="c-article-author-affiliation__authors-list"><li class="c-article-author-affiliation__authors-item">Feixiong Cheng</li><li class="c-article-author-affiliation__authors-item">, István A. Kovács</li><li class="c-article-author-affiliation__authors-item"> &amp; Albert-László Barabási</li></ul></li><li id="Aff3"><h4 class="c-article-author-affiliation__address u-h3">Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44106, USA</h4><ul class="c-article-author-affiliation__authors-list"><li class="c-article-author-affiliation__authors-item">Feixiong Cheng</li></ul></li><li id="Aff4"><h4 class="c-article-author-affiliation__address u-h3">Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, 44195, USA</h4><ul class="c-article-author-affiliation__authors-list"><li class="c-article-author-affiliation__authors-item">Feixiong Cheng</li></ul></li><li id="Aff5"><h4 class="c-article-author-affiliation__address u-h3">Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA</h4><ul class="c-article-author-affiliation__authors-list"><li class="c-article-author-affiliation__authors-item">Feixiong Cheng</li></ul></li><li id="Aff6"><h4 class="c-article-author-affiliation__address u-h3">Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 02215, USA</h4><ul class="c-article-author-affiliation__authors-list"><li class="c-article-author-affiliation__authors-item">Albert-László Barabási</li></ul></li><li id="Aff7"><h4 class="c-article-author-affiliation__address u-h3">Center for Network Science, Central European University, Budapest, 1051, Hungary</h4><ul class="c-article-author-affiliation__authors-list"><li class="c-article-author-affiliation__authors-item">Albert-László Barabási</li></ul></li></ol><div class="js-hide u-hide-print" data-test="author-info"><h3 class="c-article-author-information__subtitle u-h3">Authors</h3><ol class="c-article-author-authors-search"><li id="auth-1"><h3 class="c-article-author-authors-search__title u-h3 js-search-name">Search for Feixiong Cheng in:</h3><ul class="c-article-author-authors-search__list"><li class="c-article-author-authors-search__item"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Feixiong+Cheng">PubMed</a><span class="bullet"> • </span></li><li class="c-article-author-authors-search__item"><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Feixiong+Cheng%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">
                        Google Scholar
                    </a></li></ul></li><li id="auth-2"><h3 class="c-article-author-authors-search__title u-h3 js-search-name">Search for István A. Kovács in:</h3><ul class="c-article-author-authors-search__list"><li class="c-article-author-authors-search__item"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Istv%C3%A1n A.+Kov%C3%A1cs">PubMed</a><span class="bullet"> • </span></li><li class="c-article-author-authors-search__item"><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Istv%C3%A1n A.+Kov%C3%A1cs%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">
                        Google Scholar
                    </a></li></ul></li><li id="auth-3"><h3 class="c-article-author-authors-search__title u-h3 js-search-name">Search for Albert-László Barabási in:</h3><ul class="c-article-author-authors-search__list"><li class="c-article-author-authors-search__item"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Albert-L%C3%A1szl%C3%B3+Barab%C3%A1si">PubMed</a><span class="bullet"> • </span></li><li class="c-article-author-authors-search__item"><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Albert-L%C3%A1szl%C3%B3+Barab%C3%A1si%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">
                        Google Scholar
                    </a></li></ul></li></ol></div><h3 class="c-article-author-information__subtitle u-h3" id="contributions">Contributions</h3><p>A.-L.B. conceived the study. F.C. performed all experiments and data analysis. I.A.K. performed data analysis. F.C. and A.-L.B. wrote the manuscript.</p><h3 class="c-article-author-information__subtitle u-h3" id="corresponding-author">Corresponding author</h3><p>Correspondence to
                <a id="corresp-c1" rel="nofollow" href="/articles/s41467-019-09186-x/email/correspondent/c1/new">Albert-László Barabási</a>.</p></div></div></section><section aria-labelledby="ethics"><div class="c-article-section js-article-section" id="ethics-section"><h2 class="c-article-section__title u-h2 js-section-title js-c-reading-companion-sections-item" id="ethics">Ethics declarations</h2><div class="c-article-section__content js-collapsible-section" id="ethics-content">
              
                <h3 class="c-article__sub-heading u-h3">Competing interests</h3>
                <p>A.-L.B. is a co-founder of Scipher, a startup that uses network concepts to explore human disease. The other authors declare no competing interests.</p>
              
            </div></div></section><section aria-labelledby="additional-information"><div class="c-article-section js-article-section" id="additional-information-section"><h2 class="c-article-section__title u-h2 js-section-title js-c-reading-companion-sections-item" id="additional-information">Additional information</h2><div class="c-article-section__content js-collapsible-section" id="additional-information-content"><p><b>Journal peer review information:</b> <i>Nature Communications</i> thanks the anonymous reviewers for their contribution to the peer review of this work. Peer reviewer reports are available.</p><p><b>Publisher’s note:</b> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div></div></section><section aria-labelledby="Sec23"><div class="c-article-section js-article-section" id="Sec23-section"><h2 class="c-article-section__title u-h2 js-section-title js-c-reading-companion-sections-item" id="Sec23">Supplementary information</h2><div class="c-article-section__content js-collapsible-section" id="Sec23-content">
                  
                  
                  
                  
                  
                  
                  
                  
                  
                <div class="c-article-supplementary__item" data-test="supp-item" id="MOESM1"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-category="article body" data-track-action="view supplementary info" data-track-label="link" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41467-019-09186-x/MediaObjects/41467_2019_9186_MOESM1_ESM.pdf" data-supp-info-image="">Supplementary Information</a></h3></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM2"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-category="article body" data-track-action="view supplementary info" data-track-label="link" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41467-019-09186-x/MediaObjects/41467_2019_9186_MOESM2_ESM.docx" data-supp-info-image="">Description of Additional Supplementary Files</a></h3></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM3"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-category="article body" data-track-action="view supplementary info" data-track-label="link" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41467-019-09186-x/MediaObjects/41467_2019_9186_MOESM3_ESM.xlsx" data-supp-info-image="">Supplementary Data 1</a></h3></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM4"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-category="article body" data-track-action="view supplementary info" data-track-label="link" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41467-019-09186-x/MediaObjects/41467_2019_9186_MOESM4_ESM.xlsx" data-supp-info-image="">Supplementary Data 2</a></h3></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM5"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-category="article body" data-track-action="view supplementary info" data-track-label="link" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41467-019-09186-x/MediaObjects/41467_2019_9186_MOESM5_ESM.xlsx" data-supp-info-image="">Supplementary Data 3</a></h3></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM6"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-category="article body" data-track-action="view supplementary info" data-track-label="link" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41467-019-09186-x/MediaObjects/41467_2019_9186_MOESM6_ESM.xlsx" data-supp-info-image="">Supplementary Data 4</a></h3></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM7"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-category="article body" data-track-action="view supplementary info" data-track-label="link" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41467-019-09186-x/MediaObjects/41467_2019_9186_MOESM7_ESM.xlsx" data-supp-info-image="">Supplementary Data 5</a></h3></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM8"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-category="article body" data-track-action="view supplementary info" data-track-label="link" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41467-019-09186-x/MediaObjects/41467_2019_9186_MOESM8_ESM.pdf" data-supp-info-image="">Peer Review File</a></h3></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM9"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-category="article body" data-track-action="view supplementary info" data-track-label="link" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41467-019-09186-x/MediaObjects/41467_2019_9186_MOESM9_ESM.pdf" data-supp-info-image="">Reporting Summary</a></h3></div></div></div></section><section aria-labelledby="rightslink"><div class="c-article-section js-article-section" id="rightslink-section"><h2 class="c-article-section__title u-h2 js-section-title js-c-reading-companion-sections-item" id="rightslink">Rights and permissions</h2><div class="c-article-section__content js-collapsible-section" id="rightslink-content"><div class="c-article-license">
                <p><b>Open Access</b>  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <a href="http://creativecommons.org/licenses/by/4.0/" rel="license" itemprop="license">http://creativecommons.org/licenses/by/4.0/</a>.</p>
              </div><p class="c-article-rights"><a data-track="click" data-track-action="view rights and permissions" data-track-category="article body" data-track-label="link" href="https://s100.copyright.com/AppDispatchServlet?imprint=Nature&amp;oa=CC%20BY&amp;title=Network-based%20prediction%20of%20drug%20combinations&amp;author=Feixiong%20Cheng%20et%20al&amp;contentID=10.1038%2Fs41467-019-09186-x&amp;publication=Nature%20Communications&amp;publicationDate=2019-03-13&amp;publisherName=SpringerNature&amp;orderBeanReset=true">Reprints and Permissions</a></p></div></div></section><section aria-labelledby="article-info"><div class="c-article-section js-article-section" id="article-info-section"><h2 class="c-article-section__title u-h2 js-section-title js-c-reading-companion-sections-item" id="article-info">About this article</h2><div class="c-article-section__content js-collapsible-section" id="article-info-content"><div class="c-bibliographic-information"><div class="u-hide-print c-bibliographic-information__column"><a data-crossmark="10.1038/s41467-019-09186-x" target="_blank" rel="noopener" href="https://crossmark.crossref.org/dialog/?doi=10.1038/s41467-019-09186-x" data-track="click" data-track-action="Click Crossmark" data-track-category="article body" data-track-label="link"><img width="57" height="81" alt="Verify currency and authenticity via CrossMark" src="data:image/svg+xml;base64,<svg height="81" width="57" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="m17.35 35.45 21.3-14.2v-17.03h-21.3" fill="#989898"/><path d="m38.65 35.45-21.3-14.2v-17.03h21.3" fill="#747474"/><path d="m28 .5c-12.98 0-23.5 10.52-23.5 23.5s10.52 23.5 23.5 23.5 23.5-10.52 23.5-23.5c0-6.23-2.48-12.21-6.88-16.62-4.41-4.4-10.39-6.88-16.62-6.88zm0 41.25c-9.8 0-17.75-7.95-17.75-17.75s7.95-17.75 17.75-17.75 17.75 7.95 17.75 17.75c0 4.71-1.87 9.22-5.2 12.55s-7.84 5.2-12.55 5.2z" fill="#535353"/><path d="m41 36c-5.81 6.23-15.23 7.45-22.43 2.9-7.21-4.55-10.16-13.57-7.03-21.5l-4.92-3.11c-4.95 10.7-1.19 23.42 8.78 29.71 9.97 6.3 23.07 4.22 30.6-4.86z" fill="#9c9c9c"/><path d="m.2 58.45c0-.75.11-1.42.33-2.01s.52-1.09.91-1.5c.38-.41.83-.73 1.34-.94.51-.22 1.06-.32 1.65-.32.56 0 1.06.11 1.51.35.44.23.81.5 1.1.81l-.91 1.01c-.24-.24-.49-.42-.75-.56-.27-.13-.58-.2-.93-.2-.39 0-.73.08-1.05.23-.31.16-.58.37-.81.66-.23.28-.41.63-.53 1.04-.13.41-.19.88-.19 1.39 0 1.04.23 1.86.68 2.46.45.59 1.06.88 1.84.88.41 0 .77-.07 1.07-.23s.59-.39.85-.68l.91 1c-.38.43-.8.76-1.28.99-.47.22-1 .34-1.58.34-.59 0-1.13-.1-1.64-.31-.5-.2-.94-.51-1.31-.91-.38-.4-.67-.9-.88-1.48-.22-.59-.33-1.26-.33-2.02zm8.4-5.33h1.61v2.54l-.05 1.33c.29-.27.61-.51.96-.72s.76-.31 1.24-.31c.73 0 1.27.23 1.61.71.33.47.5 1.14.5 2.02v4.31h-1.61v-4.1c0-.57-.08-.97-.25-1.21-.17-.23-.45-.35-.83-.35-.3 0-.56.08-.79.22-.23.15-.49.36-.78.64v4.8h-1.61zm7.37 6.45c0-.56.09-1.06.26-1.51.18-.45.42-.83.71-1.14.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.36c.07.62.29 1.1.65 1.44.36.33.82.5 1.38.5.29 0 .57-.04.83-.13s.51-.21.76-.37l.55 1.01c-.33.21-.69.39-1.09.53-.41.14-.83.21-1.26.21-.48 0-.92-.08-1.34-.25-.41-.16-.76-.4-1.07-.7-.31-.31-.55-.69-.72-1.13-.18-.44-.26-.95-.26-1.52zm4.6-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.07.45-.31.29-.5.73-.58 1.3zm2.5.62c0-.57.09-1.08.28-1.53.18-.44.43-.82.75-1.13s.69-.54 1.1-.71c.42-.16.85-.24 1.31-.24.45 0 .84.08 1.17.23s.61.34.85.57l-.77 1.02c-.19-.16-.38-.28-.56-.37-.19-.09-.39-.14-.61-.14-.56 0-1.01.21-1.35.63-.35.41-.52.97-.52 1.67 0 .69.17 1.24.51 1.66.34.41.78.62 1.32.62.28 0 .54-.06.78-.17.24-.12.45-.26.64-.42l.67 1.03c-.33.29-.69.51-1.08.65-.39.15-.78.23-1.18.23-.46 0-.9-.08-1.31-.24-.4-.16-.75-.39-1.05-.7s-.53-.69-.7-1.13c-.17-.45-.25-.96-.25-1.53zm6.91-6.45h1.58v6.17h.05l2.54-3.16h1.77l-2.35 2.8 2.59 4.07h-1.75l-1.77-2.98-1.08 1.23v1.75h-1.58zm13.69 1.27c-.25-.11-.5-.17-.75-.17-.58 0-.87.39-.87 1.16v.75h1.34v1.27h-1.34v5.6h-1.61v-5.6h-.92v-1.2l.92-.07v-.72c0-.35.04-.68.13-.98.08-.31.21-.57.4-.79s.42-.39.71-.51c.28-.12.63-.18 1.04-.18.24 0 .48.02.69.07.22.05.41.1.57.17zm.48 5.18c0-.57.09-1.08.27-1.53.17-.44.41-.82.72-1.13.3-.31.65-.54 1.04-.71.39-.16.8-.24 1.23-.24s.84.08 1.24.24c.4.17.74.4 1.04.71s.54.69.72 1.13c.19.45.28.96.28 1.53s-.09 1.08-.28 1.53c-.18.44-.42.82-.72 1.13s-.64.54-1.04.7-.81.24-1.24.24-.84-.08-1.23-.24-.74-.39-1.04-.7c-.31-.31-.55-.69-.72-1.13-.18-.45-.27-.96-.27-1.53zm1.65 0c0 .69.14 1.24.43 1.66.28.41.68.62 1.18.62.51 0 .9-.21 1.19-.62.29-.42.44-.97.44-1.66 0-.7-.15-1.26-.44-1.67-.29-.42-.68-.63-1.19-.63-.5 0-.9.21-1.18.63-.29.41-.43.97-.43 1.67zm6.48-3.44h1.33l.12 1.21h.05c.24-.44.54-.79.88-1.02.35-.24.7-.36 1.07-.36.32 0 .59.05.78.14l-.28 1.4-.33-.09c-.11-.01-.23-.02-.38-.02-.27 0-.56.1-.86.31s-.55.58-.77 1.1v4.2h-1.61zm-47.87 15h1.61v4.1c0 .57.08.97.25 1.2.17.24.44.35.81.35.3 0 .57-.07.8-.22.22-.15.47-.39.73-.73v-4.7h1.61v6.87h-1.32l-.12-1.01h-.04c-.3.36-.63.64-.98.86-.35.21-.76.32-1.24.32-.73 0-1.27-.24-1.61-.71-.33-.47-.5-1.14-.5-2.02zm9.46 7.43v2.16h-1.61v-9.59h1.33l.12.72h.05c.29-.24.61-.45.97-.63.35-.17.72-.26 1.1-.26.43 0 .81.08 1.15.24.33.17.61.4.84.71.24.31.41.68.53 1.11.13.42.19.91.19 1.44 0 .59-.09 1.11-.25 1.57-.16.47-.38.85-.65 1.16-.27.32-.58.56-.94.73-.35.16-.72.25-1.1.25-.3 0-.6-.07-.9-.2s-.59-.31-.87-.56zm0-2.3c.26.22.5.37.73.45.24.09.46.13.66.13.46 0 .84-.2 1.15-.6.31-.39.46-.98.46-1.77 0-.69-.12-1.22-.35-1.61-.23-.38-.61-.57-1.13-.57-.49 0-.99.26-1.52.77zm5.87-1.69c0-.56.08-1.06.25-1.51.16-.45.37-.83.65-1.14.27-.3.58-.54.93-.71s.71-.25 1.08-.25c.39 0 .73.07 1 .2.27.14.54.32.81.55l-.06-1.1v-2.49h1.61v9.88h-1.33l-.11-.74h-.06c-.25.25-.54.46-.88.64-.33.18-.69.27-1.06.27-.87 0-1.56-.32-2.07-.95s-.76-1.51-.76-2.65zm1.67-.01c0 .74.13 1.31.4 1.7.26.38.65.58 1.15.58.51 0 .99-.26 1.44-.77v-3.21c-.24-.21-.48-.36-.7-.45-.23-.08-.46-.12-.7-.12-.45 0-.82.19-1.13.59-.31.39-.46.95-.46 1.68zm6.35 1.59c0-.73.32-1.3.97-1.71.64-.4 1.67-.68 3.08-.84 0-.17-.02-.34-.07-.51-.05-.16-.12-.3-.22-.43s-.22-.22-.38-.3c-.15-.06-.34-.1-.58-.1-.34 0-.68.07-1 .2s-.63.29-.93.47l-.59-1.08c.39-.24.81-.45 1.28-.63.47-.17.99-.26 1.54-.26.86 0 1.51.25 1.93.76s.63 1.25.63 2.21v4.07h-1.32l-.12-.76h-.05c-.3.27-.63.48-.98.66s-.73.27-1.14.27c-.61 0-1.1-.19-1.48-.56-.38-.36-.57-.85-.57-1.46zm1.57-.12c0 .3.09.53.27.67.19.14.42.21.71.21.28 0 .54-.07.77-.2s.48-.31.73-.56v-1.54c-.47.06-.86.13-1.18.23-.31.09-.57.19-.76.31s-.33.25-.41.4c-.09.15-.13.31-.13.48zm6.29-3.63h-.98v-1.2l1.06-.07.2-1.88h1.34v1.88h1.75v1.27h-1.75v3.28c0 .8.32 1.2.97 1.2.12 0 .24-.01.37-.04.12-.03.24-.07.34-.11l.28 1.19c-.19.06-.4.12-.64.17-.23.05-.49.08-.76.08-.4 0-.74-.06-1.02-.18-.27-.13-.49-.3-.67-.52-.17-.21-.3-.48-.37-.78-.08-.3-.12-.64-.12-1.01zm4.36 2.17c0-.56.09-1.06.27-1.51s.41-.83.71-1.14c.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.37c.08.62.29 1.1.65 1.44.36.33.82.5 1.38.5.3 0 .58-.04.84-.13.25-.09.51-.21.76-.37l.54 1.01c-.32.21-.69.39-1.09.53s-.82.21-1.26.21c-.47 0-.92-.08-1.33-.25-.41-.16-.77-.4-1.08-.7-.3-.31-.54-.69-.72-1.13-.17-.44-.26-.95-.26-1.52zm4.61-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.08.45-.31.29-.5.73-.57 1.3zm3.01 2.23c.31.24.61.43.92.57.3.13.63.2.98.2.38 0 .65-.08.83-.23s.27-.35.27-.6c0-.14-.05-.26-.13-.37-.08-.1-.2-.2-.34-.28-.14-.09-.29-.16-.47-.23l-.53-.22c-.23-.09-.46-.18-.69-.3-.23-.11-.44-.24-.62-.4s-.33-.35-.45-.55c-.12-.21-.18-.46-.18-.75 0-.61.23-1.1.68-1.49.44-.38 1.06-.57 1.83-.57.48 0 .91.08 1.29.25s.71.36.99.57l-.74.98c-.24-.17-.49-.32-.73-.42-.25-.11-.51-.16-.78-.16-.35 0-.6.07-.76.21-.17.15-.25.33-.25.54 0 .14.04.26.12.36s.18.18.31.26c.14.07.29.14.46.21l.54.19c.23.09.47.18.7.29s.44.24.64.4c.19.16.34.35.46.58.11.23.17.5.17.82 0 .3-.06.58-.17.83-.12.26-.29.48-.51.68-.23.19-.51.34-.84.45-.34.11-.72.17-1.15.17-.48 0-.95-.09-1.41-.27-.46-.19-.86-.41-1.2-.68z" fill="#535353"/></g></svg>" /></a></div><div class="c-bibliographic-information__column"><ul class="c-bibliographic-information__list" data-test="publication-history"><li class="c-bibliographic-information__list-item"><h4 class="u-h4">Received</h4><p class="c-bibliographic-information__value"><time datetime="2018-04-26">26 April 2018</time></p></li><li class="c-bibliographic-information__list-item"><h4 class="u-h4">Accepted</h4><p class="c-bibliographic-information__value"><time datetime="2019-02-20">20 February 2019</time></p></li><li class="c-bibliographic-information__list-item"><h4 class="u-h4">Published</h4><p class="c-bibliographic-information__value"><time datetime="2019-03-13">13 March 2019</time></p></li><li class="c-bibliographic-information__list-item"><h4 class="u-h4"><abbr title="Digital Object Identifier">DOI</abbr></h4><p class="c-bibliographic-information__value"><a href="https://doi.org/10.1038/s41467-019-09186-x" data-track="click" data-track-action="view doi" data-track-category="article body" data-track-label="link" itemprop="sameAs">https://doi.org/10.1038/s41467-019-09186-x</a></p></li></ul><div data-component="share-box"></div><div data-component="article-info-list"></div></div></div></div></div></section>

                        
    <section aria-labelledby="further-reading">
      <div class="c-article-section js-article-section" id="further-reading-section">
        <h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="further-reading">Further reading</h2>
        <div class="c-article-section__content js-collapsible-section" id="further-reading-content">
        <ul class="c-article-further-reading__list" id="further-reading-list">
          
            <li class="c-article-further-reading__item js-ref-item" id="further-reading-item-1">
              <h3 class="c-article-further-reading__title">
                <a class="print-link"
                   data-track="click"
                   data-track-action="view further reading article"
                   data-track-category="article body"
                   data-track-label="link:Mechanism of action of celastrol against rheumatoid arthritis: A network pharmacology analysis"
                   href="https://doi.org/10.1016/j.intimp.2019.105725"
                   id="title-link-1">
                  Mechanism of action of celastrol against rheumatoid arthritis: A network pharmacology analysis
                </a>
              </h3>
              
                <ul data-test="author-list"
                    class="c-article-further-reading__authors-list js-list-authors-3 js-etal-collapsed"
                    id="authors-1">
                  <li><span
                        class="js-separator"></span><span>Xinqiang Song</span></li><li><span
                        class="js-separator">, </span><span>Yu Zhang</span></li><li><span
                        class="js-separator">, </span><span>Erqin Dai</span></li><li><span
                        class="js-separator">, </span><span>Hongtao Du</span></li><li><span
                        class="js-separator">&nbsp;&amp;&nbsp;</span><span>Lei Wang</span></li></ul>
              
              <p class="c-article-further-reading__journal-title" id="journal-name-1">
                <i>International Immunopharmacology</i>
                (2019)
              </p>
            </li>
          
            <li class="c-article-further-reading__item js-ref-item" id="further-reading-item-2">
              <h3 class="c-article-further-reading__title">
                <a class="print-link"
                   data-track="click"
                   data-track-action="view further reading article"
                   data-track-category="article body"
                   data-track-label="link:KinomeX: a web application for predicting kinome-wide polypharmacology effect of small molecules"
                   href="https://doi.org/10.1093/bioinformatics/btz519"
                   id="title-link-2">
                  KinomeX: a web application for predicting kinome-wide polypharmacology effect of small molecules
                </a>
              </h3>
              
                <ul data-test="author-list"
                    class="c-article-further-reading__authors-list js-list-authors-3 js-etal-collapsed"
                    id="authors-2">
                  <li><span
                        class="js-separator"></span><span>Zhaojun Li</span></li><li><span
                        class="js-separator">, </span><span>Xutong Li</span></li><li><span
                        class="js-separator">, </span><span>Xiaohong Liu</span></li><li><span
                        class="js-separator">, </span><span>Zunyun Fu</span></li><li><span
                        class="js-separator">, </span><span>Zhaoping Xiong</span></li><li><span
                        class="js-separator">, </span><span>Xiaolong Wu</span></li><li><span
                        class="js-separator">, </span><span>Xiaoqin Tan</span></li><li><span
                        class="js-separator">, </span><span>Jihui Zhao</span></li><li><span
                        class="js-separator">, </span><span>Feisheng Zhong</span></li><li><span
                        class="js-separator">, </span><span>Xiaozhe Wan</span></li><li><span
                        class="js-separator">, </span><span>Xiaomin Luo</span></li><li><span
                        class="js-separator">, </span><span>Kaixian Chen</span></li><li><span
                        class="js-separator">, </span><span>Hualiang Jiang</span></li><li><span
                        class="js-separator">, </span><span>Mingyue Zheng</span></li><li><span
                        class="js-separator">&nbsp;&amp;&nbsp;</span><span>Jonathan Wren</span></li></ul>
              
              <p class="c-article-further-reading__journal-title" id="journal-name-2">
                <i>Bioinformatics</i>
                (2019)
              </p>
            </li>
          
            <li class="c-article-further-reading__item js-ref-item" id="further-reading-item-3">
              <h3 class="c-article-further-reading__title">
                <a class="print-link"
                   data-track="click"
                   data-track-action="view further reading article"
                   data-track-category="article body"
                   data-track-label="link:A genome-wide positioning systems network algorithm for in silico drug repurposing"
                   href="https://doi.org/10.1038/s41467-019-10744-6"
                   id="title-link-3">
                  A genome-wide positioning systems network algorithm for in silico drug repurposing
                </a>
              </h3>
              
                <ul data-test="author-list"
                    class="c-article-further-reading__authors-list js-list-authors-3 js-etal-collapsed"
                    id="authors-3">
                  <li><span
                        class="js-separator"></span><span>Feixiong Cheng</span></li><li><span
                        class="js-separator">, </span><span>Weiqiang Lu</span></li><li><span
                        class="js-separator">, </span><span>Chuang Liu</span></li><li><span
                        class="js-separator">, </span><span>Jiansong Fang</span></li><li><span
                        class="js-separator">, </span><span>Yuan Hou</span></li><li><span
                        class="js-separator">, </span><span>Diane E. Handy</span></li><li><span
                        class="js-separator">, </span><span>Ruisheng Wang</span></li><li><span
                        class="js-separator">, </span><span>Yuzheng Zhao</span></li><li><span
                        class="js-separator">, </span><span>Yi Yang</span></li><li><span
                        class="js-separator">, </span><span>Jin Huang</span></li><li><span
                        class="js-separator">, </span><span>David E. Hill</span></li><li><span
                        class="js-separator">, </span><span>Marc Vidal</span></li><li><span
                        class="js-separator">, </span><span>Charis Eng</span></li><li><span
                        class="js-separator">&nbsp;&amp;&nbsp;</span><span>Joseph Loscalzo</span></li></ul>
              
              <p class="c-article-further-reading__journal-title" id="journal-name-3">
                <i>Nature Communications</i>
                (2019)
              </p>
            </li>
          
            <li class="c-article-further-reading__item js-ref-item" id="further-reading-item-4">
              <h3 class="c-article-further-reading__title">
                <a class="print-link"
                   data-track="click"
                   data-track-action="view further reading article"
                   data-track-category="article body"
                   data-track-label="link:A Systems Pharmacology Approach Uncovers Wogonoside as an Angiogenesis Inhibitor of Triple-Negative Breast Cancer by Targeting Hedgehog Signaling"
                   href="https://doi.org/10.1016/j.chembiol.2019.05.004"
                   id="title-link-4">
                  A Systems Pharmacology Approach Uncovers Wogonoside as an Angiogenesis Inhibitor of Triple-Negative Breast Cancer by Targeting Hedgehog Signaling
                </a>
              </h3>
              
                <ul data-test="author-list"
                    class="c-article-further-reading__authors-list js-list-authors-3 js-etal-collapsed"
                    id="authors-4">
                  <li><span
                        class="js-separator"></span><span>Yujie Huang</span></li><li><span
                        class="js-separator">, </span><span>Jiansong Fang</span></li><li><span
                        class="js-separator">, </span><span>Weiqiang Lu</span></li><li><span
                        class="js-separator">, </span><span>Zihao Wang</span></li><li><span
                        class="js-separator">, </span><span>Qi Wang</span></li><li><span
                        class="js-separator">, </span><span>Yuan Hou</span></li><li><span
                        class="js-separator">, </span><span>Xingwu Jiang</span></li><li><span
                        class="js-separator">, </span><span>Ofer Reizes</span></li><li><span
                        class="js-separator">, </span><span>Justin Lathia</span></li><li><span
                        class="js-separator">, </span><span>Ruth Nussinov</span></li><li><span
                        class="js-separator">, </span><span>Charis Eng</span></li><li><span
                        class="js-separator">&nbsp;&amp;&nbsp;</span><span>Feixiong Cheng</span></li></ul>
              
              <p class="c-article-further-reading__journal-title" id="journal-name-4">
                <i>Cell Chemical Biology</i>
                (2019)
              </p>
            </li>
          
            <li class="c-article-further-reading__item js-ref-item" id="further-reading-item-5">
              <h3 class="c-article-further-reading__title">
                <a class="print-link"
                   data-track="click"
                   data-track-action="view further reading article"
                   data-track-category="article body"
                   data-track-label="link:deepDR: a network-based deep learning approach to in silico drug repositioning"
                   href="https://doi.org/10.1093/bioinformatics/btz418"
                   id="title-link-5">
                  deepDR: a network-based deep learning approach to in silico drug repositioning
                </a>
              </h3>
              
                <ul data-test="author-list"
                    class="c-article-further-reading__authors-list js-list-authors-3 js-etal-collapsed"
                    id="authors-5">
                  <li><span
                        class="js-separator"></span><span>Xiangxiang Zeng</span></li><li><span
                        class="js-separator">, </span><span>Siyi Zhu</span></li><li><span
                        class="js-separator">, </span><span>Xiangrong Liu</span></li><li><span
                        class="js-separator">, </span><span>Yadi Zhou</span></li><li><span
                        class="js-separator">, </span><span>Ruth Nussinov</span></li><li><span
                        class="js-separator">, </span><span>Feixiong Cheng</span></li><li><span
                        class="js-separator">&nbsp;&amp;&nbsp;</span><span>Lenore Cowen</span></li></ul>
              
              <p class="c-article-further-reading__journal-title" id="journal-name-5">
                <i>Bioinformatics</i>
                (2019)
              </p>
            </li>
          
        </ul>
      </div>
    </div>
    </section>
  

                        
                            <section aria-labelledby="article-comments"><div class="c-article-section js-article-section" id="article-comments-section"><h2 class="c-article-section__title u-h2 js-section-title js-c-reading-companion-sections-item" id="article-comments">Comments</h2><div class="c-article-section__content js-collapsible-section" id="article-comments-content"><p>By submitting a comment you agree to abide by our <a href="/info/tandc.html">Terms</a> and <a href="/info/community-guidelines.html">Community Guidelines</a>. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.</p></div></div></section>
                            <div id="inject-comments">
                                <div class="placeholder" data-replace="true"
                                     data-placeholder="/platform/disqus?doi=10.1038/s41467-019-09186-x #article-comments-container">
                            </div>
                        </div>
                        

                        <span data-recommended="jobs"></span>
                    </div>
            </div>

            <div class="c-article-extras u-hide-print" role="complementary" data-container-type="reading-companion" data-track-component="reading companion">
                
                    
    
        
        <div class="c-pdf-download u-clear-both">
            <a href="/articles/s41467-019-09186-x.pdf" class="c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="download-pdf" data-draft-ignore="true" data-track="click" data-track-action="download pdf" data-track-category="article body" data-track-label="link">
                <span>Download PDF</span>
            </a>
        </div>
        
    

                
                
    
        <div class="c-article-metrics-bar__wrapper u-clear-both">
            <div class="c-article-metrics-bar">
                <h3 class="u-visually-hidden">Article metrics</h3>
                
                    <div class="c-article-metrics-bar__item">
                        <h4 class="c-article-metrics-bar__label">Accesses</h4>
                        <p class="c-article-metrics-bar__count">9800</p>
                    </div>
                
                
                    <div class="c-article-metrics-bar__item">
                        <h4 class="c-article-metrics-bar__label">Citations</h4>
                        <p class="c-article-metrics-bar__count">11</p>
                    </div>
                
                
                    
                        <div class="c-article-metrics-bar__item">
                            <h4 class="c-article-metrics-bar__label">Altmetric</h4>
                            <p class="c-article-metrics-bar__count">76</p>
                        </div>
                    
                    
                        <div class="c-article-metrics-bar__item">
                            <h4 class="u-visually-hidden">More details</h4>
                            <p class="c-article-metrics-bar__details"><a href="/articles/s41467-019-09186-x/metrics" data-track="click" data-track-action="view metrics" data-track-category="article body" data-track-label="link" rel="nofollow">Metrics</a></p>
                        </div>
                    
                
            </div>
        </div>
    


                
                    
                

                

                <div class="c-reading-companion">
                    <div class="c-reading-companion__sticky" data-component="reading-companion-sticky">
                        <div class="c-reading-companion__panel c-reading-companion__sections c-reading-companion__panel--active" id="tabpanel-sections">
                            
    <div id="div-gpt-ad-right-2"
         class="div-gpt-ad advert medium-rectangle js-ad text-center hide-print grade-c-hide"
         data-ad-type="right"
         data-gpt-unitpath="/285/nature_communications/article"
         data-gpt-sizes="300x250"
         data-gpt-targeting="type=article;pos=right;artid=s41467-019-09186-x;doi=10.1038/s41467-019-09186-x;techmeta=118,119,129;subjmeta=114,154,2408,2710,360,553,555,631,92;kwrd=Biochemical networks,Network topology,Networks and systems biology,Target identification">
        <noscript>
            <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/285/nature_communications/article&amp;sz=300x250&amp;c=-1001855252&amp;t=pos%3Dright%26type%3Darticle%26artid%3Ds41467-019-09186-x%26doi%3D10.1038/s41467-019-09186-x%26techmeta%3D118,119,129%26subjmeta%3D114,154,2408,2710,360,553,555,631,92%26kwrd%3DBiochemical networks,Network topology,Networks and systems biology,Target identification">
                <img data-test="gpt-advert-fallback-img"
                     src="//pubads.g.doubleclick.net/gampad/ad?iu=/285/nature_communications/article&amp;sz=300x250&amp;c=-1001855252&amp;t=pos%3Dright%26type%3Darticle%26artid%3Ds41467-019-09186-x%26doi%3D10.1038/s41467-019-09186-x%26techmeta%3D118,119,129%26subjmeta%3D114,154,2408,2710,360,553,555,631,92%26kwrd%3DBiochemical networks,Network topology,Networks and systems biology,Target identification"
                     alt="Advertisement"
                     width="300"
                     height="250"></a>
        </noscript>
    </div>

                        </div>
                        <div class="c-reading-companion__panel c-reading-companion__figures c-reading-companion__panel--full-width" id="tabpanel-figures"></div>
                        <div class="c-reading-companion__panel c-reading-companion__references c-reading-companion__panel--full-width" id="tabpanel-references"></div>
                    </div>
                </div>
            </div>
        </article>
    </div>
</div>
</div>


<div class="hide-print js-header-menu menu mb20 z-index-50 composite-layer background-white border-bottom-2 border-gray-medium tighten-line-height" id="menu" data-track-component="menu">
    <div class="menu-inner content js-hide">
        <nav>
            <div class="cleared border-bottom-1 border-gray-medium ml20 mr20">
                <div class="grid-ng grid-1of4 mq875-grid-12">
                    <h3 class="h3 pa20 mq875-pa0 mq875-mt20">
                        Nature Communications<span class="visually-hidden"> menu</span>
                    </h3>
                </div>
                
    
    <div class="grid-ng grid-1of4 text14 pa20 mq875-grid-4 mq640-grid-12">
        <ul class="clean-list mb0">
            
            <li class="mb4 pr10"><a href="/ncomms/news-and-comment" data-track="click" data-track-action="news &amp; comment" data-track-label="link">News &amp; Comment</a></li>
            
            <li class="mb4 pr10"><a href="/ncomms/research" data-track="click" data-track-action="research" data-track-label="link">Research</a></li>
            
        </ul>
    </div>
    

    
    <div class="grid-ng grid-1of4 text14 pa20 mq875-grid-4 mq640-grid-12">
        <ul class="clean-list mb0">
            
            <li class="mb4 pr10"><a href="/ncomms/articles" data-track="click" data-track-action="browse articles" data-track-label="link">Browse Articles</a></li>
            
            <li class="mb4 pr10"><a href="/ncomms/collections" data-track="click" data-track-action="browse collections" data-track-label="link">Browse Collections</a></li>
            
            <li class="mb4 pr10"><a href="/ncomms/browse-subjects" data-track="click" data-track-action="browse subjects" data-track-label="link">Browse Subjects</a></li>
            
        </ul>
    </div>
    

    
    <div class="grid-ng grid-1of4 text14 pa20 mq875-grid-4 mq640-grid-12">
        <ul class="clean-list mb0">
            
            <li class="mb4 pr10"><a href="/ncomms/about" data-track="click" data-track-action="about the journal" data-track-label="link">About the journal</a></li>
            
            <li class="mb4 pr10"><a href="/ncomms/submit" data-track="click" data-track-action="submit" data-track-label="link">Submit</a></li>
            
            <li class="mb4 pr10"><a href="/ncomms/journal-policies" data-track="click" data-track-action="journal policies" data-track-label="link">Journal policies</a></li>
            
            <li class="mb4 pr10"><a href="/ncomms/editorshighlights" data-track="click" data-track-action="editors&#x27; highlights" data-track-label="link">Editors&#x27; Highlights</a></li>
            
            <li class="mb4 pr10"><a href="/ncomms/contact" data-track="click" data-track-action="contact" data-track-label="link">Contact</a></li>
            
            <li class="mb4 pr10"><a href="/ncomms/top50" data-track="click" data-track-action="top 50 read articles of 2018" data-track-label="link">Top 50 Read Articles of 2018</a></li>
            
        </ul>
    </div>
    

            </div>
            <div class="cleared ml20 mr20">
                <div class="cleared pb10">
    <div class="grid-ng grid-1of4 mq875-grid-12">
        <h3 class="serif pa20 mq875-pa0 mq875-mt20">Nature Research<span class="visually-hidden"> menu</span></h3>
    </div>
    <div class="grid-ng grid-1of4 text14 pa20 mq875-grid-4 mq640-grid-12">
        <h4 class="mb4">Our Journals</h4>
        <ul class="clean-list mb0">
            <li class="mb4 pr10"><a href="/nature" data-track="click" data-track-action="nature" data-track-label="link">Nature</a></li>
            <li class="mb4 pr10"><a href="/ncomms" data-track="click" data-track-action="nature communications" data-track-label="link">Nature Communications</a></li>
            <li class="mb4 pr10"><a href="/nprot" data-track="click" data-track-action="nature protocols" data-track-label="link">Nature Protocols</a></li>
            <li class="mb4 pr10"><a href="/srep" data-track="click" data-track-action="scientific reports" data-track-label="link">Scientific Reports</a></li>
            <li class="mb4 pr10"><a href="/siteindex" data-track="click" data-track-action="journal a-z view all" data-track-label="link">View all journals</a></li>
        </ul>
    </div>
    <div class="grid-ng grid-1of4 text14 pa20 mq875-grid-4 mq640-grid-12">
        <h4 class="mb4">Subjects</h4>
        <ul class="clean-list mb0">
            <li class="mb4 pr10"><a href="/subjects/biological-sciences" data-track="click" data-track-action="biological sciences" data-track-label="link">Biological Sciences</a></li>
            <li class="mb4 pr10"><a href="/subjects/scientific-community-and-society" data-track="click" data-track-action="scientific community and society" data-track-label="link">Scientific Community &amp; Society</a></li>
            <li class="mb4 pr10"><a href="/subjects/earth-and-environmental-sciences" data-track="click" data-track-action="earth and environmental sciences" data-track-label="link">Earth &amp; Environmental Sciences</a></li>
            <li class="mb4 pr10"><a href="/subjects/health-sciences" data-track="click" data-track-action="health sciences" data-track-label="link">Health Sciences</a></li>
            <li class="mb4 pr10"><a href="/subjects/physical-sciences" data-track="click" data-track-action="physical sciences" data-track-label="link">Physical Sciences</a></li>
            <li class="mb4 pr10"><a href="/subjects" data-track="click" data-track-action="subjects view all" data-track-label="link">View all subjects</a></li>
        </ul>
    </div>
    <div class="grid-ng grid-1of4 text14 pa20 mq875-grid-4 mq640-grid-12">
        <h4 class="mb4">More</h4>
        <ul class="clean-list mb0">
            <li class="mb4 pr10"><a href="https://support.nature.com/support/home" data-track="click" data-track-action="subscriptions" data-track-label="link">Contact us</a></li>
            <li class="mb4 pr10"><a href="/authors/index.html" data-track="click" data-track-action="authors and referees" data-track-label="link">Authors &amp; Referees</a></li>
            <li class="mb4 pr10"><a href="/libraries/index.html" data-track="click" data-track-action="librarians" data-track-label="link">Librarians</a></li>
            <li class="mb4 pr10"><a href="/advertising/index.html" data-track="click" data-track-action="advertisers" data-track-label="link">Advertisers</a></li>
            <li class="mb4 pr10"><a href="/npg_/press_room/index.html" data-track="click" data-track-action="press" data-track-label="link">Press</a></li>
            <li class="mb4 pr10"><a href="/npg_/index_npg.html" data-track="click" data-track-action="about" data-track-label="link">About Nature Research</a></li>
        </ul>
    </div>
</div>

            </div>
        </nav>
    </div>
</div>


<div id="search-menu" class="menu pt20 mb20 z-index-50 composite-layer background-white border-gray-medium border-bottom-2" data-component="tray" data-track-component="header">
    <div class="menu-inner js-hide">
        <section>
            <h2 class="visually-hidden">Search</h2>
            <div class="hide-print content mb40 mq1200-padded position-relative" data-test="inline-search">
                <div class="pt30 cleared background-white sans-serif">
                    <div class="grid grid-8 grid-left-2 mq875-grid-12 mq875-ml0 mq640-pb30">
                        <form action="/search" method="get" role="search" autocomplete="off" class="standard-space-below" data-track="submit" data-track-action="search" data-track-label="form">
                            <label for="keywords" class="block strong">Article search</label>
                            <div class="position-relative">
                                <input type="search" id="keywords" class="border-gray border-all-1 equalize-line-height pa10 pr40 box-sizing grid-12" name="q" value="" placeholder="Search by keywords or author" data-test="search-keywords">
                                <div class="position-absolute position-right position-top mt1 mr1">
                                    <button type="submit" class="icon icon-center search-btn kill-border" data-test="search-submit">
                                        Search
                                    </button>
                                </div>
                                <p class="mb0 mt4 text14"><a href="/search/advanced" data-track="click" data-track-action="advanced search" data-track-label="link">Advanced search</a></p>
                            </div>
                        </form>
                        <h3 class="h3 strong mb4 border-gray-medium border-bottom-1 sans-serif">Quick links</h3>
                        <ul class="clean-list mb0 text14">
                            <li class="grid-ng grid-1of2 mb6 mt6"><a href="/subjects" data-track="click" data-track-action="explore articles by subject" data-track-label="link">Explore articles by subject</a></li>
                            <li class="grid-ng grid-1of2 mb6 mt6"><a href="/naturecareers" data-track="click" data-track-action="find a job" data-track-label="link">Find a job</a></li>
                            <li class="grid-ng grid-1of2"><a href="/authors/index.html" data-track="click" data-track-action="guide to authors" data-track-label="link">Guide to authors</a></li>
                            <li class="grid-ng grid-1of2"><a href="/authors/editorial_policies/" data-track="click" data-track-action="editorial policies" data-track-label="link">Editorial policies</a></li>
                        </ul>
                    </div>
                </div>
            </div>
        </section>
    </div>
</div>


<footer>
    

    <div class="container-footer mt40 cleared container-footer-full" itemscope itemtype="http://schema.org/Periodical">
        <meta itemprop="publisher" content="Springer Nature">
        
          <div class="content pt20 pr30 pl30">
            <div class="grid grid-12 last clear-float cleared mb15 text-gray-light text13 flex-box flex-wrap-reverse">
                <h2 aria-level="2" class="text13 strong emphasis ma0 sans-serif" itemprop="name">Nature Communications</h2>
                <p class="pt0 pr10 pb0 pl10 ma0"><abbr title="International Standard Serial Number">ISSN</abbr> <span itemprop="issn">2041-1723</span> (online)</p>
            </div>
          </div>
        

        <div class="grid grid-12 pl30 pr30 last" id="footer">
        <h2 aria-level="2" class="hide">nature.com sitemap</h2>
    </div>

    <div class="pl30 pr30 content" data-track-component="footer">

        <div class="grid grid-12 last clear-float cleared mb5 pt20 text-gray-light flex-wrap">
            <div class="grid grid-3 mq875-grid-12 just-mq640-last just-mq875-last mb20"><img alt="Nature Research" src="/static/images/natureresearch-logo.2fe351a520.svg" loading="lazy"></div>
            <ul class="grid grid-7 mq875-grid-8 mq640-grid-12 just-mq640-last clean-list mb10 mt10 text15 u-hide-print">
                <li class="grid grid-3 mq875-grid-3 mq640-grid-6 mq480-grid-12"><a href="https://www.nature.com/npg_/company_info/index.html" data-track="click" data-track-action="about us" class="text-gray-light" data-track-label="link">About us</a></li>
                <li class="grid grid-3 mq875-grid-3 mq640-grid-6 mq480-grid-12 just-mq640-last just-mq480-last"><a href="https://www.nature.com/npg_/press_room/press_releases.html" data-track="click" data-track-action="press releases" data-track-label="link" class="text-gray-light">Press releases</a></li>
                <li class="grid grid-3 mq875-grid-3 mq640-grid-6 mq480-grid-12"><a href="https://press.nature.com/" data-track="click" data-track-action="press office" data-track-label="link" class="text-gray-light">Press office</a></li>
                <li class="grid grid-3 mq875-grid-3 mq640-grid-6 mq480-grid-12 last"><a href="https://support.nature.com/support/home" data-track="click" data-track-action="contact us" class="text-gray-light" data-track-label="link">Contact us</a></li>
            </ul>
            <ul class="grid grid-2 mq875-grid-4 mq640-grid-12 last clean-list mb10 mt4 u-hide-print">
                <li class="grid grid-4 mq875-grid-3"><a href="https://www.facebook.com/nature/" data-track="click" data-track-action="facebook" data-track-label="link" class="text-gray-light"><img src="/static/images/fb.49ba391f15.svg" class="cleared text-footer-img" alt="Facebook"/></a></li>
                <li class="grid grid-4 mq875-grid-3"><a href="https://twitter.com/nresearchnews?lang=en" data-track="click" data-track-action="twitter" data-track-label="link" class="text-gray-light"><img src="/static/images/twitter.a90dbeb03a.svg" class="cleared text-footer-img" alt="Twitter"/></a></li>
                <li class="grid grid-4 mq875-grid-3 last"><a href="https://www.youtube.com/channel/UCvCLdSgYdSTpWcOgEJgi-ng" data-track="click" data-track-action="youtube" data-track-label="link" class="text-gray-light"><img src="/static/images/youtube.6071f6012c.svg" class="cleared text-footer-img" alt="Youtube"/></a></li>
            </ul>
        </div>

        <div class="cleared z-index-1 pt30 pb20 border-top-1 border-gray text-footer-mobile-bottom hide-print u-hide-print">
            <div class="grid grid-3 mq875-grid-4 mq640-grid-6 mq480-grid-12">
                <h3 class="text-footer-heading">Discover content</h3>
                <ul class="clean-list ma0 mb6 text15">
                    <li class="pb4"><a href="https://www.nature.com/siteindex/" data-track="click" data-track-action="journals a-z" data-track-label="link" class="text-gray-light">Journals A-Z</a></li>
                    <li class="pb4"><a href="https://www.nature.com/subjects/" data-track="click" data-track-action="article by subject" data-track-label="link" class="text-gray-light">Articles by subject</a></li>
                    <li class="pb4"><a href="https://nano.nature.com/" data-track="click" data-track-action="nano" data-track-label="link" class="text-gray-light">Nano</a></li>
                    <li class="pb4"><a href="https://www.nature.com/protocolexchange/" data-track="click" data-track-action="protocol exchange" data-track-label="link" class="text-gray-light">Protocol Exchange</a></li>
                    <li class="pb4"><a href="https://www.natureindex.com/" data-track="click" data-track-action="nature index" data-track-label="link" class="text-gray-light">Nature Index</a></li>
                </ul>
            </div>

            <div class="grid grid-3 mq875-grid-4 mq640-grid-6 mq480-grid-12 just-mq640-last">
                <h3 class="text-footer-heading">Publish with us</h3>
                <ul class="clean-list ma0 mb6 text15">
                    <li class="pb4"><a href="https://www.nature.com/authors/author_resources/index.html" data-track="click" data-track-action="guide to authors" data-track-label="link" class="text-gray-light" >Guide to Authors</a></li>
                    <li class="pb4"><a href="https://www.nature.com/authors/peer_review/" data-track="click" data-track-action="guide to referees" data-track-label="link" class="text-gray-light">Guide to Referees</a></li>
                    <li class="pb4"><a href="https://www.nature.com/authors/editorial_policies/" data-track="click" data-track-action="editorial policies" data-track-label="link" class="text-gray-light">Editorial policies</a></li>
                    <li class="pb4"><a href="http://www.nature.com/openresearch/publishing-with-npg/" data-track="click" data-track-action="open access" data-track-label="link" class="text-gray-light">Open access</a></li>
                    <li class="pb4" ><a href="https://www.nature.com/reprints/" data-track="click" data-track-action="reprints and permissions" data-track-label="link" class="text-gray-light">Reprints &amp; permissions</a></li>
                </ul>
            </div>

            <div class="grid grid-3 mq875-grid-4 mq640-grid-6 mq480-grid-12 just-mq875-last">
                <h3 class="text-footer-heading">Researcher services</h3>
                <ul class="clean-list ma0 mb6 text15">
                    <li class="pb4"><a href="https://www.springernature.com/gp/authors/research-data" data-track="click" data-track-action="data research service" data-track-label="link" class="text-gray-light">Research data</a></li>
                    <li class="pb4"><a href="https://authorservices.springernature.com/go/nr" data-track="click" data-track-action="language editing" data-track-label="link" class="text-gray-light">Language editing</a></li>
                    <li class="pb4"><a href="https://authorservices.springernature.com/scientific-editing/" data-track="click" data-track-action="scientific editing" data-track-label="link" class="text-gray-light">Scientific editing</a></li>
                    <li class="pb4"><a href="https://masterclasses.nature.com/" data-track="click" data-track-action="nature masterclasses" data-track-label="link" class="text-gray-light">Nature Masterclasses</a></li>
                    <li class="pb4"><a href="https://partnerships.nature.com/product/nature-research-academies/" data-track="click" data-track-action="nature research academies" data-track-label="link" class="text-gray-light">Nature Research Academies</a></li>
                </ul>
            </div>

            <div class="grid grid-3 mq875-grid-4 mq640-grid-6 mq480-grid-12 just-mq875-clear just-mq640-last full-size-last just-mq1200-last just-mq875-last just-mq480-last">
                <h3 class="text-footer-heading">Libraries &amp; institutions</h3>
                <ul class="clean-list ma0 mb6 text15">
                    <li class="pb4"><a href="https://www.springernature.com/gp/librarians/tools-services" data-track="click" data-track-action="librarian service and tools" data-track-label="link" class="text-gray-light">Librarian service &amp; tools</a></li>
                    <li class="pb4"><a href="https://www.springernature.com/gp/librarians/manage-your-account/librarianportal" data-track="click" data-track-action="librarian portal" data-track-label="link" class="text-gray-light">Librarian portal</a></li>
                    <li class="pb4"><a href="http://www.nature.com/openresearch/about-open-access/information-for-institutions/" data-track="click" data-track-action="open research" data-track-label="link" class="text-gray-light">Open research</a></li>
                </ul>
            </div>
        </div>

        <div class="cleared z-index-1 pt30 pb20 border-top-1 border-gray text-footer-mobile-top hide-print u-hide-print">
            <div class="grid grid-3 mq875-grid-4 mq640-grid-6 mq480-grid-12">
                <h3 class="text-footer-heading">Advertising &amp; partnerships</h3>
                <ul class="clean-list ma0 mb6 text15">
                    <li class="pb4"><a href="https://partnerships.nature.com/" data-track="click" data-track-action="advertising" data-track-label="link" class="text-gray-light">Advertising</a></li>
                    <li class="pb4"><a href="https://partnerships.nature.com/home/services/" data-track="click" data-track-action="partnerships and services" data-track-label="link" class="text-gray-light">Partnerships &amp; Services</a></li>
                    <li class="pb4"><a href="https://partnerships.nature.com/home/resources/" data-track="click" data-track-action="media kits" data-track-label="link" class="text-gray-light">Media kits</a></li>
                    <li class="pb4"><a href="https://partnerships.nature.com/product/branded-content-native-advertising/" data-track-action="branded content" data-track-label="link" class="text-gray-light">Branded content</a></li>
                </ul>
            </div>

            <div class="grid grid-3 mq875-grid-4 mq640-grid-6 mq480-grid-12 just-mq640-last just-mq875-last">
                <h3 class="text-footer-heading">Career development</h3>
                <ul class="clean-list ma0 mb6 text15">
                    <li class="pb4"><a href="https://www.nature.com/naturecareers" data-track="click" data-track-action="nature careers" data-track-label="link" class="text-gray-light">Nature Careers</a></li>
                    <li class="pb4"><a href="https://www.nature.com/natureconferences/" data-track="click" data-track-action="nature conferences" data-track-label="link" class="text-gray-light">Nature<span class="visually-hidden"> </span> Conferences</a></li>
                    <li class="pb4"><a href="https://www.nature.com/natureevents/" data-track="click" data-track-action="nature events" data-track-label="link" class="text-gray-light">Nature<span class="visually-hidden"> </span> events</a></li>
                </ul>
            </div>

            <div class="grid grid-3 mq875-grid-4 mq640-grid-6 mq480-grid-12">
                <h3 class="text-footer-heading">Regional websites</h3>
                <ul class="clean-list ma0 mb6 text15">
                    <li class="pb4"><a href="http://www.naturechina.com" data-track="click" data-track-action="nature china" data-track-label="link" class="text-gray-light">Nature China</a></li>
                    <li class="pb4"><a href="https://www.nature.com/nindia" data-track="click" data-track-action="nature india" data-track-label="link" class="text-gray-light">Nature India</a></li>
                    <li class="pb4"><a href="https://www.natureasia.com/ja-jp/" data-track="click" data-track-action="nature japan" data-track-label="link" class="text-gray-light">Nature Japan</a></li>
                    <li class="pb4"><a href="https://www.natureasia.com/ko-kr/" data-track="click" data-track-action="nature korea" data-track-label="link" class="text-gray-light">Nature Korea</a></li>
                    <li class="pb4"><a href="https://www.nature.com/nmiddleeast/" data-track="click" data-track-action="nature middle east" data-track-label="link" class="text-gray-light">Nature Middle East</a></li>
                </ul>
            </div>
        </div>
    </div>

    <div class="container-footer-box cleared text14 border-gray-medium border-top-1">
        <div class="content">
            <img src="/static/images/sn-logo.4368f3b177.svg" alt="Springer Nature" loading="lazy" class="cleared"/>
            <p class="mb10 text-gray-light">© 2019 Springer Nature Limited</p>
            <ul class="ma0 clean-list grid grid-12 hide-print u-hide-print">
                <li class="grid grid-2 mq875-grid-4 mq640-grid-6 mq480-grid-12 mb10 just-mq480-last"><a href="https://www.nature.com/info/privacy.html" data-track="click" data-track-action="privacy policy" data-track-label="link" class="text-gray-light">Privacy Policy</a></li>
                <li class="grid grid-2 mq875-grid-4 mq640-grid-6 mq480-grid-12 mb10 just-mq640-last just-mq480-last"><a href="https://www.nature.com/info/cookies.html" data-track="click" data-track-action="use of cookies" data-track-label="link" class="text-gray-light">Use of cookies</a></li>
                <li class="grid grid-2 mq875-grid-4 mq640-grid-6 mq480-grid-12 mb10 just-mq875-last just-mq480-last"><a href="javascript:;" class="optanon-toggle-display text-gray-light" data-track="click" data-track-action="manage cookies" data-track-label="link">Manage cookies</a></li>
                <li class="grid grid-2 mq875-grid-4 mq640-grid-6 mq480-grid-12 mb10 just-mq640-last just-mq480-last"><a href="https://www.nature.com/info/legal_notice.html" data-track="click" data-track-action="legal notice" data-track-label="link" class="text-gray-light">Legal notice</a></li>
                <li class="grid grid-2 mq875-grid-4 mq640-grid-6 mq480-grid-12 mb10 just-mq480-last"><a href="https://www.nature.com/info/accessibility_statement.html" data-track="click" data-track-action="accessibility statement" data-track-label="link" class="text-gray-light">Accessibility statement</a></li>
                <li class="grid grid-2 mq875-grid-4 mq640-grid-6 mq480-grid-12 mb10 last"><a href="https://www.nature.com/info/tandc.html" data-track="click" data-track-action="terms and conditions" data-track-label="link" class="text-gray-light">Terms &amp; Conditions</a></li>
            </ul>
        </div>
    </div>


    </div>
</footer>




    
        
    






    
         
    



<script src="https://cdn.ravenjs.com/3.12.0/raven.min.js" crossorigin="anonymous"></script>
<script>
    if (Raven) {
        Raven.config('https://46e8b5cbb6a34c8ab1888c41c7f86c61@sentry.dc.springernature.pe/388').install();
    }
</script>


<noscript>
    <img hidden src="https://verify.nature.com/verify/nature.png" border="0" width="0" height="0" style="display: none">
</noscript>



<script src="//content.readcube.com/ping?doi=10.1038/s41467-019-09186-x&amp;format=js&amp;last_modified=2019-04-15" async></script>
<img src="/platform/track/article/s41467-019-09186-x" width="1" height="1" alt="" class="visually-hidden"/>
</body>
</html>
